HETEROCYCLIC COMPOUNDS AS PESTICIDES, AGROCHEMICAL FORMULATIONS, METHODS FOR CONTROLLING ANIMAL PESTS AND THEIR USES

Abstract

Compounds of formula (1), where X, R 1 , R 2 , R 3 , V yn have the meanings mentioned above, their use as acaricides and / or insecticides to control animal pests and methods and intermediaries for their preparation.

Description

HETEROCYCLIC DERIVATIVES AS PESTICIDES The present invention relates to heterocyclic derivatives of Formula (I), to their use as acaricides and / or insecticides to control animal pests, especially arthropods and in particular insects and arachnids, and to methods and intermediates for their preparation. Heterocyclic derivatives with insecticidal properties are described in the literature, for example in WO 2010 / 125985, WO 2012 / 074135, WO 2012 / 086848, WO 2013 / 018928, WO2013 / 180193, WO 2013 / 191113, WO 2014 / 142292, WO 2014 / 148451, WO 2015 / 000715, WO 2016 / 124563, WO 2016 / 124557, WO 2015 / 121136, WO 2015 / 133603, WO 2015 / 198859, WO 2015 / 002211, WO 2015 / 071180, WO 2015 / 091945, WO 2016 / 005263, WO 2016 / 039441, WO 2015 / 198817, WO 2016 / 041819, WO 2016 / 039441, WO2016 / 039444, WO2016 / 026848, WO2016 / 023954, WO2016 / 020286, WO 2016 / 046071, WO 2016 / 058928, WO 2016 / 059145, WO 2016 / 071214, WO 2016 / 091731, WO 2016 / 096584, WO 2016 / 107742, WO 2016 / 107831, WO 2016 / 113155, WO 2016 / 116338, WO 2016 / 121997, WO 2016 / 125621, WO 2016 / 125622, WO 2016 / 129684, WO 2016 / 142326, WO 2016 / 142327, WO 2016 / 169882, WO 2016 / 169886, WO 2018 / 130437 and WO 2018 / 130443. Modern plant protection products have to meet many requirements, for example with regard to the amount, duration and extent of their effect and their possible use. There are problems of toxicity, protection of beneficial insects and pollinators, environmental properties, application dose, the ability to combine with other substances or formulation auxiliaries as well as the effort required to synthesize an active ingredient, as well as resistance, just to name a few. parameters. For all these reasons, CLARKE MODET Y CIA (ARGENTINA) - 30540437455 Digitally signed by PORTALTRAM ITES - INPI Date: 2019.06.26 09:15:48 -03:00 Reason: Digitally Signed by INPI Location: Buenos Aires, Argentina It can be considered that the search for new pesticides is not easy and there is a constant need for new compounds with improved properties compared to known compounds, at least in terms of individual aspects of their properties. The object of the present invention comprises providing compounds capable of broadening the spectrum of pesticides in various aspects and / or of improving their activity. New heterocyclic derivatives have been found, which offer advantages with respect to the already known compounds, for example, better biological or ecological properties, broader application methods, better insecticidal and acaricidal activity, as well as good compatibility with the crops mentioned. Heterocyclic derivatives can be used in combination with other agents to improve their efficacy, particularly for difficult-to-control insects. Therefore, the object of the present invention comprises new compounds of Formula (I) ^r1(O^sf R2 N R—V (|) where (Embodiment 1-1) R1 is (C1-C6)alkyl, (C1-C6)cyanoalkyl, (C1-C6)hydroxyalkyl, (C1-C6)alkoxy-(C1-C6)alkyl, (C1-C6)haloalkyl, (C2-C6)alkenyl,(C C6)haloalkenyl, (C2-C6)alkynyl, (C2-C6)haloalkynyl or (C3-C8)cycloalkyl, R2is hydrogen, (C1-C6)alkyl, (C1-C6)haloalkyl,(C1C6)cyanoalkyl, (CrC6)hydroxyalkyl, (C1-C6)alkoxy-(CrC6)alkyl,(Ci2 C6)haloalkoxy-(C1-C6)alkyl, (C2-C6)alkenyl, (C2-C6)alkenyloxy-(C1-C6)alkyl, (C2-C6)haloalkenyloxy-(C1-C6)alkyl, (C2-C6 )haloalkenyl, (C2-C6)cyanoalkenyl, (C2-C6)alkynyl, (C2-C6)alkynyloxy-(C1-C6)alkyl, (C2C6)haloalkynyloxy-(C1-C6)alkyl, (C2-C6)haloalkynyl, (C2 -C6)cyanoalkynyl, (C3-C8)cycloalkyl, (C3-C8)cycloalkyl-(C3-C8)cycloalkyl, (C1-C6)alkyl-(C3-C8)cycloalkyl, halo(C3-C8)cycloalkyl, cyano(C3- C8)cycloalkyl, (C1-C6)alkylthio(Ci-Ce)alkyl, (Gi-C6)haloalkylthio-(Ci-Ce)alkyl, (Gi-Ce)alkylsulfinyl-(CiC6)alkyl, (Ci-C6)haloalkylsulfinyl- (Ci-C6)alkyl, (Ci-C6)alkylsulfonyl-(CiC6)alkyl, (Ci-C6)haloalkylsulfonyl-(Ci-C6)alkyl, (Ci-C6)alkylcarbonyl-(CiC6)alkyl, (Ci-C6) haloalkylcarbonyl-(Ci-C6)alkyl, (Ci-C6)alkoxycarbonyl-(CiC6)alkyl or (Ci-C6)haloalkoxycarbonyl-(Ci-C6)alkyl, R3 is mono- or polysubstituted aryl optionally with the same or different substituents or is a saturated, partially saturated or heteroaromatic ring optionally mono- or polysubstituted with the same or different substituents, in which at least one C atom is replaced by a heteroatom, where in each case optionally there may be at least one carbonyl group and / or where in each case the substituents may comprise: cyano, carboxyl, halogen, nitro, acetyl, hydroxy, amino, SCN, tri(Ci-C6)alkylsilyl, (Ci -C6)alkyl, (Ci-C6)haloalkyl, (Ci-C6)cyanoalkyl, (CiC8)hydroxyalkyl, hydroxycarbonyl-(Ci-C8)-alkoxy, (Ci-C6)alkoxycarbonyl-(CiC8)alkyl, (Ci-C6 )alkoxy-(Ci-C6)alkyl, (C2-C8)alkenyl, (C2-C8)haloalkenyl, (C2-C8)cyanoalkenyl, (C2-C8)alkynyl, (C2-C8)haloalkynyl, (C2-C8)cyanoalkynyl, (C3-C8)cycloalkyl, (C3-C6)cycloalkyl-(C3-C6)cycloalkyl, (CiC4)alkyl-(C3-C8)cycloalkyl(Ci-C8)alkoxy, (Ci-C8)haloalkoxy, (Ci-C8 )cyanoalkoxy, (Ci-C6)alkoxy rbonyl-(Ci-C6)alkoxy, (Ci-C6)alkoxy-(Ci-C6)alkoxy, (Ci3 C6)alkoxyimino, -N=C(H)-O(Ci-C6)alkyl, -C(H)=N-O(Ci-C6)alkyl, (C1C6)haloalkyl-(C1-C6)alkoxyimino, (C1-C6 )alkylthio, (Ci-C6)haloalkylthio, (C1-C6)alkoxy-(Ci-C6)alkylthio, (C1-C6)alkylthio-(C1-C6)alkyl, (C1-C6)alkylsulfinyl, (C1-C6)haloalkylsulfinyl, (C1-C6)alkoxy-(C1-C6)alkylsulfinyl, (C1-C6)alkylsulfinyl(C1-C6)alkyl, (C1-C6)alkylsulfonyl, (C1-C6)haloalkylsulfonyl, (C1-C6)alkoxy(C1- C6)alkylsulfonyl, (C1-C6)alkylsulfonyl-(C1-C6)alkyl, (C1-C6)alkylsulfonyloxy, (C1-C6)alkylcarbonyl, (C1-C6)haloalkylcarbonyl, (C1-C6)alkylcarbonyloxy, (C1-C6)alkoxycarbonyl, ( C1-C6)haloalkoxycarbonyl, aminocarbonyl, (C1-C6)alkylaminocarbonyl, di-(C1-C6)alkyl-aminocarbonyl, (C2-C6)alkenylaminocarbonyl, di-(C2-C6)-alkenylaminocarbonyl,(C C8)cycloalkylaminocarbonyl, (C1-C6)alkylsulfonylamino, (C1-C6)alkylamino, di(C1-C6)alkylamino, aminosulfonyl, (C1-C6)alkylaminosulfonyl, di-(C1-C6)alkylaminosulfonyl, (C1-C6)alkylsulfoximino, aminothiocarbonyl ,(C C6)alkylaminothiocarbonyl, di-(C1-C6)alkylaminothiocarbonyl,(C C8)cycloalkylamino, (C1-C6)alkylcarbonylamino, V is a (C3-C6)cycloalkyl or aryl in each case optionally monosubstituted or polysubstituted with the same or different substituents or is an optionally mono- or polysubstituted saturated, partially saturated or heteroaromatic ring with the same or different substituents, in which at least one C atom is replaced by a heteroatom, where in each case there may optionally be at least one carbonyl group and / or where in each case the substituents may comprise: cyano, carboxyl, halogen, nitro, acetyl, hydroxy, amino, SCN, tri-(C1-C8)alkylsilyl, (C1-C8)alkyl, (C1-C8)haloalkyl, (C1-C8)cyanoalkyl, (C1-C8)hydroxyalkyl, hydroxycarbonyl-(C1-C6)-alkoxy, (C1-C6) alkoxycarbonyl-(C1-C6)alkyl, (C1-C6)alkoxy-(C1-C6)alkyl, (C2-C6)alkenyl, (C2-C6)haloalkenyl, (C2-C6)cyanoalkenyl, (C2-C6)alkynyl , (C2-C6)haloalkynyl, (C2-C6)cyanoalkynyl, (C3-C6)cycloalkyl, (C3C6)cycloalkyl-(C3-C6)cycloalkyl, (C1-C4)alkyl-(C3-C6)cycloalkyl(C1- C6)alkoxy, (C1- C6)haloalkoxy, (C1-C6)cyanoalkoxy, (C1-C6)alkoxycarbonyl-(C1-C6)alkoxy, (CiC6)alkoxy-(Ci-C6)alkoxy, (Ci-C6)alkoxyimino, -N=C(H )-O(Ci-C6)alkyl, -C(H)=NO(Ci-C6)alkyl, (Ci-C6)haloalkyl-(Ci-C6)alkoxyimino, (Ci-C6)alkylthio, (CiC6)haloalkylthio, (Ci-C6)alkoxy-(Ci-C6)alkylthio, (Ci-C6)alkylthio-(Ci-C6)alkyl, (Ci-C6)alkylsulfinyl, (Ci-C6)haloalkylsulfinyl, (Ci-C6)alkoxy-( CiC6)alkylsulfinyl, (Ci-C6)alkylsulfinyl-(Ci-C6)alkyl, (Ci-C6)alkylsulfonyl, (CiC6)haloalkylsulfonyl, (Ci-C6)alkoxy-(Ci-C6)alkylsulfonyl, (Ci-C6)alkylsulfonyl (Ci-C6)alkyl, (Ci-C6)alkylsulfonyloxy, (Ci-C6)alkylcarbonyl, (CiC6)haloalkylcarbonyl, (Ci-C6)alkylcarbonyloxy, (Ci-C6)alkoxycarbonyl, (CiC6)haloalkoxycarbonyl, aminocarbonyl, (Ci- C6)alkylaminocarbonyl, di-(CiC6)alkyl-aminocarbonyl, (C2-C6)alkenylaminocarbonyl, di-(C2-C6)alkenylaminocarbonyl, (C3-C8)cycloalkylaminocarbonyl, (CiC6)alkylsulfonylamino, (Ci-C6)alkylamino, di- (Ci-C6)alkylamino, aminosulfonyl, (Ci-C6)alkylaminosu Phonyl, di-(Ci-C6)alkylaminosulfonyl, (CiC6)alkylsulfoximino, aminothiocarbonyl, (Ci-C6)alkylaminothiocarbonyl, di-(CiC6)alkylaminothiocarbonyl, (C3-C3)cycloalkylamino, (Ci-C6)alkylcarbonylamino, X is a 9-membered fused heteroaromatic bicyclic ring system selected from Qi through Q6, Q1 Q4 Q5 Q6 R4 is hydrogen, (C1-C6)alkyl, (C1-C6)haloalkyl,(C1-C6)cyanoalkyl, (C1-C6)hydroxyalkyl, (C1-C6)alkoxy-(C1-C6)alkyl,(C1-C6)haloalkoxy-(C1 -C6)alkyl, (C2-C6)alkenyl, (C2-C6)alkenyloxy-(C1-C6)alkyl, (C2-C6)haloalkenyloxy-(C1-C6)alkyl, (C2-C6)haloalkenyl,(C2C6) cyanoalkenyl, (C2-C6)alkynyl, (C2-C6)haloalkynyl or (C3-C8)cycloalkyl, R5, R6 are independently hydrogen, cyano, halogen, (C1-C6)alkyl, (C1-C6)haloalkyl, (C2-C6)alkenyl, (C2-C6)haloalkenyl, (C2-C6)alkynyl, ( C2-C6)haloalkynyl, (C3-C8)cycloalkyl, (C3-C8)cycloalkyl-(C3-C8)cycloalkyl, (C1-C6)alkyl-(C3-C8)cycloalkyl,(C1-C6)haloalkyl-(C3-C8)cycloalkyl , cyano-(C3-C8)cycloalkyl, halo-(C3-C8)cycloalkyl, (C1-C6)alkoxy, (C1-C6)haloalkoxy, (C1-C6)alkoxyimino, (C1-C6)haloalkoxyimino (C1-C6)alkylthio, ( C1-C6)haloalkylthio, (C1-C6)alkylsulfinyl, (C1-C6)haloalkylsulfinyl, (C1-C6)alkylsulfonyl, (C1-C6)haloalkylsulfonyl, (C1-C6)alkylsulfonyloxy, (C1-C6)haloalkylsulfonyloxy, (C1-C6) )alkylcarbonyl, (C1-C6)haloalkylcarbonyl, aminocarbonyl, (C1-C6)alkylaminocarbonyl, di-(C1-C6)alkyl-aminocarbonyl, (C1-C6)alkylsulfonylamino, (C1-C6)alkylamino, di-(C1-C6)alkylamino, aminosulfonyl, ( C1-C6)alkylaminosulfonyl or di-(C1-C6)alkylaminosulfonyl, is 0, 1 or 2. In addition, it has been found that the compounds of Formula (I) have a very good activity as pesticides, preferably as insecticides and / or acaricides, likewise, as a general rule, they are very well tolerated by plants, in particular by crop plants. . Compounds according to the invention are generally defined by Formula (I). The preferred substituents or ranges of the radicals listed in the Formulas mentioned above and hereinafter are described below: Embodiment 2-1 R1 preferably is (C1-C4)alkyl, (C1-C4)cyanoalkyl, (C1-C4)alkoxy-(C1-C4)alkyl, (C1-C4)haloalkyl, (C2-C4)alkenyl, (C2C4)haloalkenyl, (C2- C4)alkynyl, (C2-C4)haloalkynyl or (C3-C6)cycloalkyl, R2 is preferably hydrogen, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)cyanoalkyl, (C1-C4)hydroxyalkyl, (C1-C4)alkoxy-(C1-C4)alkyl, (C1-C4)haloalkoxy -(C1-C4)alkyl, (C3-C6)cycloalkyl, (C3-C6)cycloalkyl-(C3C6)cycloalkyl, (C1-C4)alkyl-(C3-C6)cycloalkyl, halo(C3-C6)cycloalkyl, cyano (C3-C6)cycloalkyl, (C1-C4)alkylthio-(C1-C4)alkyl, (C1-C4)haloalkylthio-(C1C4)alkyl, (C1-C4)alkylsulfinyl-(C1-C4)alkyl, (C1- C4)haloalkylsulfinyl-(C1C4)alkyl, (C1-C4)alkylsulfonyl-(C1-C4)alkyl or (C1-C4)haloalkylsulfonyl-(C1C4)alkyl, R3 preferably represents a mono or disubstituted aryl optionally with the same or different substituents or is an optionally mono or disubstituted saturated, partially saturated or heteroaromatic ring with the same or different substituents, in which at least one C atom is replaced by a heteroatom from the group of N, O or S, where in each case there may optionally be at least one carbonyl group and / or where in each case the substituents may comprise: cyano, halogen, nitro, acetyl, amino, (C1-C4)alkyl , (C1-C4)haloalkyl, (C1-C4)cyanoalkyl, (C1-C4)hydroxyalkyl, (C1-C4)alkoxy-(C1-C4)alkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C2-C4 )cyanoalkenyl, (C2-C4)alkynyl, (C2-C4)haloalkynyl, (C2-C4)cyanoalkynyl, (C3-C6)cycloalkyl, (C3-C6)cycloalkyl-(C3-C6)cycloalkyl, (C1-C4) alkyl-(C3-C6)cycloalkyl, (C1-C4)alkoxy, (C^haloalkoxy, (CiC4)cyanoalkoxy, (C1-C4)alkoxy-(C1-C4)alkoxy, (C1-C4)alkoxyimino, -N= C(H)-O(C1-C4)alkyl, -C(H)=N-O(C1-C4)al chyl, (C1-C4)haloalkyl-(C1-C4)alkoxyimino, (C1C4)alkylthio, (C^haloalkylthio, (C1-C4)alkylthio-(C1-C4)alkyl, (CiC4)alkylsulfinyl, (C1-C4) haloalkylsulfinyl, (C1-C4)alkylsulfinyl-(C1-C4)alkyl, (C1-C4)alkylsulfonyl, (C1-C4)haloalkylsulfonyl, (C1-C4)alkylsulfonyl-(C1-C4)alkyl, (C1-C4)alkylsulfonyloxy, ( C1-C4)alkylcarbonyl, (C1-C4)haloalkylcarbonyl, aminocarbonyl, (C1-C4)alkylaminocarbonyl, di-(C1C4)alkyl-aminocarbonyl, (C1-C4)alkylsulfonylamino, (C1-C4)alkylamino, di-(C1C4)alkylamino, aminosulfonyl, (C1-C4)alkylaminosulfonyl, di-(C1-C4)alkylaminosulfonyl, (C1-C4)alkylcarbonylamino, V preferably represents, in each case, a (C3-C6)cycloalkyl or aryl optionally monosubstituted or disubstituted by the same or different substituents or preferably is a saturated, partially saturated or heteroaromatic ring, optionally monosubstituted or disubstituted by the same or different substituents, in the in which at least one C atom is replaced by a heteroatom from the N, O or S group, where in each case there may optionally be at least one carbonyl group and / or where in each case the substituents may comprise: cyano , halogen, nitro, acetyl, amino, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)cyanoalkyl, (01C4)hydroxyalkyl, (C1-C4)alkoxy-(C1-C4)alkyl, ( C2-C4)alkenyl, (C2-C4)haloalkenyl, (C2-C4)cyanoalkenyl, (O2-O4)alkynyl, (C2-C4)haloalkynyl, (O2-O4)cyanoalkynyl, (C3-C6)cycloalkyl, (O3-C6 )cycloalkyl-(O3-C6)cycloalkyl, (O1-O4)alkyl-(O3-O6)cycloalkyl, (Ci-C^alkoxy, (C^haloalkoxy, (CiC4)cyanoalkoxy, (Ci-O4)alkoxy-(Oi -O4)alkoxy, (Oi-O4)alkoxyimino, -N=C(H)-O(C1C4)alkyl, -C(H)=N-O(Ci-C4)alkyl, (Ci-C^haloalkylHCi-C^alkoxyimino , (CiC4)alkylthio, (C1-C4)haloalkylthio, (C1-C4)alkylthio-(C1-C4)alkyl, (C1-C4)alkylsulfinyl, (O1-O4)haloalkylsulfinyl, (O1-O4)alkylsulfinyl-(O1-O4 )alkyl, (O1-O4)alkylsulfonyl, (O1-O4)haloalkylsulfonyl, (O1-C4)alkylsulfonyl-(O1C4)alkyl, (C1-O4)alkylsulfonyloxy, (Ci-C4)alkylcarbonyl, (CiC4)haloalkylcarbonyl, aminocarbonyl, (O1-C4)alkylaminocarbonyl, di-(01C4)alkyl-aminocarbonyl, (Ci-C4)alkylsulfonylamino, (Ci-C4)alkylamino, di-(CiC4)alkylamino, aminosulfonyl, (Ci-C4)alkylaminosulfonyl, di-(CiC4 )alkylaminosulfonyl, (Ci-C4)alkylcarbonylamino, X preferably represents a 9-membered fused heteroaromatic bicyclic ring system which is selected from Qi to Q6, R4 is preferably hydrogen, (Ci-C4)alkyl, (Ci-C4)haloalkyl, (O1-O4)cyanoalkyl, (C1-O4)alkoxy-(C1-O4)alkyl, (O1-O4)haloalkoxy-(O1C4)alkyl , (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C2-C4)alkynyl, (C2-C4)haloalkynyl or (C3-C6)cycloalkyl, R5, R6 are preferably independently hydrogen, cyano, halogen, (Ci-C4)alkyl, (Ci-C4)haloalkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C2-C4) alkynyl, (C2-C4)haloalkynyl, (C3-C6)cycloalkyl, (C3-C6)cycloalkyl-(C3-C6)cycloalkyl, (C1-C4)alkyl-(C3-C6)cycloalkyl, (C-iC4)haloalkyl -(C3-C6)cycloalkyl, cyano-(C3-C6)cycloalkyl, halo-(C3C6)cycloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkoxyimino, (C1C4)haloalkoxyimino, (C1-C4)alkylthio, (C1-C4)haloalkylthio, (C1-C4)alkylsulfinyl, (C1-C4)haloalkylsulfinyl, (C1-C4)alkylsulfonyl, (C1-C4)haloalkylsulfonyl, (C1-C4)alkylsulfonyloxy, (C1- C4)haloalkylsulfonyloxy, (C1-C4)alkylcarbonyl or (C1-C4)haloalkylcarbonyl, n is preferably 0, 1 or 2. Embodiment 3-1 R1 is particularly preferably (C1-C4)alkyl, (C1-C4)haloalkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl or (C3-C6)cycloalkyl, R2 is particularly preferably hydrogen, (C1-C4)alkyl, (C1-C4)haloalkyl, (C3-C6)cycloalkyl or halo(C3-C6)cycloalkyl, R3-V particularly preferably represent a 5- or 6-membered ring optionally mono or disubstituted with substituents that are the same or different, selected from U-1 to U-83, where in each case the substituents may comprise: cyano, halogen , (C1-C4)alkyl, (C1-C4)alkoxy or (C1-C4)haloalkoxy, / ----V v jOf ^s^ .----V V .----V V ^N7 u M__ V / —N V V V U-1 U-2 Π U-3 U-4 U-5 U-6 U-7 [T^ o' / -NV o N—Λ V X? V s' V O' V N' H λ-νΛ Η U-8 U-9 U-10 U-11 U-12 U-13 U-14 N-^V X? H N-N ^oYv N-N ΛΚ» o N-N H V 7 / ^ N N' H V 7 / ^ N O' V 7 / 7 N S' U-15 U-16 U-17 U-18 U-19 U-20 U-21 V Y-N N O' V^N V ^?V \__ V XNZ N N' H H H U-22 U-23 U-24 U-25 U-26 U-27 U-28 V ¥ s' s' Hv o' o' ft N H U -29 U-30 U-31 U-32 U-33 U-34 U-35 Nx J^V o ¥^v N Av S Vn / v Ni N 1 1 -V V Of N 1 Oiv N' 1 U-36 U-37 U-38 H U-39 U-40 U-41 U-42 ​​ / -NV fy N 1 N-N ςκ 1 N' 1 N' 1 V ÍT^ N, N N' I V N— / H \\ N N N' I N-N 11 w Nx JYV NX 1 U-43 U-44 U-45 U-46 1 U-47 1 U-48 U-49 V n-n' X Λ^ο NX u 1 H 1 νΛ LI N^ N^ N-O N-S U-50 U-51 Π U-52 U-53 U-54 U-55 U-56 0—N S-N H N-O H N-S / —ξ / N=\ 1 \ 7 Λ \xv / Λ ^v NK o - Vv or VvH or U-57 U-58 U-59 U-60 U-61 U-62 U-63 Η U-64 U-65 U-66 H U-69 U-70 U-71 U-72 U-73 U-74 U-75 U-76 U-77 U-78 U-79 U-80 U-81 U-82 U-83 where V particularly preferably represents a 3- to 6-membered ring optionally mono or disubstituted with substituents that are the same or different, selected from V-1 to V-105, where in each case the substituents may comprise: cyano, halogen, ( C1-C4)alkyl, (C1-C4)alkoxy or (C1-C4)haloalkoxy, V-1 V-2 V-3 V-4 V-5 V-6 V-7 V-8 V-9 V-10 V-11 V-12 V-13 V-14 V-15 V-16 V-17 V-18 V-19 V-20 V-21 V-22 V-23 V-24 V-25 V-26 V-27 V-28 Η Η H V-29 V-30 V-31 V-32 V-33 V-34 H V-36 V-37 V-38 V-39 V-40 V-41 V-35 V-42 V-43 V-44 V-45 V-46 V-47 V-48 V-49 V-50 V-51 V-52 V-53 V-54 V-55 V-56 Y-N H V-57 V-58 V-59 V-60 V-61 V-62 V-6313 Η Ν-Ο V-64 V-65 V-66 V-67 V-68 V-69 Ο Ο V-70 V-71 V-72 V-73 V-74 V-75 V-76 V-78 Ν-Ο Ο Ο Ο Ο V-77 V-79 V-82 Η V-84 Η Ν-Ο Ο V-80 V-81 Ο V-83 V-85 V-86 V-87 Η Ο II V-88 V-90 V-91 V-92 V-93 V-89 V-95 V-98 V-94 V-96 V-97 V-99 V-100 V-101 V-102 V-103 Ν^^Ν V-105 V-104 X is particularly preferably a 9-membered fused heteroaromatic bicyclic ring system selected from Q1, Q2 or Q3, R4 is particularly preferably hydrogen, (C1-C4)alkyl, (C1-C4)haloalkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C2-C4)alkynyl, (C2-C4)haloalkynyl, (C1- C4)alkoxy-(C1-C4)alkyl or (C3-C6)cycloalkyl, R5 is particularly preferably halogen, (C1-C4)alkyl, (C1-C4)haloalkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C2-C4)alkynyl, (C2-C4)haloalkynyl, (C3-C6) cycloalkyl, (C1-C4)haloalkyl-(C3-C6)cycloalkyl, cyano(C3-C6)cycloalkyl, halo-(C3-C6)cycloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1- C4)alkoxyimino, (C1-C4)haloalkoxyimino, (C1-C4)alkylthio, (C1-C4)haloalkylthio, (C1-C4)alkylsulfinyl, (C1-C4)haloalkylsulfinyl, (C1-C4)alkylsulfonyl, (C1-C4)haloalkylsulfonyl , (C1-C4)alkylsulfonyloxy, (C1-C4)haloalkylsulfonyloxy, (C1-C4)alkylcarbonyl or (C1-C4)haloalkylcarbonyl, R6 is particularly preferably hydrogen, cyano, halogen, (C1-C4)alkyl, (C1-C4)haloalkyl or (C3-C6)cycloalkyl, particularly preferably n is 0, 1 or 2. In a particularly preferred embodiment, in addition to V, R3 may optionally be mono- or di-substituted with the same or different substituents by cyano, halogen, (C1-C4)alkyl, (C1-C4)alkoxy or (C1-C4)haloalkoxy. Embodiment 4-1 R1 is particularly preferably methyl, ethyl, n-propyl, i-propyl, cyclopropyl, fluoromethyl, difluoromethyl, trifluoromethyl, fluoroethyl, difluoroethyl, trifluoroethyl, tetrafluoroethyl or pentafluoroethyl, R2 is most preferably hydrogen, methyl, ethyl, n-propyl, i-propyl, cyclopropyl, n-butyl, i-butyl, tert-butyl, cyclobutyl, fluoromethyl, difluoromethyl, trifluoromethyl, fluoroethyl, difluoroethyl, trifluoroethyl, tetrafluoroethyl or pentafluoroethyl, R3-V is particularly preferably an optionally monosubstituted 5- or 6-membered ring selected from U-1, U-2, U-3, U-4, U-5, U-6, U-7, U- 8, U-9, U-10, U-11, U-12, U-13, U-14, U-15, U-24, U-25, U-26, U27, U-28, U- 29, U-30, U-31, U-32, U-33, U-34, U-35, U-41, U-42, U-43, U-44, U45, U-46, U- 47, U-51, U-52, U-53, U-54, U-55, U-56, U-57, U-58, U-61, U-62, U68, U-69, U- 70, U-71, U-72, U-73, U-74, U-75, U-76, U-77, U-78 or U-79, where in each case the substituents may comprise: cyano, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, methoxy or trifluoromethoxy, where V very preferably represents a 3- to 6-membered ring, optionally monosubstituted or disubstituted, with the same or different substituents selected from cyano, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, i-propyl, n-butyl, i -butyl, tert-butyl, methoxy or trifluoromethoxy, selected from V-1, V-2, V-3, V-4, V-5, V-6, V-7, V-8, V-9, V -10, BL-11, BL-12, V-13, V-14, V-15, V-16, V-17, V-18, V-19, V-28, V-29, V-30, V-31, V-32,V- 33, V-34, V-35, V-36, V-37, V-38, V-39, V-45, V-46, V-47, V-48, V-49, V-50, V- 51, V-58, V-59, V-62, V-63, V-86, V-87, V-88, V-89, V-90, V-91, V-92, V-93,V- 94, V-95, V-96, V-97, V-98, V-99, V-100 or V-101, X is particularly preferably a heteroaromatic ring system selected from Q2 or Q3, R4 is particularly preferably methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, methoxymethyl or methoxyethyl, R5 is particularly preferably fluorine, chlorine, fluoromethyl, difluoromethyl, trifluoromethyl, fluoroethyl, difluoroethyl, trifluoroethyl, tetrafluoroethyl, pentafluoroethyl, trifluoromethoxy, difluorochloromethoxy, dichlorofluoromethoxy, trifluoromethylthio, trifluoromethylsulfonyl or trifluoromethylsulfinyl, R6 is most preferably hydrogen, cyano, methyl, trifluoromethyl, fluorine or chlorine, n is particularly preferably 0, 1 or 2. A particularly preferred embodiment, R3, in addition to V, may optionally be monosubstituted with substituents selected from cyano, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, tert. -butyl, methoxy or trifluoromethoxy. Embodiment 5-1 R1 is preferably ethyl, R2 is preferably methyl, R3-V are preferably a ring preferably monosubstituted with bromine which is selected from U-1, U-13, U-28, U-42, U-57 or U-70, where V is preferably a ring optionally monosubstituted with a cyano or chlorine substituent selected from V-1, V-92, V-93 or V-94, X is preferably a heteroaromatic ring system selected from Q2, R4 is preferably methyl, R5 is preferably trifluoromethyl or pentafluoroethyl, R6 is preferably hydrogen, n is preferably 2. In preferred embodiment 5-2, R3, in addition to V, is preferably substituted with bromine. Embodiment 5-2 R1 preferably is ethyl, R2 is preferably methyl, R3-V are preferably a ring preferably monosubstituted with cyano or bromine that is selected from U-1, U-13, U-28, U-41, U-42, U-57, U-70, U-71 or U -72, where V is preferably a ring optionally monosubstituted with a cyano, fluorine or chlorine substituent selected from V-1, V-5, V-87, V-92, V-93 or V-94, X is preferably a heteroaromatic ring system selected from Q2, R4 is preferably methyl, R5 is preferably trifluoromethyl or pentafluoroethyl, R6 is preferably hydrogen, n is preferably 2. In preferred embodiment 5-2, R3, in addition to V, is preferably substituted with cyano or bromine. Substitution on rings U-1 to U-83 as well as V-1 to V-105 may comprise substitution of hydrogen on the C atom and / or on the N atom. In a preferred embodiment, the invention relates to compounds of Formula (I), and R1, R2, R3, V and n are as defined in embodiment (11) or embodiment (2-1) or embodiment (3-1) or embodiment (4-1 ) or embodiment (5-1) or embodiment (5-2). In a preferred embodiment, the invention relates to compounds of Formula (I), and R1, R2, R3, V and n are as defined in embodiment (11) or embodiment (2-1) or embodiment (3-1) or embodiment (4-1 ) or embodiment (5-1) or embodiment (5-2). In a preferred embodiment, the invention relates to compounds of Formula (I), where X is Q1 and R1, R2, R3, R4, R5, R6, V and n are as defined in embodiment ( 2-1) or embodiment (3-1) or embodiment (4-1) or embodiment (5-1) or embodiment (5-2). In a preferred embodiment, the invention relates to compounds of Formula (I), where X is Q2 and R1, R2, R3, R4, R5, R6, V and n are as defined in embodiment ( 2-1) or embodiment (3-1) or embodiment (4-1) or embodiment (5-1) or embodiment (5-2). In a preferred embodiment, the invention relates to compounds of Formula (I), where X is Q3 and R1, R2, R3, R5, R6, V and n are as defined in embodiment (2- 1) or embodiment (31) or embodiment (4-1) or embodiment (5-1) or embodiment (5-2). In a preferred embodiment, the invention relates to compounds of Formula (I), where X is Q4 and R1, R2, R3, R5, R6, V and n are as defined in embodiment (2- 1) or embodiment (31) or embodiment (4-1) or embodiment (5-1) or embodiment (5-2). In a preferred embodiment, the invention relates to compounds of Formula (I), where X is Q5 and R1, R2, R3, R5, R6, V and n are as defined in embodiment (2- 1) or embodiment (31) or embodiment (4-1) or embodiment (5-1) or embodiment (5-2). In a preferred embodiment, the invention relates to compounds of Formula (I), where X is Q6 and R1, R2, R3, R5, R6, V and n are as defined in embodiment (2- 1) or embodiment (31) or embodiment (4-1) or embodiment (5-1) or embodiment (5-2). Unless otherwise indicated, in the general or preferred ranges of the definitions, the halogen is selected from the group comprising fluorine, chlorine, bromine and iodine, preferably it is selected from fluorine, chlorine and bromine. Aryl is selected (also as part of a larger radical such as arylalkyl), unless otherwise defined elsewhere, from the group consisting of phenyl, naphthyl, anthryl, phenanthrenyl, and again preferably is phenyl. . Unless otherwise defined elsewhere, the term "alkyl", either alone or in combination with other groups, such as haloalkyl, in the context of the present invention represents a radical of an aliphatic hydrocarbon group of 1 to 12 carbon atoms, straight or branched chain. Examples of C1-C12-alkyl radicals include methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, 1-methylbutyl, 2-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, and ndodecyl. Among these alkyl radicals, C1-C6-alkyl radicals are particularly preferred. More particularly preferred are C1C4-alkyl radicals. Unless otherwise defined elsewhere, the term "alkenyl", either alone or in combination with other groups, comprises according to the invention a linear or branched C2-C12-alkenyl radical, comprising at least a double bond, eg vinyl, allyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1,3-butadienyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1 ,3-pentadienyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, and 1,4-hexadienyl. Among these radicals, the C2-C6-alkenyl radicals are particularly preferred and the C2-C4-alkenyl radicals are even more preferred. Unless otherwise defined elsewhere, the term "alkynyl", either alone or in combination with other groups, comprises according to the invention a linear or branched C2-C12-alkynyl radical, comprising at least a triple bond, eg, ethynyl, 1-propynyl, and propargyl. Among these radicals, the C3-C6-alkynyl radicals are particularly preferred and the C3-C4-alkynyl radicals are still more preferred. The alkyl radical can also comprise at least one double bond. Unless otherwise defined elsewhere, the term "cycloalkyl", either alone or in combination with other groups, according to the invention comprises a C3-C8-cycloalkyl radical, e.g. cyclopropyl, cyclobutyl, cyclopentyl , cyclohexyl, cycloheptyl and cyclooctyl. More preferred radicals comprise C3-C6-cycloalkyl radicals. The term "alkoxy", either alone or in combination with other groups, such as haloalkoxy, means herein an O-alkyl radical, where the term "alkyl" has the meaning defined above. Halogen-substituted radicals, for example haloalkyl (=haloalkyl), are monosubstituted or polysubstituted with the maximum possible number of halogenated substituents. In the case of multiple halogenation, the halogen atoms can be the same or different. In this case halogen refers to fluorine, chlorine, bromine or iodine, in particular fluorine, chlorine or bromine. Unless otherwise specified, optionally substituted radicals may be monosubstituted or polysubstituted, where multiple substituents may be the same or different. The definitions or descriptions of the general or preferred radicals indicated above apply correspondingly to the final products as well as to the starting materials and intermediates. These radical definitions can be combined with one another as desired, ie also between the respective preferred ranges. According to the invention, it is preferred to use the compounds of Formula (I) which comprise a combination of the definitions listed above as being preferred. According to the invention, it is particularly preferred to use the compounds of Formula (I) which comprise a combination of the definitions listed above as being particularly preferred. According to the invention, it is more particularly preferred to use the compounds of Formula (I) which comprise a combination of the definitions listed above as being more particularly preferred. According to the invention, it is particularly preferred to use the compounds of the formula (I) which comprise a combination of the definitions listed above as particularly preferred. The compounds of Formula (I) may be present, depending on the nature of the substituents, as geometric isomers and / or as optically active isomers or as mixtures of the corresponding isomers in different compositions. These stereoisomers comprise, for example, enantiomers, diastereomers, atropisomers, or geometric isomers. Therefore, the invention includes both the pure stereoisomers and any mixture thereof. Compounds of Formula (I) according to the invention can be obtained by the methods illustrated in the following Schemes: Method A α-« μ-ι» η The radicals R1, R2, R3, R5, R6 and V have the meanings described above. A1 is N or CH and A2 is -N-R4, O or S, where R4 has the meaning described above. X1 and X2 are halogen. R7is (C-r C4)alkyl. Step a) Compounds of Formula (III) can be prepared from the imidazole derivatives of Formula (II), for example by reaction with a halogenating reagent such as A / -bromosuccinimide (NBS) in a solvent such as tetrahydrofuran or by reaction of the compounds of Formula (II) with NBS in combination with azobis(isobutyronitrile) (AIBN) in tetrachloromethane or chloroform, for example analogously to the methods described in WO2013 / 149997, WO2014 / 115077 or WO2011 / 123609. Imidazole derivatives of Formula (II) are commercially available or can be prepared by known methods, for example analogously to the methods described in WO2014 / 191894, US2003 / 229079 or WO2013 / 156608. Step b) Compounds of Formula (III), in which X1 is preferably a halogen selected from chlorine or bromine, can be converted to compounds of Formula (IV), for example by transition metal-mediated cross-coupling [see, Chem. Rev. 1995, 95, 2457-2483; Tetrahedron 2002, 58, 9633-9695; Metal-Catalyzed Cross-Coupling Reactions (Editors: A. de Meijere, F. Diederich), 2nd edition, Wiley-VCH, Weinheim, 2004] or by nucleophilic aromatic substitution (see methods described in Bioorganic and Medicinal Chemistry Letters, 2007, 17, 5825-5830 or US Patent No: US4125726). For example, compounds of Formula (III), in which X1 is preferably chlorine or bromine, can be reacted with [V-R3-B(OH)2] boronic acids or suitable boronic esters by known methods (see, WO2012 / 143599, US2014 / 094474, US2014 / 243316, US2015 / 284358 or Journal of Organic Chemistry, 2004, 69, 8829-8835) in the presence of suitable catalysts which are selected from transition metal salts to give the compounds of Formula (IV). Examples of suitable cross-coupling catalysts are palladium catalysts such as [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(triphenylphosphine)palladium(II) dichloride, or tetrakis(triphenylphosphine)palladium. For the methods, sodium, potassium or cesium carbonates are preferably used as suitable basic reaction auxiliaries. Suitable boronic acid derivatives [V-R3-B(OH)2] or boronic ester derivatives are known and / or commercially available or can be prepared by generally known methods (see, Boronic Acids (Eds.: D. G. Hall), 2nd edition, Wiley-VCH, Weinheim, 2011). The reaction is preferably carried out in a mixture of water and an organic solvent, which is selected from conventional solvents which are inert under the prevailing reaction conditions. Ethers such as tetrahydrofuran, dioxane or 1,2-dimethoxyethane are often used. Alternatively, stannane derivatives [VR3-Sn(n-bu)3] can also be used as a coupling member (see, US2013 / 281433, WO2004 / 099177 or WO2016 / 071214). Suitable stannane derivatives [V-R3-Sn(nbu)3] are well known and / or are commercially available or can be prepared by known methods (see WO2016 / 071214 or WO2007 / 148093). The coupling of the halogenated imidazole derivatives of the Formula (III) with NH-containing heteroaromatics, such as the optionally substituted imidazoles or pyrazoles described above, with the compounds of the formula (IV) can be carried out by reaction in a base ( eg with sodium hydride in dimethylformamide, see eg WO2005 / 058898). Alternatively, the reaction can be carried out under an inert gas atmosphere by catalysis with copper(I) salts, such as copper(I) iodide, in the presence of a suitable ligand, such as trans -N ,N'-dimethylcyclohexane-1,2-diamine or R-(+)-proline, and a suitable base, for example potassium carbonate or potassium phosphate, in a suitable solvent, such as, for example, 1,4 -dioxane or toluene (see for example WO2016 / 109559). Step c) Imidazole derivatives of Formula (V), in which X2 is preferably a halogen selected from bromine or iodine, can be prepared by standard methods from compounds of Formula (IV) by reaction, for example, with bromine or N-bromosuccinimide (NBS), (see, WO2009 / 115572 or WO2010 / 091411) or N-iodosuccinimide (NIS), if necessary, in the presence of acetic acid or trifluoroacetic acid (see, WO2008 / 063287, WO2007 / 087548 or WO2009 / 152025). Step d) Compounds of Formula (V), in which X2 is preferably a halogen selected from bromine or iodine, can be converted to compounds of Formula (VI) for example under basic conditions by reaction with mercaptan derivatives (R1-SH ) and copper-(I) salts (see, EP257918 or WO2009 / 152025) or by nucleophilic aromatic substitution (see, Australian Journal of Chemistry 1987, 40, 1415-1425). As an alternative, the reaction of the compounds of Formula (V) in which X2 is preferably a halogen selected from bromine or iodine, is carried out with mercaptan derivatives (R1-SH) in the presence of palladium catalysts such as tris( dibenzylideneacetone)dipalladium [Pd2(dba)3]. Amine bases, for example triethylamine or N,N-diisopropylethylamine (DIPEA), as well as phosphine ligands, for example Xantphos (see WO2013 / 025958, WO2013 / 066869, US2009 / 027039, WO2011 / 058149, WO2011 / 143466 or Bioorganic and Medicinal Chemistry Letters, 2016, 26, 2984-2987). The reaction is preferably carried out in a solvent which is selected from conventional solvents which are inert under the prevailing reaction conditions. Preferably, ethers such as tetrahydrofuran, dioxane or 1,2-dimethoxyethane are used. Mercaptan derivatives such as methyl mercaptan, ethyl mercaptan or isopropyl mercaptan are commercially available or can be prepared by known methods, for example analogous to those described in US2006 / 025633, US2006 / 111591, US2820062, Chemical Communications 2000, 13, 1163-1164 or Journal of the American Chemical Society 1922, 44, 1323-1333. Step e) The esters of Formula (VI) can be converted to the carboxylic acids of Formula (VII) using standard methods (see for example WO2014 / 191894, US2006 / 194779, WO2014 / 086663 or European Journal of Organic Chemistry, 2009, 213-222) in a carboxylic acid of Formula (VII), for example with an alkali hydroxide base such as sodium hydroxide or lithium hydroxide in an alcohol solvent such as methanol or ethanol. Step f) Compounds of Formula (I, n=0) can be prepared from compounds of Formula (VII) with compounds of Formula (VIII) in the presence of a condensing agent. Compounds of Formula (VIII) are commercially available or can be prepared by known methods, for example, by methods analogous to those described in WO 2010 / 125985, WO 2012 / 074135, WO 2012 / 086848, WO 2013 / 018928, WO 2015 / 000715, WO 2015 / 121136, WO2016 / 039441, WO2016 / 059145, WO2016 / 071214, WO 2016 / 169882, WO 2016 / 169886 or WO2016 / 124557. The reaction to obtain the compounds of Formula (I, n = 0) can be carried out in a substance or in a solvent, preferably the reaction is carried out in a solvent that is selected from conventional solvents that are inert in the prevailing reaction conditions. Ethers are preferred, eg diisopropyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, tert-butyl methyl ether; halogenated hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, or chlorobenzene; alcohols such as methanol, ethanol or isopropanol; nitriles, such as acetonitrile or propionitrile; aromatic hydrocarbons such as toluene or xylene; aprotic polar solvents such as N,N-dimethylformamide or N-methylpyrrolidone or nitrogen-containing compounds such as pyridine. Examples of suitable condensing agents are carbodiimides such as 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) or 1,3-dicyclohexylcarbodiimide; anhydrides such as acetic anhydride, trifluoroacetic anhydride; a mixture of triphenylphosphine, a base and carbon tetrachloride or a mixture of triphenylphosphine and an azo diester such as, for example, diethylazodicarboxylic acid. The reaction can be carried out in the presence of a suitable catalyst, such as 1-hydroxybenzotriazole. The reaction can be carried out in the presence of an acid or a base. Examples of acids that can be used in the described reaction are sulfonic acids such as methanesulfonic acid or paratoluenesulfonic acid; carboxylic acids such as acetic acid or polyphosphoric acids. Examples of suitable bases are nitrogen-containing heterocycles such as pyridine, picoline, 2,6-lutidine, 1,8-diazabicyclo[5.4.0]-7undecene (DBU); tertiary amines such as triethylamine and N,N-diisopropylethylamine; inorganic bases such as potassium phosphate, potassium carbonate and sodium hydride. Step g) Compounds of Formula (I, n = 1 or 2) can be prepared by oxidation of compounds of Formula (I, n = 0), by methods analogous to those described in WO 2016 / 169882 or WO 2016 / 124557. The oxidation is usually carried out in a solvent. Halogenated hydrocarbons are preferred, such as, for example, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane or chlorobenzene; alcohols such as methanol or ethanol; formic acid, acetic acid, propionic acid or water. Examples of suitable oxidizing agents include hydrogen peroxide and meta-chloroperbenzoic acid. Method B The radicals R1, R2, R3, R5, R6 and V have the meanings described above. A1 is N or CH and A2 is -N-R4, O or S, where R4 has the meaning described above. X1 is halogen. R7 is (CrC4)alkyl. Step a) Compounds of Formula (III) can be prepared from the imidazole derivatives of Formula (II), for example by reaction with a halogenating reagent such as AZ-bromosuccinimide (NBS) in a solvent such as tetrahydrofuran or by reaction of the compounds of the formula (II) with NBS in combination with azobis(isobutyronitrile) (AIBN) in tetrachloromethane or chloroform, for example analogously to the methods described in WO2013 / 149997, WO2014 / 115077 or WO2011 / 123609. The imidazole derivatives of Formula (II) are commercially available or can be prepared by known methods, for example analogously to the methods described in WO2014 / 191894, US2003 / 229079 or WO2013 / 156608. Step b) Imidazole derivatives of Formula (IX) can be prepared using standard methods with compounds of Formula (III) by reaction with a disulfide (R1-S-S-R1) and, for example, a strong base, preferably lithium diisopropylamide (LDA) in tetrahydrofuran (see, Bioorganic and Medicinal Chemistry Letter, 2010, 20, 1084-1089) or, for example, hydrogen peroxide and iodine in ethanol (see, Síntesis, 2015, 47, 659-671). Step c) The reaction of the compounds of the Formula (IX) to obtain the compounds of the Formula (X) is carried out analogously to Method A, Step e). Step d) The reaction of the compounds of the Formula (X) with the compounds of the Formula (VIII) to obtain the compounds of the Formula (XI, n = 0) is carried out analogously to Method A, Step f). Steps e,h) The reaction of (XI, n = 0) to give compounds of Formula (XI, n = 1 or 2) and the reaction of compounds of Formula (I, n = 0) to give compounds of Formula ( I, n = 1 or 2) is carried out analogously to Method A, Step g). Steps f,g) The reaction of the compounds of the Formula (XI, n = 0) to obtain the compounds of the Formula (I, n = 0) and the reaction of the compounds of the Formula (XI, n = 1 or 2) to obtain the compounds of Formula (I, n = 1 or 2) is performed analogously to Method A, Step b). The radicals R1, R2, R3, R5, R6 and V have the meanings described above. A1 is N or CH and A2 is -N-R4, O or S, where R4 has the meaning described above. X1 or X2 is halogen. n is 0.1 or 2. Step a) The preparation of compounds of Formula (XII) in which R3X2 is a ring, N-bonded to the rest of the molecule, which can be selected, for example, from compounds of Formula (XI), in which X1 is preferably a halogen that is selected from chlorine or bromine, by methods known in the literature (see, for example, Journal of Organic Chemistry, 2010, 69, 5578-5587) for example in the presence of copper (I) iodide and auxiliaries of basics, such as, for example, trans-N,N'-dimethylcyclohexane-1,2-diamine and potassium carbonate, in a suitable solvent or diluent. Suitable solvents or diluents are all inert organic solvents, for example aliphatic or aromatic hydrocarbons. Preferably, toluene is used. Furthermore, the coupling of compounds of Formula (XI), for which X1 is preferably a halogen selected from the group of fluorine, chlorine or bromine, without metal catalysis in the presence of a suitable base such as potassium carbonate or carbonate cesium in a suitable solvent or diluent. Suitable solvents or diluents are all inert organic solvents, for example aliphatic or aromatic hydrocarbons. In this case, acetonitrile or dimethylformamide is preferably used. Compounds of the Formula H-R3-X2 are commercially available or can be prepared by known methods. Compounds of Formula (XII) in which R3-X2 is a ring attached to the moiety of the C molecule of the ring can be selected, for example, from compounds of Formula (XI) in which X 1 preferably is a halogen selected from the group of chlorine or bromine, by generally known methods (see, Chem. Rev., 1995, 95, 2457-2483; Tetrahedron, 2002, 58, 9633-9695; Metal-Catalyzed Cross-Coupling Reactions (Eds.: A. de Meijere, F. Diederich), 2nd edition, Wiley-VCH, Weinheim, 2004). For example, compounds of Formula (XI) in which X1 is preferably chlorine or bromine, can be reacted with suitable arylboronic acids or their esters by known methods (see WO2010071819) in the presence of suitable catalysts selected from salts of transition metals to obtain the compounds of Formula (XII). Examples of suitable coupling catalysts are palladium catalysts such as [1,1' bis(diphenylphosphino)ferrocene]dichloropalladium(II) or tetrakis(triphenylphosphine)palladium. For the methods, sodium or potassium carbonates are preferably used as suitable basic reaction auxiliaries. Suitable (hetero)arylboronic acids or (hetero)-arylboronic esters are, in some cases, known and / or commercially available or can be prepared by generally known methods (see, Boronic Acids (Eds.: D. G. Hall)). , 2nd edition, Wiley-VCH, Weinheim, 2011). Step b) The preparation of the compounds of Formula (I) in which R3-V is a radical that is N-bonded to the rest of the molecule, can be selected, for example, from the compounds of Formula (XII) in which X2 is preferably a halogen that is selected from chlorine or bromine, by methods known in the literature (see, for example, Journal of Organic Chemistry, 2010, 69, 5578-5587) for example in the presence of copper (I) iodide and basic reaction aids such as trans-N,N'-dimethylcyclohexane-1,2-diamine and potassium carbonate, in a suitable solvent or diluent. Suitable solvents or diluents are all inert organic solvents, for example aliphatic or aromatic hydrocarbons. Preferably, toluene is used. Furthermore, the coupling of compounds of Formula (XII), for which X2 is preferably a halogen selected from the group of fluorine, chlorine or bromine, without metal catalysis in the presence of a suitable base such as potassium carbonate or cesium carbonate in a suitable solvent or diluent. Suitable solvents or diluents are all inert organic solvents, for example aliphatic or aromatic hydrocarbons. In this case, acetonitrile or dimethylformamide is preferably used. Compounds of Formula H-V are commercially available or can be prepared by known methods. Compounds of Formula (I) in which R3-V is a bicyclic radical attached to the radical of the bicyclic molecule C can be selected, for example, from compounds of Formula (XII) in which X2 is preferably a halogen which is selected from chlorine or bromine, by generally known methods (see, Chem. Rev., 1995, 95, 2457-2483; Tetrahedron, 2002, 58, 9633-9695; Metal-Catalyzed Cross-Coupling Reactions (Eds.: A. de Meijere, F. Diederich), 2nd edition, Wiley-VCH, Weinheim, 2004). For example, compounds of Formula (XII) in which X2 is preferably chlorine or bromine, can be reacted with suitable arylboronic acids or their esters by known methods (see, WO2010 / 071819) in the presence of suitable catalysts which are selected between transition metal salts to obtain the compounds of Formula (I). Examples of suitable coupling catalysts are palladium catalysts such as [1,1'bis(diphenylphosphino)ferrocene]dichloropalladium(II) or tetrakis(triphenylphosphino)palladium. For the methods, sodium or potassium carbonates are preferably used as suitable basic reaction auxiliaries. Suitable (hetero)arylboronic acids or (hetero)-arylboronic esters are, in some cases, known and / or commercially available or can be prepared by generally known methods (see, Boronic Acids (Eds.: D. G. Hall)). , 2nd edition, Wiley-VCH, Weinheim, 2011). Method D (where R3-V is U-57) a) b) (XI) (XIII) (I) The radicals R1, R2, R3, R5, R6 and V have the meanings described above. A1 is N or CH and A2 is -N-R4, O or S, where R4 has the meaning described above. X1 is halogen. n is 0.1 or 2. Step a) The reaction of the compounds of the Formula (XI) to obtain the compounds of the Formula (XIII) is carried out analogously to Method A, Step b). Step b) Compounds of Formula (I) can be prepared from vinyl derivatives of Formula (XIII), for example, by reaction with a halogenation reagent such as, for example, N-chlorosuccinimide (NCS) in a solvent such as example trichloromethane, for example analogously to the method described in WO2009 / 067613 or Bulletin Chemical Society Japan, 1984, 57, 2184-2187. Aldoximes of Formula (XIV) are commercially available or can be prepared by known methods, eg analogously to the methods described in US2007 / 037816. Methods and uses The invention also relates to methods for controlling animal pests, in which the compounds of Formula (I) can act on animal pests and / or on their habitat. Preference is given to the control of animal pests in agriculture and forestry and in the protection of materials. Therefore, methods for surgical or therapeutic treatment of the human or animal body and diagnostic methods that are performed on the human or animal body are excluded. The invention further relates to the use of the compounds of Formula (I) as phytosanitary agents, in particular pesticides. In the context of this application, the term phytosanitary control always includes the term pesticide. The compounds of Formula (I) are suitable for the protection of plants, with acceptable toxicity for warm-blooded animals and good compatibility with the environment, for the protection of plants and plant organs against biotic and abiotic stress factors, to increase crop yields, improve crop quality and control animal pests, in particular insects, arachnids, helminths, in particular nematodes and molluscs found in agriculture, horticulture, livestock, aquaculture, forests, gardens and recreational facilities, in the protection of supplies and materials and in the hygiene sector. In the context of this patent application, the term "hygiene" will be interpreted in the sense of measures, standards and procedures whose purpose is to prevent diseases, in particular infectious diseases, and which serve to protect human health. and to protect animals and / or protect the environment, and / or to maintain cleanliness. According to the invention, this particularly includes measures to clean, disinfect and sterilize, for example, textiles or hard surfaces, in particular glass, wood, cement, porcelain, ceramic, plastic or metal surfaces to ensure that they are free from pests, and / or their excretions that could affect hygiene. Surgical or therapeutic treatment regimens that could be applied to the human or animal body and diagnostic arrangements made on the human or animal body are preferably excluded from the scope of the invention in this regard. The term hygiene sector covers all areas, technical fields and industrial applications in which these hygiene measures, regulations and procedures could be important, for example, with regard to hygiene in kitchens, bakeries, airports, bathrooms , swimming pools, department stores, hotels, hospitals, stables, livestock etc. Therefore, the term detrimental to hygiene will be interpreted as referring to one or more animal pests whose presence in the hygiene sector is problematic, in particular for health reasons. Therefore, it is an important objective to avoid or minimize the presence of hygiene pests and / or exposure to them in the healthcare sector. This can be achieved, in particular, by the use of a pesticide that can be used both to prevent an infestation and to control an existing infestation. It is also possible to use preparations that prevent or reduce exposure to pests. Hygiene pests include, for example, the organisms mentioned below. The term “hygiene protection” thus encompasses all activities that enable hygiene measures, standards and procedures to be maintained and / or improved. The compounds of Formula (I) can preferably be used as pesticides. They are active against normally sensitive and resistant species, as well as against all or some stages of their development. The pests mentioned above belong to: Parasites from the group Arthropoda, in particular from the class of arachnids such as, for example, Acarus spp, for example Acarus siro, Aceria kuko, Aceria sheldoni, Aculops spp., Aculus spp, for example Aculus fockeui, Aculus schlechtendali, Amblyomma spp , Amphitetranychus viennensis, Argas spp, Boophilus spp, Brevipalpus spp, for example Brevipalpus phoenicis, Bryobia graminum, Bryobia praetiosa, Centruroides spp, Chorioptes spp, Dermanyssus gallinae, Dermatophagoides pteronyssinus, Dermatophagoides farinae, Dermacentor spp, Eotetranychus hicootrany spp, for example Epitrimerus pyri, Eutetranychus spp, for example Eutetranychus banksi, Eriophyes spp, for example Eriophyes pyri, Glycyphagus domesticus, Halotydeus destructor, Hemitarsonemus spp, for example Hemitarsonemus latus (= Polyphagotarsonemus latus), Hyalomma spp, Ixodes spp, Latrodectus spp, Loxosceles spp, Neutrombicula autumnalis, Nuphersa spp, Oligonychus spp, for example Oligonychus coffeae, Oligonychus conif erarum, Oligonychus ilicis, Oligonychus indicus, Oligonychus mangiferus, Oligonychus pratensis, Oligonychus punicae, Oligonychus yothersi, Ornithodorus spp, Ornithonyssus spp, Panonychus spp, e.g. Panonychus citri (= Metatetranychus citri), Panonychus ulmi (= Metatetranychus ulmita), Phyllocop Platytetranychus multidigituli, Polyphagotarsonemus latus, Psoroptes spp, Rhipicephalus spp, Rhizoglyphus spp, Sarcoptes spp, Scorpio maurus, Steneotarsonemus spp, Steneotarsonemus spinki, Tarsonemus spp, eg Tarsonemus confusus, Tarsonemus pallidus, Tetranychus spp, eg Tetranychus canadensis, Tetranychus canadensis, Tetranychus canadensis, turkestani, Tetranychus urticae, Trombicula alfreddugesi, Vaejovis spp, Vasates lycopersici; from the class Chilopoda, for example Geophilus spp, Scutigera spp; from the order or class of Collembola, for example, Onychiurus armatus; Sminthurus viridis; from the class Diplopoda, for example Blaniulus guttulatus; from the class Insecta, for example from the order of the Blattodea, for example Blatta orientalis, Blattella asahinai, Blattella germanica, Leucophaea Maderae, Loboptera decipiens, Neostilopyga rhombifolia, Panchloroa spp, Parcoblatta spp, Periplaneta spp, for example Periplaneta americana, Periplaneta australasiae, Pycnoscelus surinamensis, Supella longipalpa; from the order Coleoptera, for example Acalymma vittatum, Acanthoscelides obtectus, Adoretus spp, Aethina tumida, Agelastica alni, Agrilus spp, for example Agrilus planipennis, Agrilus coxalis, Agrilus bilineatus, Agrilus anxius, Agriotes spp, for example Agriotes linneatus, Agriotes mancus, Alphitobius diaperinus, Amphimallon solstitialis, Anobium punctatum, Anoplophora spp, eg Anoplophora glabripennis, Anthonomus spp, eg Anthonomus grandis, Anthrenus spp, Apion spp, Apogonia spp, Atomaria spp, eg Atomaria linearis, Attagenus spp, Baris caerulescens , Bruchidius obtectus, Bruchus spp, eg Bruchus pisorum, Bruchus rufimanus, Cassida spp, Cerotoma trifurcata, Ceutorrhynchus spp, eg Ceutorrhynchus assimilis, Ceutorrhynchus quadridens, Ceutorrhynchus rapae, Chaetocnema spp, eg Chaetocnema confinis, Chaetocnema denticulata, Chaetocnema ect mendicus, Conoderus spp, Cosmopolites spp, eg Cosmopolites sordidus, Cost elytra zealandica, Ctenicera spp, Curculio spp, for example Curculio caryae, Curculio caryatrypes, Curculio obtusus, Curculio sayi, Cryptolestes ferrugineus, Cryptolestes pusillus, Cryptorhynchus lapathi, Cryptorhynchus mangiferae, Cilindrocopturus spp, Cilindrocopturus adspersus, Cilindrocopturus furnissi, Dendroctonus sppnus, for example ponderosae, Dermestes spp, Diabrotica spp, e.g. Diabrotica balteata, Diabrotica barberi, Diabrotica undecimpunctata howardi, Diabrotica undecimpunctata undecimpunctata, Diabrotica virgifera virgifera, Diabrotica virgifera zeae, Dichocrocis spp, Dicladispa armigera, Diloboderus spp, Epicaerus spp, Epilachna Epilachna, e.g. borealis, Epilachna varivestis, Epitrix spp, for example Epitrix cucumeris, Epitrix fuscula, Epitrix hirtipennis, Epitrix subcrinita, Epitrix tuberis, Faustinus spp, Gibbium psylloides, Gnathocerus cornutus, Hellula undalis, Heteronychus arator, Heteronyx spp, Hilamorpha elegans, Hilotrupes bajulus, Hyper a postica, Hypomeces squamosus, Hypothenemus spp, for example Hypothenemus hampei, Hypothenemus obscurus, Hypothenemus pubescens, Lachnosterna consanguinea, Lasioderma serricorne, Latheticus oryzae, Lathridius spp, Lema spp, Leptinotarsa ​​decemlineata, Leucoptera spp, for example Leucoptera coffeella, Limonius ectyhoppus, oryzophilus, Listronotus (= Hyperodes) spp, Lixus spp, Luperodes spp, Luperomorpha xanthodera, Lyctus spp, Megacyllene spp, eg Megacyllene robiniae, Megascelis spp, Melanotus spp, eg Melanotus longulus oregonensis, Meligethes aeneus, Melolontha spp, eg Melolontha melolontha, Migdolus spp. Monochamus spp, Naupactus xanthographus, Necrobia spp, Neogalerucella spp, Niptus hololeucus, Oryctes rhinoceros, Oryzaephilus surinamensis, Oryzaphagus oryzae, Otiorhynchus spp, por ejemplo Otiorhynchus cribricollis, Otiorhynchus ligustici, Otiorhynchus ovatus, Otiorhynchus rugosostriarus, Otiorhynchus sulcatus, Oulema spp, por ejemplo Oulema melanopus, Oulema oryzae, Oxycetonia jucunda, Phaedon cochleariae, Phyllophaga spp, Phyllophaga helleri, Phyllotreta spp, for example Phyllotreta armoraciae, Phyllotreta pusilla, Phyllotreta ramosa, Phyllotreta striolata, Popillia japonica, Premnotrypes spp, Prostephanus truncatus, Psylliodes a Psylliodes spp, for example , Psylliodes chrysocephala, Psylliodes punctulata, Ptinus spp, Rhizobius ventralis, Rhizopertha dominica, Rhynchophorus spp, Rhynchophorus ferrugineus, Rhynchophorus palmarum, Scolytus spp, eg Scolytus multistriatus, Sinoxilon perforans, Sitophilus spp, eg Sitophilus granarius, Sitophilus linearis lus oryzae, Sitophilus zeamais, Sphenophorus spp, Stegobium paniceum, Sternechus spp, eg Sternechus paludatus, Symphiletes spp, Tanymecus spp, eg Tanymecus dilaticollis, Tanymecus indicus, Tanymecus palliatus, Tenebrio molitor, Tenebrioides mauretanicus, Tribolium audax , tribolium castaneum, tribolium confusum, Trogoderma spp, Tychius spp, Xilotrechus spp, Zabrus spp, for example Zabrus tenebrioides; from the order Dermaptera, for example, Anisolabis maritime, Forficula auricularia, Labidura riparia; from the order Diptera, for example Aedes spp, for example Aedes aegypti, Aedes albopictus, Aedes sticticus, Aedes vexans, Agromyza spp, for example Agromyza frontella, Agromyza parvicornis, Anastrepha spp, Anopheles spp, for example Anopheles quadrimaculatus, Anopheles gambiae, Asphondilia spp, Bactrocera spp, for example Bactrocera cucurbitae, Bactrocera dorsalis, Bactrocera oleae, Bibio hortulanus, Calliphora erythrocephala, Calliphora vicina, Ceratitis capitata, Chironomus spp, Chrysomya spp, Chrysops spp, Chrysozona pluvialis, Cochliomya spp, Contarinia spp, for e.g. Contarinia johnsoni, Contarinia nasturtii, Contarinia pyrivora, Contarinia schulzi, Contarinia sorghicola, Contarinia tritici, Cordilobia anthropophaga, Cricotopus sylvestris, Culex spp, e.g. Culex pipiens, Culex quinquefasciatus, Culicoides spp, Culiseta spp, Cuterebra spp, Dacus oleas pp, Das , eg Dasineura brassicae, Delia spp, eg Delia antiqua, Delia coarctata, Delia florile ga, Delia platura, Delia radicum, Dermatobia hominis, Drosophila spp, e.g. Drosphila melanogaster, Drosophila suzukii, Echinocnemus spp, Euleia heraclei, Fannia spp, Gasterophilus spp, Glossina spp, Haematopota spp, Hydrellia spp, Hydrellia griseola, Hilemya spp, Hippobosca spp, Hypoderma spp, Liriomyza spp, for example Liriomyza brassicae, Liriomyza huidobrensis, Liriomyza sativae, Lucilia spp, for example Lucilia cuprina, Lutzomyia spp, Mansonia spp, Musca spp, for example Musca domestica, Musca domestica vicina, Oestrus spp, Oscinella frit , Paratanytarsus spp, Paralauterborniella subcincta, Pegomya or Pegomyia spp, for example Pegomya betae, Pegomya hyoscyami, Pegomya rubivora, Phlebotomus spp, Phorbia spp, Phormia spp, Piophila casei, Platyparea poeciloptera, Prodiplosis spp, Psila rosae, Rhagoletis spp, for example , Rhagoletis cingulata, Rhagoletis completa, Rhagoletis fausta, Rhagoletis indifferens, Rhagoletis mendax, Rhagoletis pomonella, Sarcophaga spp, Simulium spp, by eg Simulium meridionale, Stomoxis spp, Tabanus spp, Tetanops spp, Tipula spp, eg Tipula paludosa, Tipula simplex, Toxotrypana curvicauda; from the order Hemiptera, for example Acizzia acaciaebaileyanae, Acizzia dodonaeae, Acizzia uncatoides, Acrida turrita, Acyrthosipon spp, for example Acyrthosiphon pisum, Acrogonia spp, Aeneolamia spp, Agonoscena spp, Aleurocanthus spp, Aleyrodes proletella, Aleurolobus barodensis, Aleurothrixus floccosus , Allocaridara malayensis, Amrasca spp, for example Amrasca bigutulla, Amrasca devastans, Anuraphis cardui, Aonidiella spp, for example Aonidiella aurantii, Aonidiella citrina, Aonidiella inornata, Aphanostigma piri, Aphis spp, for example Aphis citricola, Aphis craccivora, Aphis fabae, Aphis forbesi, Aphis glycines, Aphis gossypii, Aphis hederae, Aphis illinoisensis, Aphis middletoni, Aphis nasturtii, Aphis nerii, Aphis pomi, Aphis spiraecola, Aphis viburniphila, Arboridia apicalis, Arytainilla spp, Aspidiella spp, Aspidiotus spp, for example Aspidiotus nerii, Atanus spp, Aulacorthum solani, Bemisia tabaci, Blastopsylla occidentalis, Boreioglycaspis melaleucae, Brachycaudus hel ichrysi, Brachycolus spp, Brevicoryne brassicae, Cacopsylla spp, e.g. Cacopsylla pyricola, Calligypona marginata, Capulinia spp, Carneocephala fulgida, Ceratovacuna lanigera, Cercopidae, Ceroplastes spp, Chaetosiphon fragaefolii, Chionaspis tegalensis, Chlorita onukii, Chondracris rosea, Chromaphis jugolandicola aonidum, Chrysomphalus ficus, Cicadulina mbila, Coccomytilus halli, Coccus spp, for example Coccus hesperidum, Coccus longulus, Coccus pseudomagnoliarum, Coccus viridis, Cryptomyzus ribis, Cryptoneossa spp, Ctenarytaina spp, Dalbulus spp, Dialeurodes chittendeni, Dialeurodes citri, Diaphorina citri, Diaspis spp, Diuraphis spp, Doralis spp, Drosicha spp, Dysaphis spp, for example Dysaphis apiifolia, Dysaphis plantaginea, Dysaphis tulipae, Dysmicoccus spp, Empoasca spp, eg Empoasca abrupta, Empoasca fabae, Empoasca maligna, Empoasca solana, Empoasca stevensi, Eriosoma spp, eg Eriosoma americanum, Eriosoma lanigerum, Eriosoma pyricola, Erythroneura spp, Eucalyptolyma spp, Euphyllura spp, Euscelis bilobatus, Ferrisia spp, Fiorinia spp, Furcaspis oceanica, Geococcus coffeae, Glycaspis spp, Heteropsylla Cubana, Heteropsylla spinulosa, Homalodisca coagulata, Hyalopterus arundinis, Hyalopterus pruni, Icerya spp, for example Icerya purchasi, Idiocerus spp, Idioscopus spp, Laodelphax striatellus, Lecanium spp, for example Lecanium corni (= Parthenolecanium corni), Lepidosaphes spp, for example Lepidosaphes ulmi, Lipaphis erysimi, Lopholeucaspis japonica, Lycorma delicatula, Macrosiphum spp, for example Macrosiphum euphorbiae, Macrosiphum lilii, Macrosiphum rosae, Macrosteles facifrons, Mahanarva spp, Melanaphis sacchari, Metcalfiella spp, Metcalfa pruinosa, Metopolophium dirhodum, Monellia costalis, Monelliopsi s pecanis, Myzus spp, eg Myzus ascalonicus, Myzus cerasi, Myzus ligustri, Myzus ornatus, Myzus persicae, Myzus nicotianae, Nasonovia ribisnigri, Neomaskellia spp, Nephotettix spp, eg Nephotettix cincticeps, Nephotettix nigropictus, Nettigoniclla spectra, Nilaparvata lugens, Oncometopia spp, Orthezia praelonga, Oxia chinensis, Pachypsylla spp, Parabemisia myricae, Paratrioza spp, eg Paratrioza cockerelli, Parlatoria spp, Pemphigus spp, eg Pemphigus bursarius, Pemphigus populivenae, Peregrinus maidis, Perkinsiella spp, Phenacoccus spp, eg Phenacoccus madeirensis , Phloeomyzus passerinii, Phorodon humuli, Phylloxera spp, for example Phylloxera devastatrix, Phylloxera notabilis, Pinnaspis aspidistrae, Planococcus spp, for example Planococcus citri, Prosopidopsylla flava, Protopulvinaria pyriformis, Pseudaulacaspis pentágona, Pseudococcus spp, por ejemplo Pseudococcus calceolariae, Pseudococcus comstocki, Pseudococcus longispinus, Pseudococcus maritimus, Pseudococcus viburni, Psyllopsis spp, Psylla spp, por ejemplo Psylla buxi, Psylla mali, Psylla pyri, Pteromalus spp, Pulvinaria spp, Pyrilla spp, Quadraspidiotus spp, for example Quadraspidiotus juglansregiae, Quadraspidiotus ostreaeformis, Quadraspidiotus perniciosus, Quesada gigas, Rastrococcus spp, Rhopalosiphum spp, for example Rhopalosiphum maidis, Rhopalosiphum oxiacanthae, Rhopalosiphum padi, Rhopalosiphum rufiabdominale, Saffetia co Saissetia miranda, Saissetia neglecta, Saissetia oleae, Scaphoideus titanus, Schizaphis graminum, Selenaspidus articulatus, Sipha flava, Sitobion avenae, Sogata spp, Sogatella furcifera, Sogatodes spp, Stictocephala festina, Siphoninus phillyreae, Tenalaphara malayensis, Tetragonocephela spp, Tinocallis caryaef oliae, Tomaspis spp, Toxoptera spp, eg Toxoptera aurantii, Toxoptera citricidus, Trialeurodes vaporariorum, Trioza spp, eg Trioza diospyri, Typhlocyba spp, Unaspis spp, Viteus vitifolii, Zygina spp; from the suborder Heteroptera, e.g. Aelia spp, Anasa tristis, Antetiopsis spp, Boisea spp, Blissus spp, Calocoris spp, Campilomma livida, Cavelerius spp, Cimex spp, e.g. Cimex adjunctus, Cimex hemipterus, Cimex lectularius, Cimex pilosellus , Collaria spp, Creontiades dilutus, Dasynus piperis, Dichelops furcatus, Diconocoris hewetti, Dysdercus spp, Euschistus spp, e.g. Euschistus heros, Euschistus servus, Euschistus tristigmus, Euschistus variolarius, Eurydema spp, Eurygaster spp, Halyomorpha halys, Heliopeltis nobile spp, , Leptocorisa spp, Leptocorisa varicornis, Leptoglossus occidentalis, Leptoglossus phyllopus, Lygocoris spp, for example Lygocoris pabulinus, Lygus spp, for example Lygus elisus, Lygus hesperus, Lygus lineolaris, Macropes excavatus, Megacopta cribraria, Miridae, Monalonion atratum, Nezara spp, for example Nezara viridula, Nysius spp, Oebalus spp, Pentomidae, Piesma quadrata, Piezodorus spp, eg Piezodorus guildinii, Psallus spp, Pseudacysta persea, Rhodnius spp, Sahlbergella singularis, Scaptocoris castanea, Scotinophora spp, Stephanitis nashi, Tibraca spp, Triatoma spp; from the order Hymenoptera, for example Acromyrmex spp, Athalia spp, for example Athalia rosae, Atta spp, Camponotus spp, Dolichovespula spp, Diprion spp, for example Diprion similis, Hoplocampa spp, for example Hoplocampa cookei, Hoplocampa testudinea, Lasius spp, Linepithema (Iridiomyrmex) humile, Monomorium pharaonis, Paratrechina spp, Paravespula spp, Plagiolepis spp, Sirex spp, e.g. Sirex noctilio, Solenopsis invicta, Tapinoma spp, Technomyrmex albipes, Urocerus spp, Vespa spp, e.g. Vespa crabro, Wasmannia auropunctata , Xeris spp; from the order Isopods, for example, Armadillidium vulgare, Oniscus asellus, Porcellio scaber; from the order Isoptera, for example Coptotermes spp, for example Coptotermes formosanus, Cornitermes cumulans, Cryptotermes spp, Incisitermes spp, Kalotermes spp, Microtermes obesi, Nasutitermis spp, Odontotermes spp, Porotermes spp, Reticulitermes spp, for example Reticulitermes flavipes , Reticulitermes hesperus; from the order Lepidoptera, for example Achroia grisella, Acronicta major, Adoxophyes spp, for example Adoxophyes orana, Aedia leucomelas, Agrotis spp, eg Agrotis segetum, Agrotis ipsilon, Alabama spp, eg Alabama argillacea, Amyelois transitella, Anarsia spp, Anticarsia spp, eg Anticarsia gemmatalis, Argyroploce spp, Autographa spp, Barathra brassicae, Blastodacna atra, Borbo cinnara, Bucculatrix thurberiella , Bupalus piniarius, Busseola spp, Cacoecia spp, Caloptilia theivora, Capua reticulana, Carpocapsa pomonella, Carposina niponensis, Cheimatobia brumata, Chilo spp, e.g. Chilo plejadellus, Chilo suppressalis, Choreutis pariana, Choristoneura spp, Chrysodeixis chalcites, Clysia ambiguella, Cnaphalocerus spp , Cnaphalocrocis medinalis, Cnephasia spp, Conopomorpha spp, Conotrachelus spp, Copitarsia spp, Cydia spp, for example Cydia nigricana, Cydia pomonella, Dalaca noctuides, Diaphania spp, Diparopsis spp, Diatraea saccharalis, Dioryctria spp, for example Dioryctria zimmermani, Earias spp, Ecdytolopha aurantium, Elasmopalpus lignosellus, Eldana saccharina, Ephestia spp, eg Ephest ia elutella, Ephestia kuehniella, Epinotia spp, Epiphyas postvittana, Erannis spp, Erschoviella musculana, Etiella spp, Eudocima spp, Eulia spp, Eupoecilia ambiguella, Euproctis spp, e.g. Euproctis chrysorrhoea, Euxoa spp, Feltia spp, Galleria mellonella, Gracillaria spp, Grapholitha spp, eg Grapholita molesta, Grapholita prunivora, Hedilepta spp, Helicoverpa spp, eg Helicoverpa armigera, Helicoverpa zea, Heliothis spp, eg Heliothis virescens, Hofmannophila pseudospretella, Homoeosoma spp, Homona spp, Hyponomeuta padella, Kakivoria flavofasciata, Lampides spp , Laphygma spp, Laspeyresia molesta, Leucinodes orbonalis, Leucoptera spp, eg Leucoptera coffeella, Lithocolletis spp, eg Lithocolletis blancardella, Lithophane antennata, Lobesia spp, eg Lobesia botrana, Loxagrotis albicosta, Lymantria spp, eg Lymantria dispar, Lyonetia spp , for example Lyonetia clerkella, Malacosoma neustria, Maruca testulalis, Mamestra brassi cae, Melanitis leda, Mocis spp, Monopis obviella, Mythimna separata, Nemapogon cloacellus, Nymphula spp, Oiketicus spp, Omphisa spp, Operophtera spp, Oria spp, Orthaga spp, Ostrinia spp, e.g. Ostrinia nubilalis, Panolis flammea, Parnara spp, Pectinophora spp, for example Pectinophora gossypiella, Perileucoptera spp, Phthorimaea spp, for example Phthorimaea operculella, Phyllocnistis citrella, Phyllonorycter spp, for example Phyllonorycter blancardella, Phyllonorycter crataegella, Pieris spp, for example Pieris rapae, Platynota stultana, Plodia interpunctella, Plusia spp, Plutella xylostella (=Plutella maculipennis), Podesia spp, for example Podesia syringae, Prays spp, Prodenia spp, Protoparce spp, Pseudaletia spp, for example Pseudaletia unipuncta, Pseudoplusia includens, Pyrausta nubilalis, Rachiplusia nu, Schoenobius spp, for example Schoenobius bipunctifer, Scirpophaga spp, eg Scirpophaga innotata, Scotia segetum, Sesamia spp, eg Sesamia inferens, Sparganot his spp, Spodoptera spp, e.g. Spodoptera eradiana, Spodoptera exigua, Spodoptera frugiperda, Spodoptera praefica, Stathmopoda spp, Stenoma spp, Stomopteryx subsecivella, Synanthedon spp, Tecia solanivora, Thaumetopoea spp, Thermesia gemmatalis, Tinea cloacella, Tinea pellionella, Tinella bisselli Tortrix spp, Trichophaga tapetzella, Trichoplusia spp, for example Trichoplusia ni, Tryporyza incertulas, Tuta absolute, Virachola spp; from the order Orthoptera or Saltatoria, for example Acheta domesticus, Dichroplus spp, Gryllotalpa spp, for example Gryllotalpa gryllotalpa, Hieroglyphus spp, Locusta spp, for example Locusta migratoria, Melanoplus spp, for example Melanoplus devastator, Paratlanticus ussuriensis, Schistocerca gregaria ; from the order Phthiraptera, for example Damalinia spp, Haematopinus spp, Linognathus spp, Pediculus spp, Phylloxera vastatrix, Phthirus pubis, Trichodectes spp; from the order of Psocoptera, for example, Lepinotus spp, Liposcelis spp; from the order of Siphonaptera, eg Ceratophyllus spp, Ctenocephalides spp, eg Ctenocephalides canis, Ctenocephalides felis, Pulex irritans, Tunga penetrans, Xenopsylla cheopis; from the order Thysanoptera, for example Anaphothrips obscurus, Baliothrips biformis, Chaetanaphothrips leeuweni, Drepanothrips reuteri, Enneothrips flavens, Frankliniella spp, for example Frankliniella fusca, Frankliniella occidentalis, Frankliniella schultzei, Frankliniella tritici, Frankliniella vaccinii, Frankliniella williamsi, Haplothrips spp , Heliothrips spp, Hercinothrips femoralis, Kakothrips spp, Rhipiphorothrips cruentatus, Scirtothrips spp, Taeniothrips cardamomi, Thrips spp, eg Thrips palmi, Thrips tabaci; from the order of Zygentoma (=Thysanura), for example Ctenolepisma spp, Lepisma saccharina, Lepismodes inquilinus, Thermobia domestica; from the class Symphyla, eg Scutigerella spp, eg Scutigerella immaculata; Pests from the mollusc group, for example from the class of Bivalvia, for example Dreissena spp; as well as from the class of Gastropoda, for example, Arion spp, for example Arion ater rufus, Biomphalaria spp, Bulinus spp, Deroceras spp, for example Deroceras laeve, Galba spp, Lymnaea spp, Oncomelania spp, Pomacea spp, Succinea spp; Pests of the nematode group, i.e. plant parasitic nematodes, in particular Aglenchus spp, for example Aglenchus agricultural, Anguina spp, for example Anguina tritici, Aphelenchoides spp, for example Aphelenchoides arachidis, Aphelenchoides fragariae, Belonolaimus spp, for example Belonolaimus gracilis, Belonolaimus longicaudatus, Belonolaimus nortoni, Bursaphelenchus spp, for example Bursaphelenchus cocophilus, Bursaphelenchus eremus, Bursaphelenchus xilophilus, Cacopaurus spp, for example Cacopaurus pestis, Criconemella spp, for example Criconemella curvata, Criconemella onoensis, Criconemella ornata, Criconemella xenoplax ( = Mesocriconema xenoplax), Criconemoides spp, for example Criconemoides ferniae, Criconemoides onoense, Criconemoides ornatum, Ditilenchus spp, for example Ditilenchus dipsaci, Dolichodorus spp, Globodera spp, for example Globodera pallida, Globodera rostochiensis, Helicotilenchus spp, for example Helicotilenchus dihystera, Hemicri conemoides spp, Hemicicliophora spp, Heterodera spp, eg Heterodera avenae, Heterodera glycines, Heterodera schachtii, Hirschmaniella spp, Hoplolaimus spp, Longidorus spp, eg Longidorus africanus, Meloidogyne spp, eg Meloidogyne chitwoodi, Meloidogyne fallax, Meloidogyne hapla, Meloidogyne incognita , Meloinema spp, Nacobbus spp, Neotilenchus spp, Paralongidorus spp, Paraphelenchus spp, Paratrichodorus spp, eg Paratrichodorus minor, Paratilenchus spp, Pratilenchus spp, eg Pratilenchus penetrans, Pseudohalenchus spp, Psilenchus spp, Punctodera spp, Quinisulcius spp, Radopholus spp, for example Radopholus citrophilus, Radopholus similis, Rotilenchulus spp, Rotilenchus spp, Scutellonema spp, Subanguina spp, Trichodorus spp, eg Trichodorus obtusus, Trichodorus primitivus, Tilenchorhynchus spp, eg Tilenchorhynchus annulatus, Tilenchulus spp, eg Tilenchulus semipenetrans, Xiphinema spp, eg Xiphinema index. If appropriate, the compounds of Formula (I) can also be used at certain concentrations or application rates as herbicides, growth protectors or agents to improve the properties of plants, such as microbiocides or gametocides, for example as fungicides, antimycotics, bactericides, viricides (including antiviral agents) or as agents against MLO (Mycoplasma-like organisms) and RLO (Rickettsia-like organism). If appropriate, they can also be used as intermediates or precursors in the synthesis of other active ingredients. formulations The present invention further relates to formulations and application forms prepared therewith as a pesticide such as, for example, dip, drip and spray mixtures, comprising at least one compound of Formula (I). Optionally, uses include other pesticides and / or activity-enhancing adjuvants, such as penetration enhancers, for example, vegetable oils such as rapeseed oil, sunflower oil, mineral oils such as paraffin oils, alkyl esters of fatty acids. vegetable fats such as rapeseed oil or soybean oil methyl esters or alkanol alkoxylates and / or dispersing agents such as alkylsiloxanes and / or salts, for example organic or inorganic ammonium or phosphonium salts such as ammonium sulfate or phosphate diammonium acid and / or retention promoting agents such as, for example, dioctyl sulfosuccinate or hydroxypropyl guar polymers and / or humectants, for example, glycerol and / or fertilizers such as ammonium, potassium or phosphorous containing fertilizers. Typical formulations include, for example, water soluble liquids (SL), emulsion concentrates (EC), water emulsions (SE), suspension concentrates (SC, SE, FS, OD), water dispersible granules (WG), granules (GR) and concentrates in capsules (CS); these and other possible types of formulations are described, for example, in Crop Life International and in Pesticide Specifications, Manual on development and use of FAO and WHO specifications for pesticides, FAO Plant Production and Protection Papers 173, prepared by the FAO / WHO Joint Meeting on Pesticide Specifications, 2004, ISBN: 9251048576. If appropriate, the formulations contain, in addition to one or more compounds of Formula (I), additional agrochemical active agents. They preferably comprise formulations or application forms containing auxiliary agents, such as fillers, solvents, instant promoters, vehicles, emulsifiers, dispersants, antifreeze agents, biocides, thickeners and / or additional auxiliaries, for example adjuvants. In this context an adjuvant is a component that enhances the biological effect of the formulation even if the component itself does not have a biological effect. Examples of adjuvants are agents that promote retention, spreading behavior, adherence to leaf surfaces, or penetration. These formulations are prepared in a known manner, for example, by mixing the compounds of Formula (I) with excipients such as fillers, solvents and / or solid carriers and / or other excipients such as surface active agents. The preparation of the formulations is carried out in suitable systems, either before or during use. The excipients that can be used are those that are suitable for imparting special properties to the formulation of the compounds of Formula (I) or the application forms prepared from these formulations (such as, for example, pesticides usable as mixtures of sprays or coatings for seeds), such as to impart some physical, technical and / or biological properties. Suitable fillers comprise, for example, water, polar and non-polar chemical liquids such as, for example, from the aromatic and non-aromatic hydrocarbon classes (such as paraffins, alkylbenzenes, alkylnaphthalenes, chlorobenzenes), alcohols, and polyols (which may also be used). be substituted, etherified and / or esterified), ketones (such as acetone, cyclohexanone), esters (also fats and oils) and (poly)ethers, simple and substituted amines, amides, lactams (such as N-alkylpyrrolidones) and lactones, sulfones and sulfoxides (such as dimethyl sulfoxide), carbonates, and nitriles. In the case of using water as a filler, organic solvents can also be used as auxiliary solvents. Liquid solvents are essentially: aromatic compounds, such as xylene, toluene or alkylnaphthalenes, chlorinated aromatic or chlorinated aliphatic hydrocarbon compounds, such as chlorobenzenes, chloroethylene or methylene chloride, aliphatic hydrocarbons, such as cyclohexane or paraffins, for example. For example, petroleum fractions, mineral and vegetable oils, alcohols such as butanol or glycol and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylformamide or dimethylsulfoxide, carbonates such as propylene carbonate, butylene carbonate, diethyl carbonate or dibutyl carbonate; or nitriles such as acetonitrile or propanenitrile. In principle, any suitable solvent can be used. Suitable solvents comprise, for example, aromatic hydrocarbons such as xylene, toluene or alkylnaphthalenes, chlorinated aromatic or aliphatic hydrocarbons such as chlorobenzene, chloroethylene or methylene chloride, aliphatic hydrocarbons such as cyclohexane, paraffins, petroleum fractions, mineral and vegetable oils, alcohols such as methanol, ethanol, isopropanol, butanol or glycol and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethyl sulfoxide, carbonates such as propylene carbonate, butylene carbonate, diethyl carbonate or dibutyl carbonate, nitriles such as acetonitrile or propanenitrile, and water. In principle any suitable carrier can be used. In particular carriers comprise: for example, ammonium salts and ground natural minerals, such as kaolite, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals, such as highly dispersed silicic acid, oxide of aluminum and natural or synthetic silicates, resins, waxes and / or solid fertilizers. Mixtures of such carriers can also be used. Suitable carriers for granules comprise: for example, ground and fractionated natural minerals, such as calcite, marble, pumice, sepiolite and dolomite, and synthetic granules of inorganic and organic powders and granules of organic materials such as sawdust, paper, shellac. coconut, corn cobs and tobacco stems. In addition, liquefied gaseous solvents or diluents may be used. In particular, they are those fillers or carriers that are gaseous at normal temperature and under atmospheric pressure, for example, as aerosol propellants, such as halogenated hydrocarbons and butane, propane, nitrogen and carbon dioxide. Examples of emulsifying and / or foaming agents, dispersing or wetting agents with ionic or nonionic properties, or mixtures of surfactants include polyacrylic acid salts, lignosulfonic acid salts, phenolsulfonic acid salts or naphthalenesulfonic acid, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, substituted phenols (preferably alkylphenols or arylphenols), salts of sulfosuccinic acid esters, substituted taurine derivatives (preferably alkyl taurates), isethionate derivatives, organophosphates of polyethoxylated alcohols or phenols, fatty acid esters of polyols, and derivatives of the sulfate-, sulfonate-, and phosphate-containing compounds, such as polyglycol alkylaryl ethers, alkylsulfonates, alkylsulfates, arylsulfonates, protein hydrolysates, lignosulfate liquors, and methylcellulose. The presence of a surface active agent is advantageous when one of the compounds of Formula (I) and / or one of the inert carriers is not soluble in water and when applied in water. Additional auxiliary agents present in the formulations and the application forms derived from them may comprise dyes with inorganic pigments, for example iron oxide, titanium oxide, Prussian blue and organic dyes, such as alizarin dyes, azo dyes and metallic nutrients and trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc. They may also comprise stabilizers such as cold stabilizers, preservatives, antioxidants, light stabilizers, or other chemical and / or physical agents that improve stability. They may also contain foaming or defoaming agents. In addition, the formulations and the application forms derived from them may also contain as additional adjuvants, adhesives such as carboxymethylcellulose and natural and synthetic powders, granules or latex polymers such as gum arabic, polyvinyl alcohol, polyvinyl acetate and natural phospholipids, such as cephalins and lecithins and synthetic phospholipids. Other auxiliaries may comprise mineral and vegetable oils. Optionally, the formulations and the application forms derived from them may comprise other additional auxiliaries. Said additives comprise, for example, fragrances, protective colloids, binding agents, adhesives, thickeners, thixotropic agents, penetration promoters, retention agents, stabilizers, sequestering agents, complexing agents, wetting agents, dispersing agents. In general, the compounds of Formula (I) can be combined with any commonly used solid or liquid additives in order to obtain a formulation. Retention promoters comprise all those substances that reduce dynamic surface tension, such as dioctylsulfosuccinate, or increase viscoelasticity, such as hydroxypropylguar polymers. In the present context, all substances that are commonly used to improve the penetration of agrochemical active substances in plants are considered as penetration promoters. Penetrating agents are defined in this context by the fact that they penetrate from an application liquid (generally aqueous) and / or from the spray coating on the plant cuticle and in this way can increase the mobility of the active ingredients by the cuticle. The method described in the literature (Baur et al., 1997, Pesticide Science 51, 131152) can be used to determine this property. Mention may be made, by way of example, of alcohol alkoxylates, such as coconut oil ethoxylates (10) or isotridecyl ethoxylate (12), fatty acid esters such as canola or soybean oil methyl esters, fatty amine alkoxylates, such as such as ethoxylated tallow amine (15) or ammonium and / or phosphonium salts such as ammonium sulfate or diammonium hydrogen phosphate. The formulations preferably contain between 0.00000001 and 98% by weight of the compound of Formula (I), more preferably between 0.01 and 95% by weight of the compound of Formula (I), even more preferably between 0.5 and 90% by weight of the compound of Formula (I), based on the weight of the formulation. The content of the compound of the formula (I) in the use forms prepared from the formulations (in particular pesticides) can vary within wide ranges. In general, the concentration of the compound of Formula (I) in the application forms may comprise between 0.00000001 and 95% by weight of the compound of Formula (I), preferably between 0.00001 and 1% by weight, based on on the weight of the application form. The application is made in customized application forms adapted to the application formulations. blends The compounds of Formula (I) can also be used in mixtures with one or more fungicides, bactericides, acaricides, molluscicides, nematicides, insecticides, microbiological, beneficial, herbicides, fertilizers, bird repellents, phytonic agents, sterilants, protectors, semiochemicals and / or suitable plant growth regulators, for example, to broaden the spectrum of activity, extend the duration of activity, increase the speed of action, prevent repellency, or prevent the development of resistance. In addition, said combinations may comprise active ingredients for plant growth and / or tolerance to abiotic factors such as, for example, greater tolerance to high or low temperatures, against drought or against an increase in water or salinity of the I usually. In addition, flowering and fruiting behavior can be improved, germination and rooting benefits can be facilitated, crop yield and yield can be increased, crop maturity, quality and / or nutritional value can be prolonged, shelf life and / or improve crop productivity. Furthermore, the compounds of Formula (I) may be present in a mixture with other active compounds or semiochemical products, such as pheromones and / or bird repellents, and / or plant activators and / or plant growth regulators and / or fertilizers. Likewise, the compounds of Formula (I) can be used to improve plant properties, such as growth, yield and crop quality. In a particular embodiment according to the invention, the compounds of Formula (I) in the formulations or in the application forms prepared with the formulations are mixed with other compounds, preferably those that will be described below. If one of the compounds described below is found in different tautomeric forms, these forms are also included, even if they are not explicitly mentioned in each case. Furthermore, all of the foregoing mixing members may optionally form salts with suitable bases or acids, based on their functional groups. Insecticides / acaricides / nematicides The active compounds specified herein by their "common names" are known and are described, for example, in the pesticide manual ("The Pesticide Manual" 16th edition, British Crop Protection Council 2012) or on the Internet (for example at http: / / www.alanwood.net / pesticides). The classification is based on the IRAC Mode of Action Classification Scheme valid at the time of filing this patent application. (1) Acetylcholinesterase (AChE) inhibitors, preferably carbamates selected from alanicarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiophanox, triazamate, trimetacarb, XMC and xylylcarb or organophosphates, for example acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chloroethoxyphos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, Demeton-S-methyl, Diazinone, Dichlorvos / DDVP, Dicrotophos, Dimethoate, Dimethylvinphos, Disulfoton, EPN, Ethion, Ethoprophos, Famfur, Fenamiphos, Fenitrothion, Fenthion, Fostiazate, Heptenophos, Imitiaphos, Isophenphos, O-(Methoxyaminothio-phosphoryl)salicylate Isopropyl, Isoxathion, Malathion, Mecarbam, Methamidophos, Methidathion, Mevinphos, Monocrotophos, Naled, Omethoate, Oxydemeton-methyl, Parathion, Parathion-methyl, Phentoate, Phorate, phosalone, phosmet, phosphamidon, foxim, pirimiphos-methyl, profenofos, propetamphos, prothiophos, pyraclophos, pyridafenthion, quinalphos, sulfotep, tebupirimphos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorophone, and vamidothion. (2) GABA-regulated chloride channel blockers, preferably cyclodiene organochlorines selected from chlorodan and endosulfan, or phenylpyrazole (Fiprole) selected from ethiprole and fipronil. (3) Sodium channel modulators, preferably pyrethroids selected from acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, S-cyclopentenyl isomer of bioallethrin, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin , cyhalothrin, lambda-cyhalothrin, gammacyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(1R)-trans isomers], deltamethrin, empenthrin [(EZ)-(1R) isomers), esfenvalerate , etofenprox, fenpropatrin, fenvalerate, flucithrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, kadethrin, permethrin, phenothrin [(1R)-trans isomer), prallethrin, pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [ isomers (1R))], tralomethrin and transfluthrin or DDT or methoxychlor. (4) Competitive nicotinic acetylcholine receptor (nAChR) modulators, such as neonicotinoids selected from acetamipride, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam, or nicotine, or sulfoximines selected from sulfoxaflor, or butenolide selected from flupyradifurone. (5) Allosteric modulators of the nicotinic acetylcholine receptor (nAChR), preferably selected from spinosyns, spinetoram and spinosad. (6) Allosteric modulators of glutamate-dependent chloride channels (GluCl), preferably avermectin / milbemycin selected from abamectin, emamectin-benzoate, lepimectin and milbemectin. (7) Juvenile hormone mimetics, preferably juvenile hormone analogs selected from hydroprene, kinoprene and methoprene, or fenoxycarb or pyriproxyfen. (8) Various non-specific (multi-site) inhibitors, preferably selected from alkyl halides selected from methyl bromide and other alkyl halides, or chloropicrin or sulfuryl fluoride or borax or tartar emetic or methylisocyanate products selected from diazomet and metam . (9) Modulators of TRPV channels of chordotonal organs selected from pymetrozine and pirifluquinazone. (10) Mite growth inhibitors selected from clofentezine, hexythiazox, diflovidazine and etoxazole. (11) Microbial disruptors of the intestinal membrane of insects selected from Bacillus thuringiensis subsp. israelensis, Bacillus sphaericus, Bacillus thuringiensis subsp. aizawai, Bacillus thuringiensis subsp. kurstaki, Bacillus thuringiensis subsp. tenebrionis, and plant proteins B.t. selected from CryAb, CryAc, CryFa, Cry1A.105, Cry2Ab, VIP3A, mCry3A, Cry3Ab, Cry3Bb and Cry34Ab1 / 35Ab1. (12) Mitochondrial ATP synthase inhibitors, preferably ATP disruptors selected from diafenthiuron or organic tin compounds selected from azocyclotin, cyhexatin and fenbutatin oxide, or propargite or tetradifon. (13) Uncoupling of oxidative phosphorylation by interruption of the proton gradient selected from chlorfenapyr, DNOC and sulfluramid. (14) Nicotinic acetylcholine receptor channel blocker selected from bensultap, cartap hydrochloride, thiocyclam and tiosultap-sodium. (15) Chitin biosynthesis inhibitors, type 0, selected from bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron. (16) Chitin biosynthesis inhibitors, type 1, selected from buprofezin. (17) Moulting switches (in particular of Diptera, ie of the order Diptera) selected from cyromazine. (18) Ecdysone receptor agonists selected from chromafenozide, halofenozide, methoxyfenozide and tebufenozide. (19) Octopamine receptor agonists selected from amitraz. (20) Mitochondrial complex III electron transport inhibitors selected from hydramethylnone, acequinocil and fluacripirim. (21) Mitochondrial complex I electron transport inhibitors, preferably METI acaricides selected from fenazaquin, fenpiroximat, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad, or rotenone (Derris). (22) Blockers of voltage-gated sodium channels selected from indoxacarb and metaflumizone. (23) Acetyl-CoA carboxylase inhibitors, preferably tetronic and tetramic acid derivatives selected from spirodiclofen, spiromesifen and spirotetramat. (24) Mitochondrial Complex IV electron transport inhibitors, preferably phosphines selected from aluminum phosphide, calcium phosphide, phosphine and zinc phosphide, or cyanides selected from calcium cyanide, potassium cyanide and sodium cyanide. (25) Mitochondrial Complex II electron transport inhibitors, preferably beta-ketonitrile derivatives selected from cyenopyrafen and cyflumetofen, or carboxanilides selected from piflubumide. (28) Ryanodine receptor modulators, preferably diamides selected from chlorantraniliprole, cyantraniliprole and flubendiamide. (29) Modulators of the chordotonal organs (of indefinite target structure) selected from flonicamide. (30) other active compounds selected from acinonapyr, afidopyropene, afoxolaner, azadirachtin, benclothiaz, benzoximate, benzpyrimoxane, bifenazate, broflanilide, bromopropylate, quinomethionate, chloropralethrin, cryolite, cyclaniprorol, cycloxaprid, cyhalodiamide, dichloromethothiaz, dicofol, epsilon-metofluthrin, epsilon- momfluthrin, flomethoquine, fluazaindolizine, fluensulfone, flufenerim, fluphenoxystrobin, flufiprol, fluhexaphone, fluopyram, flupirimine, fluralaner, fluxametamide, fufenozide, guadipir, heptafluthrin, imidaclotiz, iprodione, kappa-bifenthrin, kappa-tefluthrin, lotilaner, meperfluthrin, oxazosulfil, paichongding, pyridalyl, pyrifluquinazon, pyriminostrobin, spirobudiclofen, spiropidione, tetramethylfluthrin, tetranyliprol, tetrachlorantraniliprole, tigolaner, thiofluoximate, triflumezopyrim, and iodomethane; preparations based on Bacillus firmus (I-1582, BioNeem, Votivo); as well as the following compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl}3-(trifluoromethyl)-1H-1,2,4-triazole-5 -amine (known from WO2006 / 043635) (CAS 885026-50-6), {1 '-[(2E)-3-(4-chlorophenyl)prop-2-en-1 -yl]-5-fluorospiro[indole -3,4'piperidin]-1(2H)-yl}(2-chloropyridin-4-yl)methanone (known from WO2003 / 106457) (CAS 637360-23-7), 2-chloro-N-[2- {1-[(2E)-3-(4-chlorophenyl)prop-2-en-1 -yl]piperidin4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (known from WO2006 / 003494) (CAS 872999-66 -1), 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one (known from WO 2010052161) (CAS 122529217 -0), 3-(4-chloro-2, 6-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en4-yl-ethylcarbonate (known from EP 2647626) ( CAS-1440516-42-6), 4-(but-2-en1 -yloxy)-6-(3,5-dimethylpiperidin-1 -yl)-5-fluoropyrimidine (known from WO2004 / 099160) (CAS 792914-58-0), PF1364 (known from JP2010 / 018586) (CAS Reg. No. 1204776-60-2), (3E)-3-[1-[(6-chloro-3 -pyridyl)methyl]-2-pyridylidene]1,1,1-trifluoropropan-2-one (known from WO2013 / 144213) (CAS 1461743-15-6), N-[3-(benzylcarbamoyl)-4-chlorophenyl] -1-methyl-3-(pentafluoroethyl)-4-(trifluoromethyl)1H-pyrazole-5-carboxamide (known from WO2010 / 051926) (CAS 1226889-140), 5-bromo-4-chloro-N-[4- chloro-2-methyl-6-(methylcarbamoyl)phenyl]-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide (known from CN103232431) (CAS 1449220-44-3), 4-[5-(3, 5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1oxido-3-thiethanyl)benzamide, 4-[5-(3,5-dichlorophenyl )-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(trans-1-oxido-3-thiethanyl)benzamide and 4-[(5S)-5-(3,5-dichlorophenyl )-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxido-3thiethanyl)benzamide (known from WO 2013 / 050317 A1) (CAS 1332628-83- 7), N[3-chloro-1 -(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3trifluoropropyl )sulfinyl]propanamide, (+)-N-[3-chloro-1 -(3-pyridinyl)-1H-pyrazol-4-yl]N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl] propanamide and (-)-N-[3-chloro-1-(3-pyridinyl)1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]propanamide (known from WO 2013 / 162715 A2, WO 2013 / 162716 A2, US 2014 / 0213448 A1) (CAS 1477923-37-7), 5-[[(2E)-3-chloro-2-propen-1-yl]amino] -1-[2,6-dichloro-4(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile (known from CN 101337937 A) (CAS 1105672-77-2), 3 -bromo-N-[4-chloro-2-methyl-6[(methylamino)thioxomethyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide, (Liudaibenjiaxuanan, known from CN 103109816A) (CAS 1232543-85-9); N[4-chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3(fluoromethoxy)-1H-pyrazole-5- carboxamide (known from WO 2012 / 034403 A1) (CAS 1268277-22-0), N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl] -3bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (known from WO 2011 / 085575 A1) (CAS 1233882-22-8), 4-[3-[2,6-dichloro-4-[(3,3-dichloro-2propen-1-yl)oxy]phenoxy]propoxy]-2 -methoxy-6-(trifluoromethyl)pyrimidine (known from CN 101337940 A) (CAS 1108184-52-6); (2E)- and 2(Z)-2-[2-(4-cyanophenyl)-1-[3(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]hydrazinecarboxamide (known from CN 101715774 A ) (CAS 1232543-85-9); 3(2,2-dichloroethenyl)-2,2-dimethyl-4-(1H-benzimidazol-2-yl)-cyclopropanecarboxylic acid phenyl ester (known from CN 103524422 A) (CAS 1542271-46-4); (4aS)-7-chloro-2,5-dihydro-2-[[(methoxycarbonyl)[467 acid methyl ester [(trifluoromethyl)thio]phenyl]amino]carbonyl]indeno[1,2-e][1,3,4]oxadiazin-4a(3H)carboxylic acid (known from CN 102391261 A) (CAS 1370358-69-2); 6-deoxy-3-Oethyl-2,4-di-O-methyl-1 -[N-[4-[1 -[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]-1H- 1,2,4-triazol3-yl]phenyl]carbamate]-a-L-mannopyranose (known from US 2014 / 0275503 A1) (CAS 1181213-14-8); 8-(2-cyclopropylmethoxy-4-trifluoromethylphenoxy)-3-(6trifluoromethylpyridazin-3-yl)-3-azabicyclo[3.2.1]octane (CAS 1253850-56-4), (8anti)-8-(2-cyclopropylmethoxy -4-trifluoromethylphenoxy)-3-(6-trifluoromethylpyridazin-3-yl)3-azabicyclo[3.2.1]octane (CAS 933798-27-7), (8-syn)-8-(2-cyclopropylmethoxy-4trifluoromethylphenoxy) -3-(6-trifluoromethylpyridazin-3-yl)-3-azabicyclo[3.2.1]octane (known from WO 2007040280 A1, WO 2007040282 A1) (CAS 934001-66-8), N-[3-chloro-1 -(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)thio]propanamide (known from WO 2015 / 058021 A1, WO 2015 / 058028 A1) (CAS 1477919-27-9) and N-[4-(aminothioxomethyl)-2-methyl-6-[(methylamino)carbonyl]phenyl]-3bromo-1-(3-chloro-2-pyridinyl)-1 H- pyrazole-5-carboxamide (known from CN 103265527 A) (CAS 1452877-50-7), 5-(1,3-dioxan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methoxy]-pyrimidine (known from WO 2013 / 115391 A1) (CAS 1449021-97-9),3(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-1,8-diazaspiro[4.5]decane-2,4-dione (known from WO 2014 / 187846 A1) (CAS 1638765-58-8), 3(4-Chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-2-oxo-1,8-diazaspiro[4.5]dec Acid Ethyl Ester -3-en-4yl-carboxylic (known from WO 2010 / 066780 A1, WO 2011 / 151146 A1) (CAS 1229023-00-0), 4-[(5S)-5-(3,5-dichloro-4- fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)3-isoxazolyl]-N-[(4 R )-2-ethyl-3-oxo-4-isoxazolidinyl]-2-methyl-benzamide (known from WO 2011 / 067272, WO2013 / 050302) (CAS 1309959-62-3). fungicides The active compounds specified herein by their "common names" are known and are described, for example, in the "Pesticide Manual" (16th edition, British Crop Protection Council 2012) or on the Internet (for example at http: / / www.alanwood .net / pesticides). Furthermore, all mixing members of Classes (1) to (15) may optionally form salts with suitable bases or acids, based on their functional groups. All of the aforementioned fungicidal mixing members of classes (1) to (15) may optionally include their tautomeric forms. 1) Ergosterol biosynthesis inhibitors, for example (1.001) cyproconazole, (1.002) difenoconazole, (1.003) epoxiconazole, (1.004) phenhexamide, (1.005) fenpropidine, (1.006) fenpropimorph, (1.007) fenpyrazamine, (1.008) fluquinconazole , (1,009) flutriafol, (1,010) imazalil, (1,011) imazalil sulfate, (1,012) ipconazole, (1,013) metconazole, (1,014) myclobutanil, (1,015) paclobutrazol, (1,016) prochloroaz, (1,017) propiconazole, (1,018 ) prothioconazole, (1.019)pyrisoxazole, (1.020)spiroxamine, (1.021)tebuconazole, (1.022)tetraconazole, (1.023)triadimenol, (1.024)tridemorph, (1.025)triticonazole, (1.026) (1R,2S,5S)-5 -(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1ylmethyl)cyclopentanol, (1.027) (1S,2R,5R)-5-(4- chlorobenzyl)-2-(chloromethyl)-2-methyl1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.028) (2R)-2-(1-chlorocyclopropyl)-4- [(1R)-2,2-dichlorocyclopropyl]-1 -(1H-1,2,4-triazol-1 -yl)butan-2-ol (1.029) (2R)-2-(1-chlorocyclopropyl)-4- [(1S)-2,2-dichlorocyclopropyl]-1 -(1H-1,2,4-triazol-1 -yl)butan-2-ol, (1.030) (2R)-2-[4-(4- chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1H-1,2,4-triazol-1 yl)propan-2-ol, (1.031) (2S)-2-(1-chlorocyclopropyl)-4- [(1R)-2,2-dichlorocyclopropyl]1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.032) (2S)-2-(1-chlorocyclopropyl)-4 -[(1S)-2,2-dichlorocyclopropyl]-1 -(1 H-1,2,4-triazol-1 -yl)butan-2-ol, (1.033) (2S)-2-[4-(4-chlorophenoxy )-2-(trifluoromethyl)phenyl]-1 -(1H-1,2,4-triazol-1 -yl)propan-2-ol, (1.034) (R)-[3-(4-chloro-2- fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3yl)methanol, (1.035) (S)-[3-(4-chloro-2-fluorophenyl)- 5-(2,4-difluorophenyl)-1,2-oxazol-4yl](pyridin-3-yl)methanol, (1.036) [3-(4-chloro-2-fluorophenyl)-5-(2,4- difluorophenyl)-1,2oxazol-4-yl](pyridin-3-yl)methanol, (1.037) 1 -({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4- methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.038) 1 ({(2S,4S )-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H1,2,4-triazole, (1.039) 1 -{ [3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H1,2,4-triazol-5-yl-thiocyanate, (1.040) 1 -{[rel( 2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl-thiocyanate, (1.041) 1{ [rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol5-yl-thiocyanate, (1.042 ) 2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4 -triazol-3-thione, (1.043) 2-[(2R,4R,5S)-1(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4 -dihydro-3H-1,2,4-triazol3-thione, (1.044) 2-[(2R,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan4 -yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.045) 2-[(2R,4S,5S)-1-(2,4dichlorophenyl)-5-hydroxy- 2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3thione, (1.046) 2-[(2S,4R,5R)-1-(2, 4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, ( 1047) 2-[(2S,4R,5S)-1 -(2,4-dichlorophenyl)5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2 ,4-triazol-3-thione, (1.048) 2[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2 ,4-dihydro3H-1,2,4-triazol-3-thione, (1.049) 2-[(2S,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy2,6,6-trimethylheptan -4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1,050) 2-[1 -(2,4-dichlorophenyl)-5-hydroxy-2,6,6- trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3thione, (1.051) 2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-1 -( 1 H-1,2,4-triazol-1 70 yl)propan-2-ol, (1.052) 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1H-1,2, 4-triazol-1 yl)butan-2-ol, (1.053) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1H-1,2,4triazol-1 -yl) butan-2-ol, (1.054) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1H1,2,4-triazol-1-yl)pentan-2-ol, ( 1.055) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1(1H-1,2,4-triazol-1 -yl)propan-2-ol, (1.056) 2-{[ 3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol- 3-thione, (1.057) 2{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H1 ,2,4-triazol-3-thione, (1.058) 2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2 ,4-dihydro-3H-1,2,4-triazol-3-thione, (1.059) 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1 -(1H-1,2,4-triazole -1 -ylmethyl)cyclopentanol, (1060) 5-(allylsulfanyl)-1 -{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H1,2, 4-triazole, (1.061) 5-(allylsulfanyl)-1 -{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4difluorophenyl)oxiran-2-yl]methyl}-1H- 1,2,4-triazole, (1.062) 5-(allylsulfanyl)-1{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl] methyl}-1H-1,2,4-triazole, (1.063)N'-(2,5-dimethyl-4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)- N-ethyl-N-methylimidoformamide, (1.064) N'-(2,5-dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (1.065) N'-(2,5-dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (1.066) N'-(2 ,5-dimethyl-4-{[3(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (1.067) N'(2,5-dimethyl-4-{3-[(1.1 ,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (1.068) N'-(2,5-dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy} phenyl)-N-ethyl-N-methylimidoformamide, (1.069) N'-(2,5dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl- N-methylimidoformamide, (1.070) N'-(2,5-dimethyl-4-{371 [(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (1.071) N'(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylimidoformamide, (1.072) N'- (4-{[3(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide, (1.073) N'-(4-{3-[(difluoromethyl)sulfanyl]phenoxy}- 2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide, (1,074) N'-[5-bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N -ethyl-N-methylimidoformamide, (1.075) N'-{4-[(4,5-dichloro-1,3thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide, (1.076) N'-{5-bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.077) N'-{ 5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.078)N'-{5-bromo-6 -[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.079) N'-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy] -2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.080)N'-{5-Bromo-6-[1 -(3,5-difluorophenyl) ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.081) mefentrifluconazole, (1.082) ipfentrifluconazole. 2) Respiratory chain inhibitors in complex I or II such as (2,001) benzovindiflupyr, (2,002) bixafeno, (2,003) boscalide, (2,004) carboxine, (2,005) fluopyram, (2,006) flutolanil, (2,007) fluxapiroxad , (2.008) furametpyr, (2.009) isofetamide, (2.010) isopyrazam (1R,4S,9S anti-epimeric enantiomers), (2.011) isopyrazam (1R,4S,9S anti-epimeric enantiomers 1S,4R,9R), (2.012) isopyrazam (1RS,4SR,9SR anti-epimeric racemate), (2.013) isopyrazam (mixture of 1RS,4SR,9RS syn-epimeric racemates and 1RS,4SR,9SR anti-epimeric racemates), (2.014) isopyrazam (1R,4S,9R synepimeric enantiomers), (2.015) isopyrazam (1R,4S,9R syn-epimeric enantiomers 1S,4R,9S), (2,016) Isopyrazam (syn-epimeric racemates 1RS,4SR,9RS), (2,017) penflufen, (2,018) penthiopyrad, (2,019) pidiflumetofen, (2,020) pyraziflumide, (2,021) sedaxane, (2,022 ) 1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.023) 1,3-dimethyl-N- [(3R)-1,1,3trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2,024) 1,3-dimethylN-[(3S)-1, 1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.025) 1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl )biphenyl-2-yl]-1H-pyrazole-4carboxamide, (2,026) 2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1Hinden-4-yl) benzamide, (2.027) 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.028) 3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.029) 3 -(difluoromethyl)-1 -methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]1H-pyrazole-4-carboxamide, (2.030) 3 -(difluoromethyl)-N-(7-fl uoro-1,1,3-trimethyl2,3-dihydro-1H-inden-4-yl)-1 -methyl-1H-pyrazole-4-carboxamide, (2.031) 3(difluoromethyl)-N-[(3R)- 7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1 -methyl1H-pyrazole-4-carboxamide, (2.032) 3-(difluoromethyl)-N-[( 3S)-7-fluoro-1,1,3trimethyl-2,3-dihydro-1H-inden-4-yl]-1 -methyl-1H-pyrazole-4-carboxamide, (2.033) 5,8difluoro-N-[ 2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4amine, (2.034)N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl -3-(difluoromethyl)-5fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.035) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro- 1-methyl-1H-pyrazole-4-carboxamide, (2.036) N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4carboxamide, ( 2.037) N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.038) N-(5-chloro-2- isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1 -methyl-1H-pyrazole-4-carboxamide, (2.039) N-[(1R,4S)-9-(dic loromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-373 (difluoromethyl)-l-methyl-1H-pyrazole-4-carboxamide, (2.040)N-[(1S, 4R)-9(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2,041) N -[1-(2,4-dichlorophenyl)-1-methoxypropan2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.042) N-[2-chloro-6(trifluoromethyl )benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4carboxamide, (2.043) N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]- N-cyclopropyl-3(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.044) N-[5-chloro-2(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl )-5-fluoro-1-methyl-1H-pyrazole-4carboxamide, (2,045) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1 -methyl-N-[5-methyl2-(trifluoromethyl)benzyl]- 1H-pyrazole-4-carboxamide, (2.046) N-cyclopropyl-3(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4carboxamide, (2.047) N -cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2- isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2,048) N-cyclopropyl-3(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4 -carbothioamide, (2.049) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1 -methyl-1H-pyrazole-4-carboxamide, (2.050) N-cyclopropyl-3-(difluoromethyl) -5-fluoro-N-(5fluoro-2-isopropylbenzyl)-1 -methyl-1H-pyrazole-4-carboxamide, (2,051) N-cyclopropyl3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl )-5-fluoro-1-methyl-1H-pyrazole-4carboxamide, (2,052) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5fluoro-1-methyl-1H-pyrazole -4-carboxamide, (2.053) N-cyclopropyl-3-(difluoromethyl)N-(2-ethyl-5-methylbenzyl)-5-fluoro-1 -methyl-1H-pyrazole-4-carboxamide, (2.054) N-cyclopropyl- N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.055) N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl) -3(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.056) N-cyclopropylN-(2-cyclopropylbenzyl)-3-(difluoromethyl) -5-fluoro-1-methyl-1H-pyrazole-474 carboxamide. 3) Respiratory chain inhibitors in complex III, for example (3,001) ametoctradine, (3,002) amisulbrom, (3,003) azoxystrobin, (3,004) coumetoxystrobin, (3,005) coumoxystrobin, (3,006) cyazofamide, (3,007) dimoxystrobin, ( 3,008) Enoxastrobin, (3,009) Famoxadone, (3,010) Fenamidone, (3,011) Fluphenoxystrobin, (3,012) Fluoxastrobin, (3,013) Kresoxymmethyl, (3,014) Methaminostrobin, (3,015) Orysastrobin, (3,016) Picoxystrobin, (3,017) Pyraclostrobin, ( 3,018) Pyramethostrobin, (3,019) Pyroxystrobin, (3,020) Trifloxystrobin (3,021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2- phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (3.022) (2E,3Z)-5-{[1 -(4-chlorophenyl)-1H-pyrazole- 3-yl]oxy}-2(methoxyimino)-N,3-dimethylpent-3-enamide, (3.023) (2R)-2-{2-[(2,5dimethylphenoxy)methyl]phenyl}-2-methoxy-N -methylacetamide, (3.024) (2S)-2-{2-[(2,5dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.025) (3S,6S,7R,8R)-8benzyl-3 -[({3-[(isobutyryloxy)methoxy]- 4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl4,9-dioxo-1,5-dioxonan-7-yl-2-methylpropanoate, (3.026) 2-{2-[(2,5dimethylphenoxy)methyl ]phenyl}-2-methoxy-N-methylacetamide, (3.027) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide, (3.028) (2E,3Z)-5-{[ 1-(4chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3enamide, (3.029) {5-[3-(2,4-dimethylphenyl Methyl )-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate. 4) Mitosis and cell division inhibitors, for example (4,001) carbendazim, (4,002) diethofencarb, (4,003) etaboxam, (4,004) fluopicolide, (4,005) pencycuron, (4,006) thiabendazole, (4,007) thiophanate- methyl, (4.008) zoxamide, (4.009) 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine, (4.010) 3-chloro-5-(4-chlorophenyl)-4-( 2,6-difluorophenyl)-6-methylpyridazine, (4.011) 3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine, (4.012) 4- (2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.013) 4-(2-bromo-4-fluorophenyl)-N-( 2-bromo-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5amine, (4.014) 4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl- 1H-pyrazol5-amine, (4.015) 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl1H-pyrazol-5-amine, (4.016) 4- (2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3dimethyl-1H-pyrazol-5-amine, (4.017) 4-(2-bromo-4-fluorophenyl)-N-(2- fluorophenyl)1,3-dimethyl-1H-pyrazol-5-amine, (4.018) 4-(2-cl oro-4-fluorophenyl)-N-(2,6difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.019) 4-(2-chloro-4-fluorophenyl)-N(2-chloro- 6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.020) 4-(2-chloro-4fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol- 5-amine, (4.021) 4-(2-chloro-4fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.022) 4-(4chlorophenyl)-5- (2,6-difluorophenyl)-3,6-dimethylpyridazin, (4,023) N-(2-bromo-6fluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5 -amine, (4.024) N-(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.025) N(4-chloro-2,6 -difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine. 5) Compounds capable of activity at multiple sites, for example (5,001) Bordeaux mixture, (5,002) captafol, (5,003) captan, (5,004) chlorothalonil, (5,005) copper hydroxide, (5,006) copper naphthenate, ( 5.007) copper oxide, (5.008) copper oxychloride, (5.009) copper(2+) sulfate, (5.010) dithianone, (5.011) dodine, (5.012) folpet, (5.013) mancozeb, (5.014) maneb, ( 5.015) metiram, (5.016) metiram-zinc, (5.017) oxine-copper, (5.018) propineb, (5.019) sulfur and sulfur preparations including calcium polysulfide, (5.020) thiram, (5.021) zineb, (5.022) ziram , (5.023) 6-ethyl-5,7-dioxo-6,7dihydro-5H-pyrrolo[3',4':5.6][1,4]dithiino[2,3-c][1,2] thiazole-3-carbonitrile. 6) Compounds with the capacity to generate defense in the host, for example (6,001) acibenzolar-S-methyl, (6,002) isotianil, (6,003) probenazol, (6,004) tiadinil. 7) Amino acid and / or protein biosynthesis inhibitors, for example (7,001) cyprodinil, (7,002) kasugamycin, (7,003) kasugamycin hydrochloride hydrate, (7,004) oxytetracycline, (7,005) pyrimethanil, (7,006) 3(5-fluoro -3,3,4,4-tetramethyl-3,4-dihydroisoquiinolin-1-yl)quinoline. (8) ATP production inhibitors, for example (8,001) silthiofam. 9) Cell wall synthesis inhibitors, for example (9,001) benthiavalicarb, (9,002) dimethomorph, (9,003) flumorph, (9,004) iprovalicarb, (9,005) mandipropamid, (9,006) pirimorph, (9,007) valifenalate, , ( 9.008) (2E)-3-(4-tertbutylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, (9.009) (2Z )-3- (4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one. 10) Lipid and membrane synthesis inhibitors, eg (10,001) propamocarb, (10,002) propamocarb hydrochloride, (10,003) tolclofosmethyl. 11) Melanin biosynthesis inhibitors, for example (11,001) tricyclazole, (11,002) 2,2,2-trifluoroethyl-{3-methyl-1-[(4-methylbenzoyl)amino]butan-2yl}carbamate. 12) Nucleic acid synthesis inhibitors, eg (12,001) benalaxyl, (12,002) benalaxyl-M (kiralaxyl), (12,003) metalaxyl, (12,004) metalaxyl-M (mefenoxam). 13) Signal transduction inhibitors, eg (13,001) fludioxonil, (13,002) iprodione, (13,003) procymidone, (13,004) proquinazid, (13,005) quinoxyfen, (13,006) vinclozolin. 14) Compounds capable of acting as uncoupling agents, for example (14,001) fluazinam, (14,002) meptyldinocap. 15) Other compounds, e.g. (15,001) abscisic acid, (15,002) benthiazole, (15,003) betoxazine, (15,004) capsimycin, (15,005) carvone, (15,006) quinomethionate, (15,007) cufraneb, (15,008) cyflufenamide, (15,009 ) cymoxanil, (15.010) cyprosulfamide, (15.011) flutianil, (15.012) fosetilaluminum, (15.013) fosetyl-calcium, (15.014) fosetyl-sodium, (15.015) methylisothiocyanate, (15.016) metrafenone, (15.017) mildiomycin, (15.018) Natamycin, (15,019) Nickel Dimethyldithiocarbamate, (15,020) Nitrothalysopropyl, (15,021) Oxamocarb, (15,022) Oxathiapiproline, (15,023) Oxyfenthiine, (15,024) Pentachlorophenol and its salts, (15,025) Phosphonic Acid and its salts, (15,026) Propamocarb -fosetilat, (15,027) pyriophenone (clazafenone) (15,028) tebufloquine, (15,029) tecloftalam, (15,030) tolnifanide, (15,031) 1-(4-{4-[(5R)-5(2,6-difluorophenyl)- 4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1 -yl]ethanone, (15.032) 1 -(4-{4-[(5S)-5-(2,6- difluoropheni l)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3(trifluoromethyl)-1H -pyrazol-1-yl]ethanone, (15,033) 2-(6-benzylpyridin-2yl)quinazoline, (15,034) 2,6-dimethyl-1 H,5H-[1,4]dithiino[2,3-c: 5,6-c']dipyrrol-1,3,5,7(2H,6H)-tetrone, (15,035) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1 -[4 -(4{5-[2-(prop-2-en-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl) piperidin1-yl]ethanone, (15,036) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro6-(prop-2 -en-1 -yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1 yl]ethanone, (15.037) 2-[ 3,5-bis(difluoromethyl)-1H-pyrazol-1 -yl]-1 -[4-(4-{5-[2-fluoro 6-(prop-2-en-1 -yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1 yl]ethanone, (15.038) 2-{(5R)-3-[2-(1-{[ 3,5-bis(difluoromethyl)-1H-pyrazol-1yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl 2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1yl]acetyl}piperidin-4-yl }-3-chlorophenyl, (15,040) methanesulfonate )-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl, (15.041) 2-{2-[(7,8-difluoro- 2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2-ol, (15.042) 2-{2-fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1yl]acetyl}piperidin-4-yl)-1 }propan-2-ol, (15.043) methanesulfonate 2-{3-[2-(1-{[3 ,5-bis(difluoromethyl)-1H-pyrazol-1yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl} phenyl, (15.045) 2-phenylphenol and its salts, (15,046) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4dihydroisoquinolin-1 -yl)quinoline, (15,047) 3-(4,4-difluoro-3,3- dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.048) 4-amino-5-fluoropyrimidin-2-ol (Tautomeric form: 4-amino-5-fluoropyrimidin-2(1H)-one), (15.049) acid 4-oxo-4-[(2-phenylethyl)amino]butyric acid, (15.050) 5-amino-1,3,4-thiadiazole-2-thiol, (15.051) 5-chloroN'-phenyl-N'-(prop-2 -yn-1-yl)thiophene-2-sulfonhydrazide, (15.052) 5-fluoro-2-[(4fluorobenzyl)oxy]pyrimidin-4-amine, (15.053) 5-fluoro-2-[(4methylbenzyl)oxy]pyrimidin -4-amine, (15,054) 9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)2,3-dihydro-1,4-benzoxazepine, (15,055) but-3-yn-1- ylo {6-[({[(Z)-(1-methyl-1Htetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, (15.056) (2Z)-3amino Ethyl -2-cyano-3-phenylacrylate, (15,057) Phenazin-1-carboxylic acid, (15,058) Propyl 3,4,5-trihydroxybenzoate, (15,059) Quinolin-8-ol, (15,060) Quinoline sulfate 8-ol (2:1), (15.061) {6-[({[(1-methyl-1H-tetrazol-5 yl)(phenyl)methylene] tert-butyl amino}oxy)methyl]pyridin-2-yl}carbamate, (15,062) 5fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2( 1H)-one. Biological pesticides as components of mixtures The compounds of Formula (I) can be combined with biological pesticides. Biological pesticides include, in particular, bacteria, fungi, yeasts, plant extracts and the products formed by microorganisms, including proteins and secondary metabolites. Biological pesticides include bacteria such as spore-forming bacteria, root-colonizing bacteria, and bacteria that act as biological insecticides, fungicides, or nematicides. Examples of bacteria that can be used as biological pesticides are: Bacillus amyloliquefaciens, strain FZB42 (DSM 231179), or Bacillus cereus, in particular B. cereus strain CNCM I-1562 or Bacillus firmus strain I-1582 (CNCM Accession No. I-1582) or Bacillus pumilus, in particular strain GB34 (ATCC Accession No. 700814) and strain QST2808 (Accession No. NRRL B-30087) or Bacillus subtilis, in particular strain GB03 (ATCC Accession No. SD1397) or strain QST713 of Bacillus subtilis (Accession No. NRRL B-21661) or Bacillus subtilis strain OST 30002 (NRRL Accession No. B-50421), Bacillus thuringiensis, in particular B. thuringiensis, subspecies israelensis (serotype H14), strain AM65-52 (ATCC Accession No. 1276) , or B. thuringiensis subsp. aizawai, in particular strain ABTS-1857 (SD-1372), or B. thuringiensis subsp. Kurstaki, strain HD-1, or B. thuringiensis subsp. Tenebrionis, strain NB 176 (SD-5428), Pasteuria penetrans, Pasteuria spp (nematode Rotilenchulus reniformie)-PR3 (ATCC Accession No. SD-5834), Streptomyces microflavus, strain AQ6121 (= QRD 31.013, NRRL B-50550), Streptomyces galbus, strain AQ 6047 (NRRL Accession No. 30232). Examples of fungi and yeasts that can be used as biological pesticides are: Beauveria bassiana, in particular the ATCC 74040 strain, Coniothirium minitans, in particular the CON / M / 91-8 strain (Accession No. DSM-9660), Lecanicillium spp, in particular the HRO LEC 12 strain, Lecanicillium lecanii (formerly known as Verticillium lecanii), in particular strain KV01, Metarhizium anisopliae, in particular strain F52 (DSM3884 / ATCC 90448), Metschnikowia fructicola, in particular strain NRRL Y-30752, Paecilomyces fumosoroseus (now: Isaria fumosorosea), in particular strain IFPC 200613 or the strain Apopka 97 (ATCC Accession No. 20874), Paecilomyces lilacinus, in particular the strain 251 of P. lilacinus (AGAL 89 / 030550), Talaromyces flavus, in particular the strain V117b, Trichoderma atroviride, in particular the strain SC1 (CBS Accession No. 122089), Trichoderma harzianum, in particular T. harzianum rifai T39 (CNCM Accession No. I-952). Examples of viruses that can be used as biological pesticides are: Adoxophyes orana (apple peel leafroller), granulovirus (GV), Cydia pomonella (apple leafroller) granulovirus (GV), Helicoverpa armigera (cotton bollworm), nuclear polyhedrosis virus (NPV), Spodoptera exigua beet) mNPV, Spodoptera frugiperda (fall armyworm) mNPV, Spodoptera littoralis (African cotton bollworm) NPV. They also include bacteria and fungi, which are added as 'inoculants' to plants or plant parts or plant organs and promote plant growth and plant health by their special properties. Examples can be mentioned: Agrobacterium spp, Azorhizobium caulinodans, Azospirillum spp, Azotobacter spp, Bradyrhizobium spp, Burkholderia spp, in particular Burkholderia cepacia (previously known as Pseudomonas cepacia), Gigaspora spp or Gigaspora monosporum, Glomus spp, Laccaria spp, Lactobacillus buchneri, Paraglomus tinctorus spp, Pisolithus , Pseudomonas spp, Rhizobium spp, in particular Rhizobium trifolii, Rhizopogon spp, Scleroderma spp, Suillus spp, Streptomyces spp. Examples of plant extracts and products formed by microorganisms, including proteins and secondary metabolites, that can be used as biological pesticides are: Allium sativum, Artemisia absinthium, Azadirachtin, Biokeeper WP, Cassia nigricans, Celastrus angulatus, Chenopodium anthelminticum, Chitin, Armour-Zen, Dryopteris filix-mas, Equisetum arvense, Fortune Aza, Fungastop, Heads Up (Chenopodium quinoa saponin extract), pyrethrum / pyrethrin, Quassia amara, Quercus, Quillaja, Regalia, “Requiem™ Insecticide11, rotenone, ryania / ryanodine, Symphytum officinale, Tanacetum vulgare, thymol, Triact 70, triCon, Tropaeulum majus, Urtica dioica, veratrin, Viscum album, extract of Brassica, in particular rapeseed or mustard powder. Protectors as components of mixtures The compounds of Formula (I) can be combined with safeners, such as, for example, benoxacor, cloquintocet (-mexil), cyometrinil, cyprosulfamide, dichloromide, fenchloroazole (-ethyl), fenchlorim, flurazole, fluxofenim, furilazole, isoxadiphene ( -ethyl), mefenpyr (-diethyl), naphthalic anhydride, oxabetrinil, 2-methoxy-N-({4-[(methylcarbamoyl)amino]phenyl}sulfonyl)benzamide (CAS 12953112-0), 4-(dichloroacetyl)-1 -oxa-4-azaspiro[4.5]decane (CAS 71526-07-3), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (CAS 52836-31-4). Plants and plant parts All plants and plant parts can be treated according to the methods of the invention. Plants are construed herein as all plants and populations of plants, such as wanted and unwanted wild plants or crop plants (including natural crop plants), for example for example cereals (wheat, rice, triticale, barley, rye, oats), corn, soybeans, potatoes, sugar beets, sugar cane, tomatoes, peppers, cucumber, melon, carrot, watermelon, onion, lettuce, spinach, leek, bean, Brassica oleracea (for example, cabbage) and other vegetables, cotton, tobacco, rapeseed, as well as fruit plants (with the fruits apples, pears, citrus and grapes). Crop plants may be plants obtainable by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or by combinations of these methods, including transgenic plants and also including plant cultivars that may be protected, or not, by breeders' rights. Plants should be understood to encompass all stages of development, such as seeds, cuttings, young (immature) plants, and mature plants. Plant parts shall include all aerial and subterranean plant parts and organs of plants, such as shoots, leaves, flowers and roots, and examples may include leaves, needles, branches, stems, flowers, fruiting bodies, fruits and seeds, roots, tubers, and rhizomes. Plant parts also include harvested crop material and vegetative and generative propagation material, for example, cuttings, tubers, rhizomes, cuttings and seeds. The treatment according to the invention of plants and parts of plants with the compounds of Formula (I) is carried out directly or by the action of the compounds on the environment, habitat or storage space in accordance with the usual treatment methods, for example by dipping, spraying, evaporation, fogging, spreading, dispersing, injection and propagating material, in particular with seeds, as well as single or multi-layer coatings. As already mentioned above, all plants and their parts can be treated according to the invention. In a preferred embodiment, common or wild-type plant species and plant varieties obtained by conventional biological breeding methods such as crossing or fusion of protoplasts and parts thereof are treated. In a further preferred embodiment, transgenic plants or plant cultivars obtained by genetic engineering in combination with conventional methods (genetically modified organisms) and parts thereof are treated. The terms "plants" or "parts of plants" have already been described above. According to the invention, it is particularly preferred to treat plants of respective commercially available or in-use plant cultivars. Plant varieties mean plants with new properties (“traits), which were obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques. They can include varieties, races, biotypes and genotypes. Transgenic plants, seed treatment and integration events Preferred plants or plant cultivars to be treated according to the invention include all plants which, as a result of genetic modification, have obtained genetic material which endows these plants with particularly advantageous valuable properties (traits). Examples of such properties include improved plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or soil water or salt content, increased flowering efficiency, easier harvesting, accelerated maturity, higher crop yields, higher quality and / or higher nutritional value of harvested products, longer shelf life and / or manageability of harvested products. Additional and particularly preferred examples of said properties comprise an increased resistance of plants to attack by animal pests and microorganisms, such as insects, arachnids, nematodes, mites, snails, caused, for example, by toxins produced in plants , in particular those produced by the genetic material of Bacillus thuringiensis (for example, by the genes CryIA (a), CryIA (b), CryIA (c), CryIIA, CryIIIA, CryIIIB2, Cry9c Cry2Ab, Cry3Bb and CryIF and combinations of the same) occurring in plants, also an increased resistance of plants to plant pathogenic fungi, bacteria and / or viruses, caused, for example, by systemic acquired resistance (SAR), systemin, phytoalexins, inducers and genes of resistance and correspondingly expressed proteins and toxins, as well as increased plant tolerance to certain herbicidally active compounds, e.g. imidazolinones, sulfonylureas, glyphose to or phosphinothricin (for example, the PAT gene). The genes that confer the desired properties (traits) can also be combined with each other in the transgenic plants. Examples of transgenic plants include major crops such as cereals (wheat, rice, triticale, barley, rye, oats), corn, soybeans, potatoes, sugar beets, sugar cane, tomatoes, peas and other vegetables, cotton, tobacco, oilseed rape and fruit trees (including apples, pears, citrus and grapes), preferably corn, soybeans, wheat, rice, potatoes, cotton, sugar cane, tobacco and rapeseed. Especially preferred properties (traits) are increased resistance of plants to insects, arachnids, nematodes and snails. Plant protection: types of treatment The treatment of plants and parts of plants with the compounds of Formula (I) is carried out directly or by acting on their environment, habitat or storage space according to the usual treatment methods, for example, by immersion, spraying spraying, sprinkling, misting, spraying, atomizing, dispersing, foaming, spreading, running off, injection, spilling (soaking), drip irrigation and spreading on a material, especially on seeds, also by dry coating, wet coating , mud lining, fouling, or multi-layer coatings, etc. It is also possible to apply the compounds of Formula (I) by the ultra low volume method or by injection of the application form or the compound of Formula (I) into the soil. A preferred direct treatment of plants is foliar application, that is, the compounds of Formula (I) are applied to the foliage, where the frequency of treatment and the application rate must be matched to the pressure of the pest infestation. respective. In the case of systemically active substances, the compounds of Formula (I) can also enter plants through the root system. The treatment of the plants is then carried out by the action of the compounds of Formula (I) in the habitat of the plant. This can be done, for example, by soaking, mixing with the soil or a nutrient solution, i.e. the location of the plant (for example, in the soil or with hydroponic systems) is impregnated with a liquid form of the nutrient compounds. Formula (I), or by application to the soil, that is, the compounds of Formula (I) according to the invention are incorporated in solid form (for example, in the form of granules) at the location of plants , or by drip application (often also called chemigation), i.e. the compounds of Formula (I) according to the invention are introduced via surface or underground drip tubes for certain periods, together with varying amounts of water in defined places near the plants. In rice crops in water, this can also be done by a metered addition of the compound of Formula (I) in solid form (eg as granules) to a flooded rice field. seed treatment The control of animal pests by treating the seeds of plants has been known for a long time and is the subject of constant improvement. However, there are a number of problems with seed treatment that cannot always be resolved satisfactorily. Therefore, it is desirable to develop methods for protecting seeds and germinating plants that eliminate or at least significantly reduce additional pesticide application during storage, after planting, or after plant emergence. Furthermore, it is desirable to optimize the amount of the active ingredient used in such a way that the germinating seeds and plants are better protected against attack by animal pests, but without harming the plant itself with the active ingredient used. In particular, seed treatment methods should also incorporate the intrinsic insecticidal or nematicidal properties of transgenic pest-resistant plants to achieve optimal protection of seeds and also germinating plants with minimal pesticide cost. Therefore, the present invention relates more particularly to a method of protecting seeds and germinating plants against attack by pests by treating the seeds with one of the compounds of Formula (I). The method according to the invention for protecting germinating seeds and plants against pest infestation further comprises a method, in which the seeds are treated simultaneously in one operation or successively with a compound of Formula (I) and a component of the mixture. It also comprises a process in which the seeds are treated at different times with a compound of Formula (I) and a component of the mixture. The invention also relates to the use of the compounds of Formula (I) in seed treatment to protect the seeds and the resulting plants against animal pests. Furthermore, the invention relates to seeds that have been treated to achieve protection against animal pests with a compound of the formula (I) according to the invention. The invention also relates to seeds treated at the same time with a compound of Formula (I) and a component of the mixture. The invention further relates to seeds that were treated at different times with a compound of Formula (I) and a component of the mixture. In the case of seeds that have been treated at different times with a compound of Formula (I) and a component of the mixture, the individual substances may be present in different layers on the seed. In this case, the layers comprising a compound of Formula (I) and the components of the mixture may optionally be separated by an intermediate layer. The invention also relates to seeds to which a compound of Formula (I) and a blend component are applied as part of a coating or as an additional layer or as additional layers in addition to a coating. Furthermore, the invention relates to seeds which, after treatment with a compound of Formula (I), are subjected to a film coating process to prevent dust abrasion on the seed. One of the advantages obtained when a compound of Formula (I) acts systemically is that the seed treatment protects not only the seeds themselves, but also the resulting plants after emergence against animal pests. In this way, immediate treatment of the crop at planting time or shortly thereafter can be omitted. Another advantage is the fact that by treating the seeds with a compound of Formula (I) the germination and emergence of the treated seeds can be promoted. Likewise, it is considered advantageous that the compounds of Formula (I) can also be used, particularly in the case of transgenic seeds. The compounds of Formula (I) can also be used in combination with signal transduction agents, whereby enhanced colonization with symbionts such as rhizobia, mycorrhizae and / or endophytic bacteria or fungi occurs and / or fixation occurs. optimized nitrogen. The compounds of Formula (I) are suitable for the protection of seeds of any variety of plants used in agriculture, in greenhouses, in forests or in horticulture. In particular, they include seeds of cereals (for example wheat, barley, rye, millet and oats), corn, cotton, soybeans, rice, potatoes, sunflower, coffee, tobacco, canola, rapeseed, turnip (for example sugar beet and fodder beet), peanuts, vegetables (for example, tomato, cucumber, broad bean, cabbage, onion and lettuce), fruit plants, lawns and ornamental plants. Of particular importance is the treatment of grain seeds (such as wheat, barley, rye and oats), corn, soybeans, cotton, canola, rapeseed, vegetables and rice. As already mentioned above, the treatment of transgenic seeds with a compound of Formula (I) is also of particular importance. These are the seeds of plants that generally contain at least one heterologous gene that controls the expression of a polypeptide that has particular insecticidal or nematicidal properties. The heterologous genes in the transgenic seeds can come from microorganisms such as Bacillus, Rhizobium, Pseudomonas, Serratia, Trichoderma, Clavibacter, Glomus or Gliocladium. The present invention is of particular utility for the treatment of transgenic seeds containing at least one heterologous gene derived from Bacillus sp. More preferably, it is a heterologous gene derived from Bacillus thuringiensis. In the context of the present invention the compound of Formula (I) is applied to seeds. Preferably, the seed is treated in a state in which it is so stable that no damage occurs during the treatment. In general, the treatment of the seeds can be carried out at any time between sowing and harvesting. Usually, seeds that have been separated from the plants and freed from cobs, husks, stems, teguments, wool or pulp are used. For example, seeds that have been harvested, cleaned and dried to a moisture content that allows storage can be used. As an alternative, seeds can be used, which after drying, for example, are treated with water and then dried again, for example, by priming. In the case of rice seeds, it is also possible to use seeds that have been soaked, for example, in water up to a certain stage of the rice embryo (Pigeon Pigeon Stage), which stimulates more uniform germination and emergence. When treating the seed, care must generally be taken that the amount of the compound of formula (I) applied to the seed and / or the amount of additional additives is chosen such that the germination of the seed is not adversely affected. adversely, or that the resulting plant is not damaged. This must be ensured particularly in the case of active compounds that could have phytotoxic effects at certain application doses. In general, the compounds of Formula (I) are applied to the seed in a suitable formulation. Suitable formulations and methods for seed treatment are known to those skilled in the art. The compounds of Formula (I) can be converted into the usual seed coating formulations, such as solutions, emulsions, suspensions, powders, foams, slurries or other seed coating compositions, and also ULV formulations. These formulations are prepared in a known manner by mixing the compounds of Formula (I) with conventional additives such as, for example, diluents and solvents or conventional diluents, colorants, wetting agents, dispersants, emulsifiers, antifoams, preservatives, secondary thickeners, adhesives, gibberellins and also water. The colorants that may be present in the seed coating formulations that can be used according to the invention are all the colorants that are common for such purposes. Pigments, which are fairly soluble in water, or dyes, which are soluble in water, can be used. Examples thereof include the dyes known by the names Rhodamine B, Pigment Red 112 C.I. and solvent red 1 C.I.. Suitable wetting agents that may be present in the seed coating formulations that can be used in accordance with the invention are all conventional wetting promoting substances for the formulation of active agrochemicals. Alkylnaphthalenesulfonates such as diisopropyl or diisobutylnaphthalenesulfonates are preferably used. Useful dispersing and / or emulsifying agents that may be present in the seed coating formulations that can be used in accordance with the invention are all non-ionic, anionic and cationic dispersants that are conventionally used for the formulation of agrochemically active compounds. It is preferred to use nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants. Particularly suitable nonionic dispersants are ethylene oxide-propylene oxide block polymers, alkylphenol polyglycol ethers, and tristyrylphenol polyglycol ethers and their phosphated or sulfated derivatives. Suitable anionic dispersants include, in particular, lignosulfonates, polyacrylic acid salts, and arylsulfonateformaldehyde condensates. The antifoams that can be present in the seed coating formulations that can be used according to the invention are all foam-inhibiting substances conventionally used for the formulation of active agrochemical compounds. Silicone defoamers and magnesium stearate can preferably be used. The preservatives that may be present in the seed coating formulations that can be used according to the invention are all substances that can be used for such purposes in agrochemical compositions. Examples include dichlorophene and hemiformal benzyl alcohol. Suitable secondary thickeners that may be present in the seed coating formulations that can be used according to the invention are all substances that can be used for such purposes in agrochemical compositions. Preferably, they comprise cellulose derivatives, acrylic acid derivatives, xanthan, modified clays and finely divided silica. Adhesives that may be present in seed coating formulations useful in accordance with the invention are all binders useful in seed coating products. They preferably comprise polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and tisole. The gibberellins that may be present in the seed coating formulations that can be used according to the invention are preferably gibberellins A1, A3 (=gibberellic acid), A4 and A7, and gibberellic acid is particularly used. Gibberellins are known (cf. R. Wegler "Chemie der Pflanzenschutz- un Schádlingsbekámpfungsmittel", Bd. 2, Springer Verlag, 1970, pages 401-412). The seed coating formulations that can be used according to the invention can be used directly or after previous dilution with water for the treatment of seeds of various types. For example, the concentrates or the preparations obtainable from them by dilution with water can be used to coat seeds of cereals, such as wheat, barley, rye, oats and triticale and also seeds of maize, rice, rapeseed , peas, beans, cotton, sunflower, soybeans and beets or a wide variety of different vegetable seeds. The seed coating formulations that can be used according to the invention or their diluted application forms can also be used to coat seeds of transgenic plants. For the treatment of seeds with the seed coating formulations that can be used according to the invention or the application forms prepared from them by the addition of water, all mixing devices that can normally be used can be considered. for a coating. Specifically, in a seed coating procedure, the seed must be placed in a mixer, operating batchwise or continuously, adding the particular desired amount of the seed coating formulations, either as such or after prior dilution. with water and mix everything until the formulation is evenly distributed throughout the seed. Optionally, a drying process follows. The application rate of the seed coating formulations that can be used according to the invention can vary within a relatively wide range. It depends on the particular content of the compounds of Formula (I) in the formulations and in the seeds. The application doses of the compound of Formula (I) generally comprise between 0.001 and 50 g per kilogram of seeds, preferably between 0.01 and 15 g per kilogram of seeds. Animal health In the field of animal health, that is to say in the field of veterinary medicine, the compounds of Formula (I) are active against animal parasites, in particular ectoparasites or endoparasites. The term endoparasite includes in particular helminths and protozoans, such as coccidia. The ectoparasites are typically and preferably arthropods, in particular insects and mites. In the field of veterinary medicine, the compounds of the formula (I) are suitable, with a favorable homeothermic toxicity, to control parasites that reproduce in animals and in animal husbandry in livestock, zoo animals, laboratory animals, experimental or pets. They are effective against all stages or individual development of parasites. Agricultural livestock includes, for example, mammals, such as sheep, goats, horses, donkeys, camels, buffalo, rabbits, reindeer, deer, and, in particular, cattle and pigs; or poultry such as turkeys, ducks, geese, and in particular chickens; fish and crustaceans, for example, in aquaculture; and also insects such as bees. Domestic animals include, for example, mammals such as hamsters, guinea pigs, rats, mice, chinchillas, ferrets, and in particular dogs, cats, caged birds, reptiles, amphibians, and aquarium fish. In accordance with a preferred embodiment, the compounds of Formula (I) are administered to mammals. According to another preferred embodiment, the compounds of Formula (I) are administered to birds, namely caged birds and in particular poultry. By using the compounds of formula (I) to control animal parasites, it is intended to reduce or prevent disease, death and yield reductions (in the case of meat, milk, wool, skins, eggs, honey and the like), in order to allow a cheaper and simpler maintenance and to achieve a better well-being for the animal. The term control or control as used herein with respect to the field of animal health, means that the compounds of formula (I) are effective in reducing the incidence of the respective parasite in an animal infected with such parasites to harmless levels. More specifically, control, as used herein, means that the compound of formula (I) is effective in killing the respective parasite, inhibiting its growth, or inhibiting its proliferation. Arthropods include, for example, in a non-exhaustive sense, the following: the order Anoplurida, for example, Haematopinus spp, Linognathus spp, Pediculus spp, Phtirus spp, Solenopotes spp; the order Mallophagida and the suborders Amblycerina and Ischnocerina, eg Bovicola spp, Damalina spp, Felicola spp; Lepikentron spp, Menopon spp, Trichodectes spp, Trimenopon spp, Trinoton spp, Werneckiella spp; the order Diptera and the suborders Nematocerina and Brachycerina, for example, Aedes spp, Anopheles spp, Atilotus spp, Braula spp, Calliphora spp, Chrysomyia spp, Chrysops spp, Culex spp, Culicoides spp, Eusimulium spp, Fannia spp, Gasterophilus spp, Glossina spp, Haematobia spp, Haematopota spp, Hippobosca spp, Hybomitra spp, Hydrotaea spp, Hypoderma spp, Lipoptena spp, Lucilia spp, Lutzomyia spp, Melophagus spp, Morellia spp, Musca spp, Odagmia spp, Oestrus spp, Philipomyia spp, Phlebotomus spp, Rhinoestrus spp, Sarcophaga spp, Simulium spp, Stomoxis spp, Tabanus spp, Tipula spp, Wilhelmia spp, Wohlfahrtia spp; the order Siphonapterida, for example Ceratophyllus spp, Ctenocephalides spp, Pulex spp, Tunga spp, Xenopsylla spp; the order Heteropterida, for example, Cimex spp, Panstrongylus spp, Rhodnius spp, Triatoma spp; as well as problematic or hygiene pests of the order Blattarida. In addition, arthropods include, in a non-exhaustive sense, the following mites: the subclass Akari (Acarina) and the order Metastigmata, for example from the family Argasidae, such as Argas spp, Ornithodorus spp, Otobius spp, from the family Ixodidae, such as Amblyomma spp, Dermacentor spp, Haemaphysalis spp, Hyalomma spp, Ixodes spp , Rhipicephalus (Boophilus) spp, Rhipicephalus spp (the original genus of multi-host ticks); the order Mesostigmata, such as Dermanyssus spp, Ornithonyssus spp, Pneumonyssus spp, Raillietia spp, Sternostoma spp, Tropilaelaps spp, Varroa spp; the order Actinedida (Prostigmata), for example Acarapis spp, Cheiletiella spp, Demodex spp, Listrophorus spp, Myobia spp, Neotrombicula spp, Ornithocheiletia spp, Psorergates spp, Trombicula spp; and the order of Acaridida (Astigmata), for example Acarus spp, Caloglyphus spp, Chorioptes spp, Cytodites spp, Hypodectes spp, Knemidocoptes spp, Laminosioptes spp, Notoedres spp, Otodectes spp, Psoroptes spp, Pterolichus spp, Sarcoptes spp, Trixacarus spp, Tyrophagus spp. Examples of parasitic protozoa include, but are not limited to: Mastigophora (Flagellata), such as: Metamonada: the order Diplomonadida, for example, Giardia spp, Spironucleus spp. Parabasala: the order Trichomonadida for example Histomonas spp, Pentatrichomonas spp, Tetratrichomonas spp, Trichomonas spp, Tritrichomonas spp Euglenozoa: the order Trypanosomatida, eg Leishmania spp, Trypanosoma spp Sarcomastigophora (Rhizopoda), such as Entamoebidae, eg Entamoeba spp, Centramoebidae, eg Acanthamoeba sp., Euamoebidae, eg Hartmanella sp. Alveolata, such as, Apicomplexa (Sporozoa): for example Cryptosporidium spp; the order Eimeriida, for example, Besnoitia spp, Cystoisospora spp, Eimeria spp, Hammondia spp, Isospora spp, Neospora spp, Sarcocystis spp, Toxoplasma spp; the order Adeleida, for example, Hepatozoon spp, Klossiella spp; the order Haemosporida, eg, Leucocytozoon spp, Plasmodium spp; the order Piroplasmida. for instance. Babesia spp, Ciliophora spp, Echinozoon spp, Theileria spp; the order Vesibuliferida, for example, Balantidium spp, Buxtonella spp Microspora such as Encephalitozoon spp, Enterocytozoon spp, Globidium spp, Nosema spp, and auEerdem, for example, Myxozoa spp Human or animal pathogenic endoparasites comprising Helminths include Helminthos, eg Acanthocephala, Nematoden, Pentastoma and Platyhelminthos (eg Monogenea, Cestodes and Trematodes). Examples of Helminths include, but are not limited to: Monogenea: for example: Dactilogyrus spp, Gyrodactylus spp, Microbothrium spp, Polystoma spp, Troglecephalus spp; Cestodes: the order Pseudophyllidea, for example: Bothridium spp, Diphyllobothrium spp, Diplogonoporus spp, Ichthyobothrium spp, Ligula spp, Schistocephalus spp, Spirometra spp The order Cyclophyllida, for example: Andyra spp, Anoplocephala spp, Avitellina spp, Bertiella spp, Cittotaenia spp, Davainea spp, Diorchis spp, Diplopilidium spp, Dipilidium spp, Echinococcus spp, Echinocotile spp, Echinolepis spp, Hydatigera spp, Hymenolepis spp, Joyeuxiella spp, Mesocestoides spp, Moniezia spp, Paranoplocephala spp, Raillietina spp, Stilesia spp, Taenia spp, Thysaniezia spp, Thysanosoma spp Trematodes: the class Digenea, for example: Austrobilharzia spp, Brachylaima spp, Calicophoron spp, Catatropis spp, Clonorchis spp, Collyriclum spp, Cotilophoron spp, Cyclocoelum spp, Dicrocoelium spp, Diplostomum spp, Echinochasmus spp, Echinoparyphium spp, Echinostoma spp, Eurytrema spp, Fasciola spp, Fasciolides spp, Fasciolopsis Fichoppius Gastrothylacus spp, Gigantobilharzia spp, Gigantocotile spp, Heterophyes spp, Hypoderaeum spp, Leucochloridium spp, Metagonimus spp, Metorchis spp, Nanophyetus spp, Notocotylus spp, Opisthorchis spp, Ornithobilharzia spp, Paragonimus spp, Paramphistomum spp, Plagiorchis spp, Posthodiplostomum spp, Prosthogonimus spp , Schistosoma spp, Trichobilharzia spp, Troglotrema spp, Typhlocoelum spp Nematodes: the order Trichinellida, for example: Capillaria spp, Trichinella spp, Trichomosoides spp, Trichuris spp The order Tilenchida, for example: Micronema spp, Parastrangiloides spp, Strongiloides spp The order Rhabditina for example: Aelurostrongylus spp, Amidostomum spp, Ancilostoma spp, Angiostrongylus spp, Bronchonema spp, Bunostomum spp, Chabertia spp, Cooperia spp, Cooperioides spp, Crenosoma spp, 100 Cyathostomum spp, Cyclococercus spp, Cyclodontostomum spp, Cilicocyclus spp, Cilicostephanus spp, Cilindropharynx spp, Cystocaulus spp, Dictyocaulus spp, Elaphostrongylus spp, Filaroides spp, Globocephalus spp, Graphidium spp, Gyalocephalus spp, Haemonchus spp. , Metastrongylus spp, Muellerius spp, Necator spp, Nematodirus spp, Neostrongylus spp, Nippostrongylus spp, Obeliscoides spp, Oesophagodontus spp, Oesophagostomum spp, Ollulanus spp; Ornithostrongylus spp, Oslerus spp, Ostertagia spp, Paracooperia spp, Paracrenosoma spp, Parafiloides spp, Parelaphostrongylus spp, Pneumocaulus spp, Pneumostrongylus spp, Poteriostomum spp, Protostrongylus spp, Spicocaulus spp, Stephanurus spp, Strongylus spp, Teladorchonsa spp, Syngamus spp, Syngamus spp, , Trichostrongylus spp, Triodontophorus spp, Troglostrongylus spp, Uncinaria spp The order Spirurida, for example: Acanthocheilonema spp, Anisakis spp, Ascaridia spp; Ascaris spp, Ascarops spp, Aspiculuris spp, Bailisascaris spp, Brugia spp, Cercopithifilaria spp, Crassicauda spp, Dipetalonema spp, Dirofilaria spp, Dracunculus spp; Draschia spp, Enterobius spp, Filaria spp, Gnathostoma spp, Gongilonema spp, Habronema spp, Heterakis spp; Litomosoides spp, Loa spp, Onchocerca spp, Oxiuris spp, Parabronema spp, Parafilaria spp, Parascaris spp, Passalurus spp, Physaloptera spp, Probstmayria spp, Pseudofilaria spp, Setaria spp, Skjrabinema spp, Spirocerca spp, Stephanofilaria spp, Strongyluris spp, Syphacia spp , Thelazia spp, Toxascaris spp, Toxocara spp, Wuchereria spp Acanthocephala: the order Oligacanthorhynchida, such as: Macracanthorhynchus spp, Prosthenorchis spp; the order Moniliformida, for 101 example: Moniliformis spp, The order Polymorphida, for example: Filicollis spp; the order Echinorhynchida, eg Acanthocephalus spp, Echinorhynchus spp, Leptorhynchoides spp Pentastoma: the order Porocephalida, eg Linguatula spp In the veterinary field and for the maintenance of animals, the administration of the compounds of formula (I) is carried out by procedures generally known in the art, such as enteral, parenteral, dermal or nasal in the form of suitable preparations. Administration can be carried out prophylactically, metaphylactically or therapeutically. Therefore, one embodiment of the present invention relates to compounds of Formula (I) for use as a medicament. A further aspect relates to the use of a compound of formula (I) as an anti-endoparasitic agent. Another specific aspect of the invention relates to the compounds of formula (I) for use as anthelmintic agents, in particular for use as nematicides, platyhelminthicides, acanthocephalicides or pentastomicides. Another specific aspect of the invention refers to the compounds of formula (I) for use as antiprotozoals. Another aspect relates to the compounds of formula (I) for use as antiectopazaramites, in particular an arthropodicide, more particularly an insecticide or an acaricide. Other aspects of the invention comprise veterinary formulations that include an effective amount of at least one compound of formula (I) 102 and at least one of the following: a pharmaceutically acceptable excipient (for example, solid or liquid diluents), a pharmaceutically acceptable adjuvant (for example, surfactants), especially a pharmaceutically acceptable excipient conventionally used in veterinary formulations, and / or a pharmaceutically acceptable adjuvant conventionally used in veterinary formulations. A related aspect of the invention is a method for preparing a veterinary formulation described herein comprising the step of admixing at least one compound of formula (I) with pharmaceutically acceptable excipients and / or adjuvants, especially pharmaceutically acceptable excipients used conventionally in veterinary formulations; or conventionally used in phytoveterinary formulations. Another special aspect of the veterinary formulations of the invention selected from the group of ectoparasiticide and endoparasiticide formulations, in particular selected from the group of anthelmintic, antiprotozoal and arthropodicide formulations, especially selected from the group of nematicide, platyhelminthicide, acanthocephalicide, pentastomicide, insecticide and acaricide formulations of agreement the mentioned aspects, as well as methods for its elaboration. Another aspect relates to a method for the treatment of a parasitic infection, in particular an infection by a parasite selected from the group of ectoparasites and endoparasites mentioned herein, by applying an effective amount of a compound of Formula (I) in an animal, in particular a non-human animal, in need of it. 103 Another aspect relates to a method for treating a parasitic infection, in particular an infection by a parasite selected from the group of ectoparasites and endoparasites mentioned herein, by applying a composition defined as a veterinary formulation to an animal, particularly a non-human animal, who needs it. Another aspect refers to the use of the compounds of Formula (I) in the treatment of parasitic infections, especially an infection by a parasite selected from the group of ectoparasites and endoparasites mentioned herein, in an animal, in particular an animal not human. In the present context of veterinary health or veterinary medicine, the term "treatment" includes prophylactic, metaphylactic and therapeutic treatment. In a particular embodiment, mixtures of at least one compound of Formula (I) with other active ingredients, especially endo and ectoparasiticides, are provided for the veterinary field. In the field of animal health, a mixture does not only mean that two (or more) different active ingredients are formulated in a single formulation and used together, but also refers to products that comprise separate formulations for each active ingredient. Therefore, if more than two drugs are to be used, all drugs can be formulated in a single formulation or all drugs can be formulated in separate formulations; Mixed forms are also conceivable in which some of the active ingredients are formulated together and some of the active ingredients are formulated separately. Separate formulations allow the separate or successive use of the active compounds in 104 question. Active compounds specified herein by their "common names" are known and are described, for example, in the "Pesticide Manual" (see above) or can be searched on the Internet (for example at http: / / www.alanwood.net / pesticides). Examples of agents from the group of ectoparasiticides as components of the composition include, but are not limited to, the insecticides and miticides described above. Other useful agents according to the aforementioned classification based on the current IRAC mode of action classification scheme are listed below: (1) acetylcholinesterase (AChE) inhibitors; (2) GABA-gated chloride channel blockers; (3) sodium channel modulators; (4) competitive modulators of the nicotinic acetylcholine receptor (nAChR); (5) allosteric modulators of the nicotinic acetylcholine receptor (nAChR); (6) allosteric modulators of the glutamate-dependent chloride channel (GluCl); (7) juvenile hormone mimetics; (8) various non-specific inhibitors (multiple sites); (9) chordotonal organ modulators; (10) mite growth inhibitors; (12) inhibitors of mitochondrial ATP synthase, such as ATP switches; (13) uncoupling of oxidative phosphorylation by proton gradient disruption; (14) nicotinic acetylcholine receptor channel blocker; (15) chitin biosynthesis inhibitors, type 0; (16) chitin biosynthesis inhibitors, type 1; (17) molt switch (especially in Diptera, ie Diptera); (18) ecdysone receptor agonists; (19) octopamine receptor agonists; (21) transport inhibitors 105 electrons from mitochondrial complex I; (25) mitochondrial complex II electron transport inhibitors; (20) mitochondrial complex III electron transport inhibitors; (22) voltage-gated sodium channel blocker; (23) acetyl-CoA carboxylase inhibitors; (28) ryanodine receptor modulators; Active compounds with unknown or non-specific mechanisms such as fentrifanil, fenoxacrim, cycloprene, chlorobenzilate, chlordimeform, flubenzimine, dicyclanil, amidoflumet, quinomethionat, triaratene, clotiazoben, tetrasul, potassium oleate, petroleum, methoxadiazone, gossiplure, flutenzine, bromopropylate, cryolite ; Compounds of the other classes, for example, butacarb, dimethylan, cloetocarb, phosphocarb, pirimiphos (ethyl), parathion (-ethyl), methacryphos, o-isopropyl salicylate, trichlorfon, tigolaner, sulfophos, propafos, sebufos, pyridathion, protoate , diclofenthion, demeton-S-methylsulfone, isazophos, cyanofenphos, dialifor, carbofenothion, autathiophos, aromfenvinphos (-methyl), azinphos (ethyl), chlorpyrifos (ethyl), phosmethylan, iodofenphos, dioxabenzophos, formothion, phonophos, flupyrazophos, fensulfothion, etrimphos ; Organochlorine compounds, eg camphechlor, lindane, heptachlor; or phenylpyrazole, eg acetoprol, oirafluprol, pyriprol, vaniliprol, sisapronil; or isoxazoline, eg sarolaner, afoxolaner, lotilaner, fluralaner; Pyrethroids such as, for example, (cis, trans) metofluthrin, profluthrin, flufenprox, flubrocitrinat, fubfenprox, fenfluthrin, protrifenbut, pyresmethrin, RU15525, terathrin, cis-resmethrin, heptafluthrin, bioethanmethrin, biopermethrin, fenpyrethrin, cis-cypermethrin, cis -permethrin, 106 clocithrin, cyhalothrin (lambda), clovaportrin or halogenated hydrocarbon compounds (HCH), Neonicotinoids, eg nthiazine dichloromezothiaz, macrocyclic triflumezopyrim lactones, eg nemadectin, ivermectin, latidectin, moxidectin, selamectin, eprinomectin, doramectin, emamectin benzoate; milbemycin-oxime tripren, epofenonane, diofenolan; Biologicals, hormones or pheromones, eg natural products, eg thuringiensin, codlemone or Neem dinitrophenol components, eg dinocap, dinobuton, binapacryl; Benzylureas, eg fluazuron, penfluron, Amidine derivatives, eg chloromebuform, cimiazol, demiditraz Miticides for Varroa mites, eg organic acids, eg formic acid, oxalic acid. Examples of active ingredients from the group of endoparasiticides, as mixture components include, but are not limited to, anthelmintic agents and antiprotozoal agents. Anthelmintic agents include, but are not limited to, the following nematicidal, trematicidal and / or cestocidal active ingredients: from the class of macrocyclic lactones, for example: eprinomectin, abamectin, nemadectin, moxidectin, doramectin, selamectin, lepimectin, latidectin, milbemectin, ivermectin, emamectin, milbemycin; from the class of benzimidazoles and probenzimidazoles, for example: oxibendazole, mebendazole, triclabendazole, thiophanat, parbendazole, oxfendazole, 107 Netobimine, Fenbendazole, Febantel, Thiabendazole, Cyclobendazole, Cambendazole, Albendazole Sulfoxide, Albendazole, Flubendazole; from the class of depsipeptides, preferably cyclic depsipeptides, in particular the 24-membered cyclic depsipeptides, for example: emodepside, PF1022A; from the tetrahydropyrimidine class, for example: morantel, pyrantel, oxantel; from the class of imidazothiazoles, for example: butamisole, levamisole, tetramisole; from the class of aminophenylamidines, for example: amidantel, deacylated amidantel (dAMD), tribendimidine; from the class of aminoacetonitriles, for example: Monepantel; from the class of paraherquamides, for example: paraherquamide, derquantel; from the class of salicylanilides, for example: tribromsalan, bromoxanide, brotianide, clioxanide, closantel, niclosamide, oxyclozanide, rafoxanide; from the class of substituted phenols, for example: nitroxinil, bithionol, disophenol, hexachlorophene, niclofolan, meniclofolan; from the class of organophosphates, for example: trichlorophone, naphthalophos, dichlorovos / DDVP, crufomat, coumaphos, haloxone; from the piperazinone / quinoline class, for example: praziquantel, epsiprantel; from the class of piperazines, for example: piperazine, hydroxyzine; from the class of tetracyclines, for example: tetracycline, chlorotetracycline, doxycycline, oxytetracycline, rolitetracycline; 108 of various other classes, for example: bunamidine, niridazole, resorantel, omfalotin, oltipraz, nitroscanate, nitroxinil, oxamniquine, mirasan, miracil, lucantone, hicanton, hetoline, emetine, diethylcarbamazine, dichlorophene, diamfenetide, clonazepam, bephenium, amoscanat, clorsulon . Antiprotozoal agents include, but are not limited to, the following active ingredients: from the class of triazines for example: diclazuril, ponazuril, cartazuril, toltrazuril; the class of polyletherionophores, for example: monensin, salinomycin, maduramicin, narasin; from the class of macrocyclic lactones including, for example: milbemycin, erythromycin; from the quinolone class, for example: enrofloxacin, pradofloxacin; from the class of quinines, for example: chloroquine; from the pyrimidine class, for example: pyrimethamine; from the class of sulfonamides, for example: sulfaquinoxaline, trimethoprim, sulfaclozin; from the thiamine class, for example: amprolium; from the class of lincosamides, for example: clindamycin; from the class of carbanilides, for example: imidocarb; from the class of nitrofurans, for example: nifurtimox; from the quinazolinone class of alkaloids, for example: halofuginone; from various other classes, for example: oxamniquine, paromomycin; of the class of vakzins or antigens of microorganisms, for 109 example: Babesia canis rossi, Eimeria tenella, Eimeria praecox, Eimeria necatrix, Eimeria mitis, Eimeria maxima, Eimeria brunetti, Eimeria acervulina, Babesia canis vogeli, Leishmania infantum, Babesia canis canis, Dictyocaulus viviparus. Furthermore, if possible based on their functional groups, all said mixture components may optionally form salts with suitable bases or acids. vector control The compounds of Formula (I) can also be used in vector control. For the purposes of the present invention, a vector is an arthropod, in particular an insect or an arachnid, capable of transmitting pathogens such as, for example, viruses, worms, unicellular organisms and bacteria from a reservoir (plant, animal, human, etc. ninai) to a guest. Pathogens can be transmitted mechanically (eg trachoma caused by non-biting flies) to a host or by injection (eg mosquito-borne malaria parasites) into a host. Examples of vectors and the diseases or pathogens they transmit are: 1) Mosquitoes - Anopheles: malaria, filariasis; - Culex: Japanese encephalitis, filariasis, other viral diseases, transmission of other worms; - Aedes: yellow fever, dengue fever, other viral diseases, filariasis; - Simulien: transmission of worms, in particular of Onchocerca 110 volvulus; - Psychodidae: transmission of leishmaniasis 2) Lice: skin infections, epidemic typhus; 3) Fleas: plague, endemic typhus, tapeworms; 4) Flies: sleeping sickness (trypanosomiasis); cholera, other bacterial diseases; 5) Mites: acariasis, epidemic typhus, rickettsiosis, tularemia, St. Louis encephalitis, tick-borne encephalitis (TBE), Crimean-Congo hemorrhagic fever, borreliosis; 6) Ticks: borreliosis such as by Borrelia duttoni, Borrelia duttoni, tick-borne meningoencephalitis, Q fever (Coxiella burnetii), babesiosis (Babesia canis canis), ehrlichiosis. Examples of vectors for the purposes of the present invention include insects, for example aphids, flies, cicadas or thrips, which can transmit viruses from plants to plants. Other vectors that can transmit plant viruses are spider mites, lice, beetles, and nematodes. Additional examples of vectors for the purposes of the present invention include insects and arachnids such as mosquitoes, in particular of the genus Aedes, Anopheles, for example A. gambiae, A. arabiensis, A. funestus, A. dirus (malaria) and Culex, lice, moths, flies, mites and ticks that can transmit pathogens to animals and / or humans. Vector control is also possible if the compounds of formula (I) succeed in overcoming resistance. The compounds of Formula (I) are suitable for use in the prevention of diseases and / or pathogens that are transmitted by 111 vectors. Therefore, an additional aspect of the present invention comprises the use of the compounds of formula (I) for the control of vectors, for example in agriculture, horticulture, in gardens and recreation facilities and also in the protection of materials and stored products. Protection of industrial materials The compounds of the formula (I) are suitable for protecting industrial materials against attack or destruction by insects, for example, from the order Coleoptera, Hymenoptera, Isoptera, Lepidoptera, Psocoptera and Zygentoma. Industrial materials refer, in the present context, to inert materials, preferably such as plastics, adhesives, glues, paper and cardboard, leather, wood, wood processing products and paints. The use of the invention in the protection of wood is particularly preferred. In a further embodiment, the compounds of Formula (I) are used together with at least one additional insecticide and / or at least one additional fungicide. In a further embodiment, the compounds of Formula (I) are present as a ready-to-use pest control agent, ie they can be applied to the material of interest without further modification. Suitable further insecticides or fungicides include, in particular, those mentioned above. Surprisingly, it has also been found that the compounds of the formula (I) can be used to protect against contamination 112 objects that may be in contact with salt water or brackish water, in particular, hulls, screens, nets, building structures, moorings and signaling systems. Likewise, the compounds of formula (I), alone or in combination with other active compounds, can be used as antipollution agents. Animal pest control in the hygiene sector The compounds of Formula (I) are suitable for controlling animal pests in the hygiene sector. In particular, the invention can be used in the protection of the domestic sector, in the hygiene sector and in the protection of stored products, especially to control insects, arachnids and mites that can be found in closed spaces such as houses, factories, offices, vehicle cabins. To control animal pests, the compounds of formula (I) are used alone or in combination with other active compounds and / or auxiliary agents. Preferably, they are used in household insecticide products. The compounds of formula (I) are effective against sensitive and resistant species, and against all stages of development. These pests include, for example, pests of the class Arachnida, of the orders Scorpiones, Araneae and Opiliones, of the classes Chilopoda and Diplopoda, of the class Insecta of the order Blattodea, of the order Coleoptera, Dermaptera, Diptera, Heteroptera, Hymenoptera, Isoptera , Lepidoptera, Phthiraptera, Psocoptera, Saltatoria or Orthoptera, Siphonaptera and Zygentoma and from the class Malacostraca of the order Isopoda. They are applied, for example, in aerosols, non-pressurized spray products, for example, pump sprayers or atomizers, systems Automatic foggers, foggers, foams, gels, products for evaporators with evaporation tablets that are made of cellulose or plastic, liquid evaporators, gel and membrane evaporators, propeller-driven evaporators, energy-free or passive evaporation systems, paper mothproofing, mothproofing bags and mothproofing gels, as well as granules or powders, in spray baits or bait stations. Preparation examples: Ethyl 2-bromo-1-methyl-1H-imidazole-4-carboxylate (III-1) 30.0 g (195 mmol) of ethyl 1-methyl-1H-imidazole-4-carboxylate was dissolved in 1.0 L of tetrahydrofuran and cooled to 0 °C. To this solution, 34.5 g (195 mmol) of N-bromosuccinimide were added portionwise, and the reaction mixture was stirred at room temperature overnight. The reaction was stopped by sodium thiosulfate solution (Na2S2O3) and 800 mL of ethyl acetate was added. The phases were separated and extracted three times with 800 ml of ethyl acetate. The organic phases were combined, dried over sodium sulfate and filtered. The solvent was removed by distillation under vacuum and the residue was purified by column chromatography with a gradient of petroleum ether / ethyl acetate (3:1) as eluant. 1H-NMR (300 MHz, d6-DMSO) □ ppm: 1.26 (t, 3H), 3.64 (s, 3H), 4.22 (q, 2H), 8.07 (s, 1H). 2-bromo-5-(ethylsulfanyl)-1-methyl-1H-imidazole-4-carboxylic acid (X-1) 114 HO 31.0 g (134 mmol) of ethyl 2-bromo-1-methyl-1H-imidazole-4-carboxylate and 24.4 g (200 mmol) of diethyl disulfide were dissolved in 620 mL of tetrahydrofuran and cooled to about 78 °C To this solution, 100 mL (2 M in THF, 200 mmol) of lithium diisopropylamide (LDA) was added dropwise, and the reaction mixture was stirred for 30 min at ca. 78 °C. The reaction was stopped by the addition of ammonium chloride solution. The phases were separated and the aqueous phase was extracted three times with 300 ml of ethyl acetate. The organic phases were combined, dried over magnesium sulfate and filtered. The solvent was removed by distillation under vacuum and the residue was purified by column chromatography with a gradient of petroleum ether / ethyl acetate as eluent. 28.5 g (97.3 mmol) of ethyl 2-bromo-5-(ethylsulfanyl)-1-methyl-1H-imidazole-4-carboxylate were obtained. This was dissolved in 300 ml of methanol and the solution was cooled to 0 °C. Then 300 mL (2N in water, 600 mmol) of sodium hydroxide was added and the mixture was stirred at room temperature for 1 hour. The mixture was concentrated on a rotary evaporator and neutralized by the addition of 1N HCl. It was then extracted with ethyl acetate. The solvent was removed by distillation under vacuum and the compound was obtained. 1H-NMR (300 MHz, d6-DMSO) □ ppm: 1.09 (t, 3H), 2.86 (q, 2H), 3.64 (s, 3H), 12.60 (s, 1H). 2-[2-bromo-5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-3-methyl-6(trifluoromethyl)-3H-imidazo[4,5-b]pyridine (XI-1 ) 115 3.00 g (15 .7 mmol) of N2-methyl-5-(trifluoromethyl)pyridin-2,3-diamine and 6.02 g (31.4 mmol) of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI). The mixture was stirred at 120°C overnight. The reaction mixture was then cooled to room temperature. The solvent was removed under vacuum. The residue was purified by RP18 by HPLC with acetonitrile / water + 0.1% formic acid as eluent. 1H-NMR (400 MHz, d6-DMSO)D ppm: 1.115 (t, 3H), 3.02 (q, 2H), 3.76 (s, 3H), 4.06 (s, 3H), 8.535 ( s, 1H), 8.77 (s, 1H). 2-[2-bromo-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-3-methyl-6(trifluoromethyl)-3H-imidazo[4,5-b]pyridine (XI-2 ) 3.22 g (7.66 mmol) of 2-[2-bromo-5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-3-methyl-6-(trifluoromethyl)-3H-imidazo were dissolved [4,5-b]pyridine in 2.0 ml of dichloromethane, at room temperature 1.45 ml (38.3 mmol) of formic acid and 5.21 g (53.6 mmol) of hydrogen peroxide were added followed by stirring at room temperature for 18 h. The solvent was removed under vacuum. The solution was then diluted by addition of dichloromethane and washed with sodium thiosulfate solution. The organic phase was separated 116 was dried with sodium sulfate and filtered. The solvent was removed by distillation under vacuum. 1H-NMR (400 MHz, d6-DMSO) □ ppm: 1.29 (t, 3H), 3.76 (q, 2H), 3.86 (s, 3H), 3.93 (s, 3H), 8.62 (s, 1H), 8.85 (s, 1H). 2-[5-(ethylsulfonyl)-1-methyl-2-vinyl-1H-imidazol-4-yl]-3-methyl-6(trifluoromethyl)-3H-imidazo[4,5-b]pyridine (XII-1 ) A solution of 624 mg (1.37 mmol) of 2-[2-bromo-5(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-3-methyl-6-(trifluoromethyl)-3H was degassed. -imidazo[4,5b]pyridine and 697 mg (2.20 mmol) of tributyl(vinyl)stannane in 2.9 mL of N,N-dimethylformamide under argon. 14.5 mg (0.021 mmol) of palladium-bis(triphenylphosphine) dichloride were added and the solution was stirred at 75 °C for 4 hours. The reaction was then concentrated. The residue was purified on silica gel by MPLC using cyclohexane / ethyl acetate as eluent. 1H-NMR (400 MHz, d6-DMSO) □ ppm: 1.27 (t, 3H), 3.72 (q, 2H), 3.87 (s, 3H), 3.98 (s, 3H), 5.77 (dd, 1H), 6.36 (dd, 1H), 7.01 (dd, 1H), 8.60 (s, 1H), 8.84 (s, 1H). 2-[2-(3-cyclopropyl-4,5-dihydro-1,2-oxazol-5-yl)-5-(ethylsulfonyl)-1-methyl1H-imidazol-4-yl]-3-methyl-6- (trifluoromethyl)-3H-imidazo[4,5-b]pyridine (I-1) A solution of 107 mg (1.25 mmol) of N 117 (cyclopropylmethylene)hydroxylamine, 167 mg (1.25 mmol) of N-chlorosuccinimide and 10.1 µl (0.125 mmol) of pyridine at room temperature for 4.5 hours. 100 mg (0.250 mmol) of 2-[5-(ethylsulfonyl)-1-methyl-2-vinyl-1H-imidazol4-yl]-3-methyl-6-(trifluoromethyl)-3H-imidazo[4.5 -b]pyridine and 0.174 ml (1.25 mmol) of triethylamine and the solution was stirred at room temperature for 18 hours. The reaction was extracted with water / dichloromethane. The organic phase was dried over sodium sulfate, filtered and concentrated. The residue was purified on silica gel by MPLC with cyclohexane / ethyl acetate as eluant. The desired fraction was purified by RP18 by HPLC with acetonitrile / water as eluent. logP[acid]: 2.73; logP[neutral]: 2.72; MH+: 483;1H-NMR (400 MHz, d6-DMSO) □ ppm: 0.83 (m, 2H), 0.90 (m, 2H), 1.27 (t, 3H), 1.86 (m , 1H), 3.28 (dd, 1H), 3.60 (dd, 1H), 3.79 (m, 2H), 3.86 (s, 3H), 3.98 (s, 3H), 5 0.91 (dd, 1H), 8.60 (s, 1H), 8.84 (s, 1H). 1-(4-{5-(ethylsulfonyl)-1-methyl-4-[3-methyl-6-(trifluoromethyl)-3Himidazo[4,5-b]pyridin-2-yl]-1H-imidazol-2- yl}phenyl)cyclopropanecarbonitrile (I5) A solution of 150 mg (0.332 mmol) 2-[2-bromo-5(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-3-methyl-6-(trifluoromethyl)-3H-imidazo[ 4,5b]pyridine, 268 mg (0.995 mmol) 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan 118 2-yl)phenyl]cyclopropanecarbonitrile and 324 mg (0.995 mmol) of cesium carbonate in 2.5 ml of 1,4-dioxane and 0.55 ml of water under argon. 38.2 mg (0.033 mmol) tetrakis-(triphenylphosphine)-palladium were added and the solution stirred in microwave at 110 °C for 30 min. The reaction was then concentrated. The residue was purified by RP18 by HPLC with acetonitrile / water as eluent. logP[acid]: 3.14; logP[neutral]: 3.07; MH+: 515;1H-NMR (400 MHz, d6DMSO) □ ppm: 1.33 (t, 3H), 1.64 (m, 2H), 1.86 (m, 2H), 3.83 (q, 2H ), 3.91 (s, 3H), 3.965 (s, 3H), 7.54 (d, 2H), 7.85 (d, 2H), 8.61 (s, 1H), 8.85 (s , 1 HOUR). 2-[2-(3-cyclopropyl-1H-pyrazol-1-yl)-5-(ethylsulfonyl)-1-methyl-1H-imidazol4-yl]-3-methyl-6-(trifluoromethyl)-3H-imidazo[ 4,5-b]pyridine (I-9) A solution of 100 mg (0.221 mmol) of 2-[2-bromo-5(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-3-methyl-6-(trifluoromethyl)-3H-imidazo was stirred [4.5b]pyridine, 167 mg (1.25 mmol) of N-chlorosuccinimide and 30.6 mg (0.221 mmol) of potassium carbonate at 95 °C for 18 hours. The reaction was then concentrated. The residue was purified by RP18 by HPLC with acetonitrile / water as eluent. The residue was purified by RP18 by HPLC with acetonitrile / water + 0.1% formic acid as eluant. logP[acid]: 3.46; logP[neutral]: 3.36; MH+: 480; 1H-NMR (400 MHz, d6DMSO) □ ppm: 0.81 (m, 2H), 0.995 (m, 2H), 1.31 (t, 3H), 2.04 (m, 1H), 3.80 (q, 2H), 3.89 (s, 3H), 4.03 (s, 3H), 6.40 (d, 1H), 8.26 (d, 1H), 8.63 (m , 1H), 8.85 (m, 1H). 119 The following compounds of Formula (I) can be obtained by analogy with the examples and according to the preparation process described above: 120 121 122 123 The determination of the logP values ​​was carried out in accordance with Regulation 79 / 831 of Annex V.A8 of the EEC by HPLC (high pressure liquid chromatography) on a phase inversion column (C18) using the following methods: [a] The logP value is determined by LC-UV measurement in the acidic range, with 0.9 ml / l formic acid in water and 1.0 ml / l formic acid in acetonitrile as eluent (linear gradient 10% acetonitrile to 95% acetonitrile). [b] The logP value is determined by LC-UV in the neutral range, with ammonium carbonate 79 mg / l in water and acetonitrile as eluent (linear gradient from 10% acetonitrile to 95% acetonitrile). Calibration was carried out with a homologous series of alkan-2-ones 124 straight chain (3 to 16 carbon atoms) with known logP values. Values ​​between consecutive alkanones are determined by linear regression. Determination of [M+H]+ or M- by LC-MS under acidic chromatographic conditions was performed with 1 ml of formic acid per liter of acetonitrile and 0.9 ml of formic acid per liter of Millipore water as eluant. A Zorbax Eclipse Plus C18 50mm*2.1mm, 1.8pm column was used at an oven temperature of 55°C. Instruments: LC-MS3: Waters UPLC equipment with SQD2 mass spectrometer and SampleManager autosampler. Linear gradient from 0.0 to 1.70 minutes from 10% acetonitrile to 95% acetonitrile, 1.70 to 2.40 minutes constant flow from 95% acetonitrile, flow rate 0.85 mL / min . LC-MS6 and LC-MS7: Agilent 1290 LC equipment, Agilent MSD mass spectrometer, HTS PAL autosampler. Linear gradient from 0.0 to 1.80 minutes from 10% acetonitrile to 95% acetonitrile, 1.80 to 2.50 minutes constant flow from 95% acetonitrile, flow rate 1.0 mL / min . Determination of [M+H]+ by LC-MS under neutral chromatographic conditions was carried out with acetonitrile and Millipore water with ammonium carbonate 79 mg / l as eluant. Instruments: LC-MS4: Waters IClass Acquity instrument with QDA mass spectrometer and FTN autosampler (Waters Acquity column, 1.7 pm, 50 mm * 2.1 mm, column oven temperature 45 °C). Linear gradient from 0.0 to 2.10 minutes from 10% acetonitrile to 95% acetonitrile, from 2.10 to 3.00 125 minutes of constant flow of 95% acetonitrile, flow rate of 0.7 ml / min. LC-MS5: Agilent 1100 LC system with MSD mass spectrometer and HTS PAL autosampler (column: Zorbax XDB C18, 1.8 pm, 50 mm * 4.6 mm, column oven temperature 55 °C). Linear gradient from 0.0 to 4.25 minutes from 10% acetonitrile to 95% acetonitrile, 1.70 to 4.25 minutes constant flow from 95% acetonitrile, flow rate 2.00 mL / min . Retention time indices were determined in all cases from a calibration measurement of a homologous series of straight-chain 3- to 16-carbon alkan-2-ones, where the index of the first alkanone was set at 300, the last at 1600 and consecutive alkanones were linearly interpolated between these values. Measurements of the 1H-NMR spectra were made with a Bruker Avance III 400 MHz spectrometer, equipped with a 1.7 mm TCI probe, using tetramethylsilane as standard (0.00 ppm) of solutions in CD3CN, CDCl3o solvents d6-DMSO. Alternatively, a Bruker Avance III 600 MHz spectrometer equipped with a 5 mm PNPSC probe or a Bruker Avance NEO 600 MHz spectrometer equipped with a 5 mm TCI probe was used to perform the measurements. As a general rule, measurements were made at a probe temperature of 298 K. If other measurement temperatures were used, the results were recorded separately. NMR data for selected examples are listed in the standard form (δ values, multiplot division, number of H atoms) or as a listing of NMR peaks. 126 In each case, the solvent in which the spectrum was recorded is indicated. NMR. NMR data of selected examples NMR Peak Listing Methods 1 H-NMR data for selected examples are shown as lists of 1 H-NMR peaks. For each signal peak, the δ value in ppm is indicated first, followed by the signal intensity in parentheses. The different pairs of δ-signal intensity values ​​are listed separated by semicolons. Therefore, the list of signal peaks for an Example takes the following form: δ1(Intensity1); δ2(Intensity2);..........; δi(Intensity^;......; δn(Intensityn) The intensity of the sharp signals correlates with the height of the signals in a printout of a 1H-NMR spectrum in cm and shows the actual relationships between the signal intensities. In the case of wide signals, several peaks are observed and considered or the center of the signals (central signal) and its relative intensity compared to the strongest signal in the spectrum are considered. To calibrate the chemical shift of 1H-NMR spectra, use tetramethylsilane or the chemical shift of the solvent if the probe does not contain tetramethylsilane. Therefore, the 1H-NMR peak listing may contain the tetramethylsilane peak. The 1H-NMR peak listings are equivalent to classical 1H-NMR plots and therefore generally contain all peaks that are listed in a classical 1H-NMR plot. 127 In addition, In addition, they can indicate, like the classic representations of 1 H-NMR, solvent signals, signals of the stereoisomers of the compounds of interest, which also constitute an object of the invention, and / or show impurity peaks. The NMR solvent signals, the tetramethylsilane peak and the water signal in the respective solvent are excluded from the relative intensity calibration, because the indicated intensity values ​​for them can be very high. The peaks of the (stereo)isomers of the compounds according to the invention and / or the impurity peaks usually have on average a lower intensity than the peaks of the compounds according to the invention (e.g. with a purity > 90%). Such stereoisomers and / or impurities may be typical of the particular preparation process. Therefore, their peaks can help to identify the replicability of the preparation process in question by means of “by-product fingerprints”. The specialist who calculates the peaks of the compounds according to the invention using known methods (MestreC, ACD simulation, but also with empirically evaluated expected values) can, as needed, identify the peaks of the compounds according to the invention, optionally using additional intensity filters. This identification is equivalent to the listing of relevant peaks from the classical 1H NMR interpretation. The used solvent can be seen in the JCAMP file in the solvent parameter, the measurement frequency of the spectrometer in the frequency of 128 observation and spectrometer model in spectrometer / data system. 13C-NMR data are provided as analogs of 1HRMN data in the form of decoupled broadband 13C-NMR peak listings. Again, the NMR tetramethylsilane and solvent signals are removed from the relative intensity calibration because they can have very high intensity signals. More details on the 1H-NMR peaks can be found in: “Citation of NMR Peaklist Data within Patent Applications” in the database Research Disclosure Database under No. 564025. I-2:1H-NMR (400.2MHz, d6-DMSO): δ= 8.8203 (2.6); 8.8171 (2.7); 8.5802 (2.7); 8.5763 (2.7); 7.7928 (4.0); 7.7714 (5.0); 7.5621 (5.0); 7.5406 (4.2); 6.2402 (1.1); 6.2234 (1.3); 6.2128 (1.3); 6.1959 (1.2); 4.2762 (1.0); 4.2594 (1.0); 4.2332 (1.2); 4.2166 (1.2); 4.0561 (14.1); 4.0381 (1.1); 4.0202 (0.9); 4.0023 (0.3); 3.9433 (1.1); 3.9158 (1.4); 3.9005 (1.0); 3.8732 (0.9); 3.8042 (16.0); 3.7792 (2.2); 3.7749 (2.2); 3.7573 (0.8); 3.3194 (114.5); 2.6749 (1.1); 2.6707 (1.4); 2.6663 (1.1); 2.5060 (178.0); 2.5017 (229.6); 2.4973 (181.7); 2.3329 (1.2); 2.3286 (1.6); 2.3243 (1.3); 1.9886 (3.5); 1.2979 (3.7); 1.2795 (7.9); 1.2611 (3.7); 1.2364 (0.4); 1.1929 (1.0); 1.1751 (1.9); 1.1574 (1.1); 1.0687 (0.4); -0.0002 (3.5)________________________________________________________________________________________________________ I-3: 1H-NMR (400.2 MHz, d6-DMSO): δ= 8.8170 (1.9); 8.8135 (1.9); 8.6853 (1.0); 8.6826 (1.2); 8.6787 (1.0); 8.6731 (1.0); 8.6706 (1.3); 8.6691 (1.2); 8.6665 (1.0); 8.5768 (2.0); 8.5724 (2.0); 7.9712 (0.6); 7.9684 (1.0); 7.9656 (0.7); 7.9513 (1.4); 7.9486 (2.2); 7.9458 (1.3); 7.9238 (1.1); 7.9195 (1.1); 7.9053 (1.4); 7.9009 (1.3); 7.8855 (0.7); 7.8812 (0.6); 7.5108 (0.9); 7.5074 (1.0); 7.4986 (0.9); 7.4952 (1.0); 7.4925 (1.0); 7.4891 (0.9); 7.4802 (0.8); 7.4768 (0.8); 6.2751 (1.0); 6.2584 (1.2); 6.2474 (1.2); 6.2305 (1.0); 4.3573 (0.9); 4.3404 (0.9); 4.3132 (1.1); 4.2965 (1.0); 4.0693 (13.1); 3.9632 (1.0); 3.9352 (1.2); 3.9191 (1.0); 3.8913 (0.8); 3.8142 (0.8); 3.7995 (16.0); 3.7777 (2.3); 3.7592 (0.8); 3.3224 (42.3); 2.6764 (0.4); 2.6718 (0.5); 2.6672 (0.4); 2.5252 (1.8); 2.5204 (2.9); 2.5119 (29.9); 2.5074 (58.5); 2.5028 (76.4); 2.4982 (56.1); 2.4937 (27.5); 2.3343 (0.3); 2.3296 (0.5); 2.3252 (0.3); 2.0749 (5.9); 1.3006 (3.2); 1.2821 (7.4); 1.2637 (3.1); -0.0002 (0.7)________________________ I-4: 1H-NMR (400.2 MHz, d6-DMsO): δ= 8.9502 (2.2); 8.9462 (2.2); 8.8204 (2.1); 8.8170 (2.1); 8.6820 (1.6); 8.6780 (1.7); 8.6700 (1.7); 8.6660 (1.7); 8.5820 (2.2); 8.5775 (2.2); 8.1740 (0.9); 8.1693 (1.3); 8.1643 (0.9); 8.1540 (1.1); 8.1492 (1.4); 8.1443 (0.9); 7.5326 (1.1); 7.5222 (1.1); 7.5206 (1.1); 7.5141 (1.1); 7.5022 (1.0); 7.5006 (1.0); 6.2717 (1.0); 6.2548 (1.2); 6.2442 (1.2); 6.2271 (1.1); 4.3316 (0.9); 4.3145 (0.9); 4.2885 (1.1); 4.2716 (1.1); 4.0662 (13.7); 3.9928 (1.0); 3.9650 (1.2); 3.9497 (1.0); 3.9222 (0.8); 3.8227 (1.0); 3.8106 (16.0); 3.7999 (2.0); 3.7861 (1.8); 3.7815 (1.8); 3.7636 (0.7); 3.3212 (74.0); 2.6756 (0.8); 2.6710 (1.0); 2.6666 (0.8); 2.6621 (0.4); 2.5244 (3.6); 2.5196 (5.8); 2.5111 (62.3); 2.5066 (121.8); 2.5020 (158.7); 2.4975 (116.5); 2.4930 (58.1); 2.3380 (0.4); 2.3334 (0.8); 2.3289 (1.0); 2.3244 (0.8); 1.3020 (3.4); 1.2836 (7.7); 1.2651 (3.3); 0.0079 (2.8); -0.0002 (73.2); -0.0085 (2.7)__________________________ ___________________________________________________ I-6:1H-NMR (400.2 MHz, d6-DMSO): 129 δ= 8.8406 (2.0); 8.8371 (2.0); 8.6042 (2.1); 8.6001 (2.0); 8.4768 (4.2); 8.3153 (0.6); 8.0015 (4.2); 8.0002 (4.2); 4.0224 (14.0); 3.8960 (0.4); 3.8865 (0.8); 3.8732 (16.0); 3.8590 (1.1); 3.8499 (0.7); 3.8403 (0.4); 3.7681 (0.9); 3.7495 (3.1); 3.7311 (3.1); 3.7126 (0.9); 3.3217 (77.4); 2.6795 (0.6); 2.6750 (1.3); 2.6705 (1.8); 2.6659 (1.3); 2.6612 (0.6); 2.5645 (1.0); 2.5239 (5.8); 2.5192 (8.5); 2.5105 (106.4); 2.5061 (213.9); 2.5015 (278.8); 2.4969 (198.4); 2.4924 (94.1); 2.3375 (0.6); 2.3329 (1.3); 2.3283 (1.7); 2.3238 (1.2); 2.3194 (0.6); 1.9885 (0.4); 1.3040 (3.4); 1.2856 (7.8); 1.2671 (3.2); 1.1695 (0.5); 1.1568 (1.3); 1.1545 (1.3); 1.1481 (2.2); 1.1401 (2.2); 1.1299 (0.8); 1.0995 (0.4); 1.0605 (0.8); 1.0483 (1.6); 1.0424 (1.9); 1.0297 (1.9); 1.0260 (1.3); 1.0238 (1.3); 1.0100 (0.5); 0.1459 (0.8); 0.0080 (6.5); -0.0002 (204.2); -0.0085 (6.5); -0.1497 (0.8) I-7:1H-NMR (400.2 MHz, d6-DMSO): δ= 10.2045 (0.6); 8.8555 (2.8); 8.6313 (2.8); 8.6271 (2.8); 7.6490 (3.3); 7.6443 (3.5); 6.8814 (3.4); 6.8767 (3.5); 5.7569 (6.6); 4.0179 (0.4); 4.0083 (0.7); 3.9993 (1.1); 3.9902 (1.5); 3.9808 (1.1); 3.9719 (0.9); 3.9629 (0.7); 3.9433 (14.6); 3.9293 (16.0); 3.8999 (1.3); 3.8820 (3.5); 3.8635 (3.6); 3.8450 (1.2); 3.3269 (144.2); 2.6710 (1.0); 2.5056 (119.2); 2.5021 (152.4); 2.3290 (1.0); 1.3569 (3.7); 1.3385 (7.9); 1.3201 (3.6); 1.0769 (0.6); 1.0638 (1.9); 1.0562 (3.0); 1.0478 (2.8); 1.0373 (0.9); 0.9571 (0.9); 0.9456 (2.0); 0.9393 (2.6); 0.9272 (2.4); 0.9223 (2.0); 0.9082 (0.6); 0.1458 (0.4); -0.0003 (72.6); -0.1501 (0.4) __________________________________________________ I-8:1H-NMR (400.2 MHz, ds-DMSO): δ= 8.8442 (3.2); 8.6094 (3.2); 7.5732 (3.1); 7.5637 (3.2); 7.0012 (3.0); 6.9917 (3.0); 4.0812 (14.8); 3.8691 (16.0); 3.7818 (1.2); 3.7636 (3.6); 3.7451 (3.7); 3.7270 (1.2); 3.3270 (128.5); 2.6717 (1.0); 2.5061 (134.1); 2.5024 (172.5); 2.4987 (143.8); 2.3289 (1.0); 2.2680 (0.4); 2.2559 (0.7); 2.2470 (0.8); 2.2351 (1.4); 2.2229 (0.9); 2.2145 (0.8); 2.2018 (0.4); 1.3110 (3.9); 1.2926 (8.2); 1.2742 (3.8); 1.1122 (0.9); 1.1013 (2.4); 1.0957 (2.9); 1.0806 (2.6); 1.0752 (2.8); 1.0649 (1.0); 0.7952 (1.0); 0.7842 (3.1); 0.7798 (3.2); 0.7728 (2.9); 0.7677 (3.4); 0.7564 (0.9); 0.1461 (0.4); -0.0004 (72.8); -0.1497 (0.4) I-10:1H-NMR (400.2 MHz, ds-DMSO): δ= 8.8584 (2.4); 8.8539 (2.4); 8.6343 (2.5); 8.6298 (2.4); 8.5855 (6.3); 8.3149 (0.4); 5.7553 (0.8); 3.9505 (14.7); 3.8928 (16.0); 3.8522 (1.0); 3.8337 (3.3); 3.8152 (3.4); 3.7968 (1.0); 3.3225 (137.3); 2.6749 (0.8); 2.6703 (1.1); 2.6661 (0.8); 2.5235 (3.0); 2.5098 (65.9); 2.5059 (129.2); 2.5015 (169.0); 2.4971 (124.0); 2.3327 (0.8); 2.3283 (1.0); 2.3240 (0.8); 2.0036 (0.6); 1.9952 (0.7); 1.9830 (1.3); 1.9706 (0.8); 1.9623 (0.7); 1.9497 (0.3); 1.3335 (3.7); 1.3151 (8.1); 1.2966 (3.6); 1.0651 (0.6); 1.0543 (1.7); 1.0479 (2.2); 1.0388 (1.2); 1.0336 (1.6); 1.0272 (2.0); 1.0186 (0.8); 0.9420 (0.9); 0.9331 (2.2); 0.9274 (2.2); 0.9211 (2.3); 0.9151 (2.1); 0.9037 (0.6); 0.1455 (0.3); 0.0072 (2.7); -0.0003 (70.7); -0.0008 (70.7); -0.0083 (3.1); -0.1498 (0.4) I-11:1H-NMR (400.2 MHz, ds-DMSO): δ= 8.8579 (1.1); 8.8546 (1.1); 8.6268 (1.2); 8.6230 (1.1); 7.8131 (1.2); 7.8032 (1.5); 7.7826 (1.4); 7.7640 (1.6); 7.7198 (1.4); 7.7099 (1.2); 7.4935 (0.7); 7.4752 (1.6); 7.4556 (1.0); 7.4074 (0.6); 7.3889 (0.8); 4.1619 (6.3); 4.0570 (1.3); 4.0392 (4.0); 4.0214 (4.0); 4.0036 (1.4); 3.9048 (6.9); 3.8111 (0.4); 3.7927 (1.5); 3.7743 (1.5); 3.7559 (0.5); 3.5871 (0.5); 3.5813 (0.3); 3.5693 (0.5); 3.3275 (12.5); 2.5083 (10.6); 2.5039 (13.7); 2.4996 (10.3); 1.9901 (16.0); 1.3363 (1.7); 1.3179 (3.6); 1.2995 (1.6); 1.1938 (4.4); 1.1760 (8.7); 1.1582 (4.3); 0.0078 (0.4); -0.0002 (8.9); -0.0083 (0.4)______________________________ _______________________________________________ I-12: 1H-NMR (400.2 MHz, d6-DMSO): δ= 8.8514 (2.3); 8.8469 (2.3); 8.6230 (2.4); 8.6189 (2.3); 8.3153 (1.2); 7.7710 (1.3); 7.7523 (1.7); 7.7215 (2.6); 7.6507 (1.0); 7.6314 (2.3); 7.6126 (1.6); 7.5936 (2.0); 7.5736 (0.8); 3.9639 (0.8); 3.9506 (13.8); 3.9029 (16.0); 3.8468 (1.0); 3.8284 (3.2); 3.8099 (3.2); 3.7915 (1.0); 3.3261 (799.2); 2.6753 (2.9); 2.6707 (4.0); 2.6662 (2.9); 2.6003 (0.4); 2.5241 (11.2); 2.5106 (243.5); 2.5063 (492.3); 2.5019 (647.4); 2.4974 (463.6); 2.4930 (223.2); 2.3330 (2.7); 2.3287 (3.9); 2.3241 (2.8); 1.8444 (1.1); 1.8312 (3.2); 1.8242 (3.5); 1.8127 (1.4); 1.6466 (1.5); 1.6345 (3.3); 1.6274 (3.5); 1.6139 (1.1); 1.3519 (3.5); 1.3336 (7.8); 1.3151 (3.4); 1.2332 (0.4); 0.1463 (0.4); 0.0079 (3.2); -0.0002 (95.6); -0.0084 (3.4); '-0.1496 (0.4)____________________________________ I-13:1H-NMR(4o0.2 MHz, de-DMSO): 130 δ= 8.8577 (2.1); 8.8542 (2.2); 8.6263 (2.2); 8.6222 (2.2); 7.7558 (3.3); 7.7459 (3.5); 7.6292 (1.9); 7.6264 (2.0); 7.6165 (2.0); 7.6137 (2.0); 7.4902 (4.9); 7.4802 (5.1); 7.1616 (2.1); 7.1525 (2.0); 7.1490 (2.0); 7.1398 (1.9); 5.7558 (2.2); 4.1468 (14.4); 3.8949 (16.0); 3.8019 (0.9); 3.7834 (3.2); 3.7649 (3.2); 3.7465 (1.0); 3.3240 (148.1); 2.6755 (0.6); 2.6709 (0.9); 2.6665 (0.7); 2.5245 (2.7); 2.5197 (4.0); 2.5110 (51.5); 2.5066 (105.2); 2.5020 (139.6); 2.4974 (101.8); 2.4929 (49.7); 2.3334 (0.7); 2.3288 (0.9); 2.3243 (0.6); 1.3293 (3.5); 1.3109 (8.1); 1.2925 (3.5); -0.0002 (4.8)_______________________________ ______________________________________________ I-14: 1H-NMR (400.2 MHz, d6-DMSO): δ= 8.8489 (0.7); 8.8453 (0.7); 8.8184 (0.7); 8.8131 (0.7); 8.6188 (0.7); 8.6147 (0.7); 8.1020 (0.5); 8.0962 (0.5); 8.0816 (0.5); 8.0759 (0.5); 7.5414 (0.7); 7.5209 (0.6); 3.9687 (4.4); 3.9298 (2.4); 3.9097 (4.9); 3.8381 (1.0); 3.8196 (1.0); 3.5858 (0.4); 3.5800 (0.3); 3.3257 (24.3); 2.5245 (0.7); 2.5112 (10.7); 2.5070 (20.8); 2.5025 (26.9); 2.4979 (19.6); 2.4936 (9.7); 2.2354 (0.4); 1.3493 (1.1); 1.3309 (2.4); 1.3124 (1.1); 1.2343 (0.6); 1.0914 (0.4); 1.0691 (16.0); 1.0485 (0.4); 1.0415 (1.1); 1.0359 (1.1); 1.0280 (0.8); 1.0232 (0.9); 1.0165 (0.4); 0.0078 (0.7); -0.0002 (16.2); -0.0084 (0.6)___________________________ ______________________________________________ I-15:1H-NMR (400.2 MHz, ds-DMSO): δ= 8.7799 (2.3); 8.7751 (2.4); 8.5716 (2.4); 8.5669 (2.3); 7.8567 (3.8); 7.8520 (1.4); 7.8402 (1.4); 7.8354 (4.6); 7.8303 (0.7); 7.5568 (4.4); 7.5520 (1.4); 7.5401 (1.3); 7.5354 (3.9); 5.7563 (1.8); 3.9669 (14.3); 3.9281 (0.6); 3.9190 (16.0); 3.8655 (0.9); 3.8471 (3.1); 3.8286 (3.2); 3.8101 (0.9); 3.3263 (47.6); 2.5255 (0.9); 2.5208 (1.3); 2.5121 (17.1); 2.5077 (35.1); 2.5031 (46.5); 2.4985 (33.6); 2.4939 (16.2); 1.8795 (1.1); 1.8666 (3.0); 1.8594 (3.4); 1.8481 (1.4); 1.6604 (1.3); 1.6479 (3.2); 1.6408 (3.3); 1.6271 (1.0); 1.3529 (3.5); 1.3345 (8.1); 1.3160 ​​(3.4); 0.0002 (1.8) I-16:1H-NMR (400.2 MHz, d6-DMSO): δ= 8.7728 (2.1); 8.7680 (2.2); 8.5585 (2.2); 8.5538 (2.2); 8.4753 (4.3); 8.3150 (0.4); 7.9996 (4.3); 7.9983 (4.3); 4.0230 (14.2); 3.8976 (0.5); 3.8857 (16.0); 3.8701 (1.5); 3.8606 (1.1); 3.8516 (0.7); 3.8419 (0.4); 3.7788 (0.9); 3.7604 (3.0); 3.7419 (3.1); 3.7235 (0.9); 3.3238 (229.8) ; 2.6797 (0.4); 2.6753 (1.0); 2.6707 (1.4); 2.6661 (1.0); 2.6618 (0.4); 2.5242 (3.7); 2.5194 (5.6); 2.5108 (78.3); 2.5063 (160.1); 2.5017 (212.3); 2.4972 (154.0); 2.4926 (74.8); 2.3377 (0.5); 2.3331 (1.0); 2.3286 (1.4); 2.3240 (1.0); 2.3195 (0.5); 1.3070 (3.5); 1.2886 (8.0); 1.2702 (3.4); 1.2345 (0.4); 1.1696 (0.7); 1.1591 (1.4); 1.1568 (1.4); 1.1548 (1.5); 1.1483 (2.5); 1.1403 (2.4); 1.1301 (1.0); 1.0999 (0.6); 1.0897 (0.4); 1.0821 (0.4); 1.0613 (1.0); 1.0491 (1.8); 1.0431 (2.1); 1.0304 (2.1); 1.0266 (1.6); 1.0247 (1.5); 1.0108 (0.6); -0.0003 (7.7)_______________ I-17:1H-NMR (400.2 MHz, de-DMSO):' δ = 9.1379 (4.9); 8.7903 (1.3); 8.7845 (2.3); 8.7799 (2.4); 8.5759 (2.4); 8.5713 (2.4); 8.3354 (5.2); 8.3153 (0.4); 8.0499 (1.2); 8.0353 (2.1); 8.0298 (0.8); 8.0234 (2.2); 8.0180 (1.3); 8.0124 (2.4); 8.0063 (0.8); 8.0006 (2.2); 7.8876 (0.5); 7.8758 (0.5); 7.8646 (0.5); 7.8529 (0.5); 7.4519 (2.3); 7.4463 (0.7); 7.4399 (0.4); 7.4298 (3.7); 7.4201 (0.3); 7.4134 (0.7); 7.4077 (2.7); 7.3852 (0.9); 7.3632 (0.5); 5.7557 (3.2); 4.1185 (14.4); 3.9196 (16.0); 3.8128 (0.9); 3.7943 (3.2); 3.7758 (3.3); 3.7574 (1.0); 3.3245 (187.5); 2.6756 (0.8); 2.6710 (1.1); 2.6666 (0.8); 2.6619 (0.4); 2.5245 (3.5); 2.5197 (5.2); 2.5110 (61.8); 2.5066 (124.0); 2.5021 (162.7); 2.4975 (117.2); 2.4930 (56.0); 2.3334 (0.7); 2.3289 (1.0); 2.3243 (0.7); 1.3321 (3.6); 1.3137 (8.2); 1.2953 (3.5); 1.2346 (1.2); 1.1587 (0.5); 1.0687 (0.6); -0.0002 (5.7)___________________________________________ I-18:1H-NMR (400.2 MHz, de-DMSO): δ= 9.0982 (4.9); 9.0969 (4.9); 8.7860 (2.2); 8.7813 (2.2); 8.5790 (2.3); 8.5742 (2.1); 8.4501 (4.9); 8.4489 (4.8); 8.3143 (0.6); 8.1622 (2.5); 8.1083 (1.5); 8.1069 (1.5); 8.0893 (1.6); 8.0868 (1.5); 7.9834 (0.4); 7.9798 (0.7); 7.9629 (2.3); 7.9590 (3.5); 7.9419 (1.5); 7.9384 (1.5); 7.9214 (0.5); 7.9178 (0.5); 7.7040 (1.1); 7.6992 (1.1); 7.6868 (1.0); 7.6845 (1.2); 7.6823 (1.2); 7.6802 (1.1); 7.6672 (0.8); 7.6628 (0.8); 5.7549 (3.2); 4.1168 (14.1); 3.9216 (16.0); 3.8213 (0.9); 3.8030 (3.1); 3.7845 (3.2); 3.7661 (1.0); 3.4734 (0.4); 3.4613 (0.4); 3.3312 (172.6); 2.6803 (0.6); 2.6758 (1.2); 2.6713 (1.6); 2.6667 (1.2); 2.6620 (0.6); 2.5416 (0.7); 2.5248 (4.5); 2.5200 (6.6); 2.5113 (91.3); 2.5068 (188.7); 2.5023 (249.9); 2.4977 (178.1); 2.4931 (83.7); 2.3382 (0.5); 2.3337 (1.1); 2.3291 (1.6); 2.3245 (1.1); 2.3201 (0.5); 1.3356 (3.4); 1.3172 (8.0); 1.2988 131 (3.6); 1.2350 (1.6); 0.8541 (0.4); -0.0003 (3.3) I-19:1H-NMR (400.2 MHz, ds-DMSO): δ= 9.2917 (4.7); 8.9826 (0.5); 8.7875 (2.2); 8.7825 (2.2); 8.5802 (2.3); 8.5755 (2.2); 8.5249 (1.5); 8.5209 (2.2); 8.4122 (5.3); 8.3592 (1.1); 8.3564 (1.0); 8.3537 (1.0); 8.3410 (1.0); 8.3385 (1.1); 8.3354 (1.0); 8.3150 (1.6); 8.1284 (0.5); 7.8837 (1.3); 7.8646 (2.0); 7.8103 (1.8); 7.7902 (2.7); 7.7702 (1.1); 7.5702 (0.3); 7.5520 (0.5); 7.5259 (0.4); 4.4990 (0.4); 4.4943 (0.4); 4.2174 (0.4); 4.2123 (0.4); 4.1370 (13.9); 3.9268 (16.0); 3.8228 (0.9); 3.8044 (3.1); 3.7859 (3.2); 3.7675 (0.9); 3.4193 (0.4); 3.4086 (0.4); 3.3251 (836.3); 2.6796 (1.5); 2.6752 (3.1); 2.6707 (4.3); 2.6663 (3.2); 2.6617 (1.5); 2.5840 (0.3); 2.5242 (11.8); 2.5193 (17.6); 2.5107 (254.7); 2.5063 (521.6); 2.5018 (688.6); 2.4972 (491.8); 2.4927 (234.0); 2.4219 (0.3); 2.3376 (1.4); 2.3330 (3.0); 2.3286 (4.3); 2.3240 (3.1); 2.3196 (1.4); 2.0740 (3.9); 1.3377 (3.5); 1.3193 (8.0); 1.3008 (3.7); 1.2964 (2.6); 1.0685 (0.3); 0.9195 (0.5); -0.0003 (2.0) I-20:1H-NMR (400.2 MHz, ds-DMSO): δ= 9.3120 (4.5); 9.1687 (2.3); 8.7879 (2.3); 8.7833 (2.4); 8.6507 (2.8); 8.6445 (2.9); 8.5810 (2.4); 8.5767 (2.4); 8.4516 (5.3); 8.4343 (0.8); 8.4286 (1.3); 8.4227 (0.7); 8.4091 (0.8); 8.4033 (1.3); 8.3973 (0.7); 8.3155 (0.8); 5.3934 (0.7); 5.3239 (0.4); 4.1315 (14.1); 3.9227 (16.0); 3.8209 (0.9); 3.8027 (3.1); 3.7843 (3.2); 3.7657 (1.0); 3.3239 (223.3); 2.6753 (1.8); 2.6709 (2.6); 2.6663 (1.9); 2.5242 (6.3); 2.5107 (153.7); 2.5063 (315.5); 2.5019 (419.0); 2.4974 (308.1) ; 2.4931 (153.9); 2.3376 (1.0); 2.3331 (1.9); 2.3287 (2.6); 2.3242 (2.0); 2.1781 (0.4); 2.0265 (0.4); 2.0079 (0.8); 1.9888 (1.0); 1.9739 (0.4); 1.9627 (0.3); 1.5512 (0.7); 1.4743 (0.4); 1.4589 (0.4); 1.3361 (3.8); 1.3178 (8.2); 1.2991 (4.8); 1.2586 (3.0); 1.2354 (10.7); 1.1927 (0.3); 1.1751 (0.3); 1.1558 (1.5); 1.1389 (1.4); 0.8700 (0.7); 0.8539 (2.0); 0.8360 (0.9); 0.1459 (0.5); 0.0080 (3.7); -0.0001 (125.6); -0.0083 (5.3); -0.1496 (0.6) I-21:1H-NMR (400.2MHz, d6-DMSO): δ= 8.7874 (2.1); 8.7826 (2.2); 8.5834 (2.2); 8.5787 (2.1); 8.2562 (2.9); 8.2497 (3.0); 8.1426 (6.0); 6.4079 (3.4); 6.4013 (3.4); 5.7503 (1.8); 4.0268 (14.7); 3.8986 (16.0); 3.8335 (1.0); 3.8150 (3.2); 3.7965 (3.2); 3.7781 (1.1); 3.7198 (0.3); 3.7062 (0.3); 3.6719 (0.4); 3.3842 (230.4); 2.6794 (0.6); 2.6747 (0.8); 2.6703 (0.6); 2.5282 (2.2); 2.5233 (3.6); 2.5148 (47.3); 2.5103 (96.3); 2.5058 (126.1); 2.5012 (89.6); 2.4967 (42.4); 2.3372 (0.6); 2.3325 (0.8); 2.3281 (0.6); 2.0728 (0.5); 2.0652 (0.6); 2.0571 (0.7); 2.0446 (1.3); 2.0323 (0.7); 2.0237 (0.7); 2.0112 (0.3); 1.3341 (3.5); 1.3157 (8.0); 1.2972 (3.4); 1.0206 (0.8); 1.0100 (2.1); 1.0039 (2.4); 0.9998 (1.0); 0.9944 (1.2); 0.9890 (2.1); 0.9829 (2.2); 0.9735 (0.9); 0.8249 (1.0); 0.8153 (2.4); 0.8124 (1.7); 0.8093 (2.4); 0.8030 (2.4); 0.7970 (2.4); 0.7863 (0.7); 0.1460 (0.6); 0.0186 (0.3); 0.0079 (5.2); -0.0002 (147.4); -0.0085 (5.0); -0.1495 (0.6)______________________________________________ I-22: 1H-NMR (400.2 MHz, ds-DMSO): δ= 8.8169 (2.1); 8.8112 (2.2); 8.7805 (2.2); 8.7758 (2.4); 8.5723 (2.3); 8.5675 (2.3); 8.3150 (0.5); 8.1007 (1.6); 8.0949 (1.6); 8.0803 (1.8); 8.0746 (1.8); 7.5422 (2.2); 7.5217 (2.0); 3.9684 (14.4); 3.9204 (16.0); 3.8651 (0.9); 3.8467 (3.1); 3.8282 (3.2); 3.8098 (0.9); 3.3241 (274.4); 2.6752 (1.1); 2.6708 (1.5); 2.6662 (1.1); 2.5243 (3.7); 2.5195 (5.8); 2.5108 (87.3); 2.5064 (180.1); 2.5018 (239.4); 2.4972 (173.2); 2.4927 (83.6); 2.3379 (0.6); 2.3332 (1.2); 2.3286 (1.6); 2.3241 (1.2); 2.2679 (0.4); 2.2552 (0.6); 2.2482 (0.7); 2.2357 (1.2); 2.2292 (0.6); 2.2233 (0.7); 2.2161 (0.7); 2.2036 (0.4); 1.3514 (3.6); 1.3330 (8.2); 1.3145 (3.5); 1.2342 (0.4); 1.0822 (0.4); 1.0689 (1.3); 1.0622 (2.8); 1.0567 (1.4); 1.0486 (1.2); 1.0417 (3.3); 1.0354 (3.1); 1.0276 (2.5); 1.0229 (2.9); 1.0161 (1.4); 1.0025 (0.3); -0.0002 (8.7)___________________________________________ I-23:1H-NMR (400.2 MHz, de-DMSO):' δ= 8.7834 (2.2); 8.7788 (2.3); 8.5753 (2.3); 8.5707 (2.2); 7.7958 (1.3); 7.7771 (1.7); 7.7744 (1.7); 7.7557 (1.6); 7.4727 (2.6); 7.4546 (2.3); 7.3084 (0.6); 7.0474 (2.0); 7.0259 (1.9); 4.3321 (13.9); 4.0382 (0.7); 4.0204 (0.7); 3.8992 (16.0); 3.8199 (0.9); 3.8014 (3.2); 3.7829 (3.3); 3.7659 (3.4); 3.7554 (4.2); 3.7424 (3.4); 3.5549 (3.4); 3.5423 (4.1); 3.5307 (2.6); 3.3264 (109.7); 2.6760 (0.4); 2.6715 (0.6); 2.6669 (0.5); 2.5249 (1.8); 2.5201 (2.8); 2.5115 (36.8); 2.5071 (75.5); 2.5025 (99.7); 2.4980 (71.3); 2.4935 (34.0); 2.3338 (0.4); 2.3293 (0.6); 2.3248 (0.4); 1.9892 (3.3); 1.3351 (0.3); 1.3245 (3.5); 1.3062 (8.1); 1.2877 (3.5); 1.2492 (0.6); 1.2347 (1.3); 1.1930 (0.9); 1.1752 (1.8); 1.1574 (0.9); 0.9639 (0.4); 0.9457 (0.7); 0.9279 (0.4); 0.8537 132 (0.4); 0.0080 (0.5); -0.0002 (15.4); -0.0084 (0.5) I-24:1H-NMR (400.2 MHz, d6-DMSO): δ= 8.7825 (2.4); 8.7780 (2.5); 8.5753 (2.5); 8.5709 (2.4); 7.9525 (0.6); 7.7708 (1.4); 7.7521 (1.8); 7.7488 (1.3); 7.7276 (1.8); 7.7234 (2.7); 7.6520 (1.0); 7.6324 (2.3); 7.6137 (1.6); 7.5968 (1.3); 7.5933 (1.9); 7.5892 (1.3); 7.5771 (0.7); 7.5728 (0.8); 4.0380 (0.5); 4.0203 (0.5); 3.9650 (0.6); 3.9522 (14.0); 3.9155 (16.0); 3.8573 (0.9); 3.8388 (3.1); 3.8203 (3.2); 3.8017 (1.0); 3.3287 (184.3); 2.8912 (4.3); 2.7316 (3.6); 2.6759 (0.5); 2.6715 (0.7); 2.6671 (0.5); 2.5247 (2.1); 2.5113 (43.2); 2.5070 (87.2); 2.5025 (114.6); 2.4980 (82.5); 2.4937 (40.0); 2.3339 (0.5); 2.3294 (0.7); 2.3248 (0.5); 1.9891 (2.0); 1.8456 (1.1); 1.8327 (3.3); 1.8255 (3.5); 1.8140 (1.4); 1.6466 (1.5); 1.6344 (3.4); 1.6273 (3.5); 1.6138 (1.0); 1.3560 (3.5); 1.3376 (8.0); 1.3191 (3.4); 1.1929 (0.6); 1.1752 (1.1); 1.1574 (0.6); 0.0079 (0.6); -0.0002 (15.8); -0.0084 (0.6) I-25:1H-NMR (400.2MHz, d6-DMSO): δ= 8.8011 (2.4); 8.7963 (2.5); 8.6018 (2.5); 8.5976 (2.4); 8.3999 (3.5); 8.3943 (3.4); 8.3849 (0.3); 8.3156 (2.0); 8.0215 (0.4); 8.0152 (0.4); 7.8477 (1.9); 7.8427 (2.6); 7.8383 (1.8); 7.7337 (0.8); 7.7294 (0.9); 7.7147 (1.5); 7.7103 (1.5); 7.6953 (0.7); 7.6909 (0.9); 7.5805 (0.4); 7.5695 (0.4); 7.5646 (0.4); 7.5054 (0.4); 7.5003 (0.4); 7.4920 (0.6); 7.4873 (0.8); 7.4663 (1.1); 7.4613 (0.8); 7.4528 (0.7); 7.4485 (0.8); 7.4149 (1.2); 7.3880 (1.3); 7.3797 (1.4); 7.3670 (0.8); 7.3611 (1.8); 7.3424 (0.8); 7.3398 (0.8); 3.9450 (16.0); 3.9174 (1.0); 3.8987 (3.5); 3.8801 (3.6); 3.8703 (13.9); 3.4391 (0.4); 3.4324 (0.3); 3.4177 (0.4); 3.3240 (1010.3); 3.2813 (0.4); 2.6797 (2.6); 2.6753 (5.4); 2.6707 (7.2); 2.6662 (5.3); 2.6404 (0.4); 2.6196 (0.5); 2.5241 (21.1); 2.5193 (33.6); 2.5107 (424.6); 2.5063 (869.0); 2.5017 (1146.8); 2.4972 (822.2); 2.4927 (393.8); 2.4009 (0.3); 2.3374 (2.3); 2.3331 (4.9); 2.3286 (7.1); 2.3240 (5.2); 2.3196 (2.5); 1.3890 (3.7); 1.3704 (8.4); 1.3519 (3.6); 1.2352 (1.2); 0.1461 (0.8); 0.0079 (6.8); -0.0002 (219.7); -0.0085 (8.1); 0.0263 (0.5); -0.1500 (0.9) I-26:1H-NMR (400.2MHz, d6-DMSO): δ= 8.8012 (2.3); 8.7967 (2.5); 8.6023 (2.4); 8.5979 (2.4); 8.3626 (3.3); 8.3568 (3.4); 7.9134 (3.2); 7.9077 (3.1); 7.7655 (2.0); 7.7603 (0.9); 7.7521 (2.2); 7.7434 (2.6); 7.7355 (1.0); 7.7300 (2.3); 7.3811 (2.2); 7.3759 (0.8); 7.3589 (4.2); 7.3419 (0.7); 7.3367 (2.0); 5.7560 (2.8); 3.9473 (16.0); 3.9237 (1.0); 3.9052 (3.3); 3.8900 (15.1); 3.8683 (1.0); 3.3246 (74.2); 2.6759 (0.5); 2.6713 (0.7); 2.6669 (0.5); 2.5248 (2.1); 2.5112 (44.0); 2.5069 (89.7); 2.5024 (117.9); 2.4979 (85.2); 2.4935 (41.7); 2.3336 (0.5); 2.3292 (0.7); 2.3246 (0.6); 2.0748 (0.3); 1.3877 (3.4); 1.3693 (7.8); 1.3508 (3.4); 0.1459 (0.4); 0.0079 (3.4); -0.0002 (98.0); -0.0085 (3.8); -0.1496 1044__________________________________________________________________________________ I-27: 1H-NMR (400.2 MHz, d6-DMSO): δ= 8.9423 (2.1); 8.9403 (2.3); 8.9367 (2.3); 8.9347 (2.1); 8.7844 (2.1); 8.7798 (2.2); 8.5783 (2.2); 8.5735 (2.2); 8.3157 (2.4); 8.3110 (1.7); 8.3053 (1.5); 8.2903 (1.8); 8.2846 (1.9); 7.7767 (2.2); 7.7748 (2.1); 7.7561 (2.1); 7.7541 (2.0); 3.9811 (14.0); 3.9224 (16.0); 3.8754 (0.9); 3.8572 (3.0); 3.8388 (3.1); 3.8205 (0.9); 3.3248 (703.0); 2.6798 (1.6); 2.6754 (3.6); 2.6708 (5.0); 2.6662 (3.6); 2.6617 (1.7); 2.5244 (14.0); 2.5196 (20.8); 2.5109 (289.1); 2.5064 (597.2); 2.5018 (790.9); 2.4972 (565.6); 2.4927 (267.4); 2.3378 (1.6); 2.3332 (3.6); 2.3287 (4.9); 2.3241 (3.6); 2.3195 (1.6); 1.9437 (1.0); 1.9312 (2.4); 1.9225 (3.3); 1.9134 (1.4); 1.8277 (1.5); 1.8179 (3.2); 1.8093 (2.4); 1.7962 (0.9); 1.3585 (3.3); 1.3400 (7.8); 1.3216 (3.2); 0.1460 (4.1); 0.0322 (0.5); 0.0228 (0.8); 0.0080 (34.8); -0.0002 (1044.9); -0.0085 (33.9); -0.0172 (1.7); -0.0253 (0.9); -0.0354 (0.5); -0.1495 (4.2) Application examples Boophilus microplus: Injection Test Solvent: dimethyl sulfoxide To produce a suitable preparation of the active compound, 133 dissolved 10 mg of the active compound in 0.5 ml of solvent and the concentrate is diluted with solvent until the desired concentration is reached. 1 μΙ of the drug solution is injected into the abdomen of 5 wet, adult female bovine ticks (Boophilus microplus). The animals are transferred to trays and kept in a climate chamber. After 7 days, the presence of eggs, especially fertile eggs, is monitored. Eggs whose fertility was not visible from the outside are kept in the climatic chamber for approximately 42 days until the hatching of the larvae. 100% efficiency means none of the ticks have laid fertile eggs, 0% means all eggs are fertile. In this test, for example, the following compounds of the preparation examples have an effect of 95% at an application dose of 20 µg / animal: I-6. In this test, for example, the following compounds of the preparation examples showed good activity of 90% at an application dose of 20 pg / animal: I-10. Ctenocephalides felis: Oral test Solvent: dimethyl sulfoxide For the preparation of a suitable preparation of active compound, 10 mg of active compound is mixed with 0.5 ml of dimethylsulfoxide. Dilution with citrated bovine blood allows obtaining the desired concentration. Approximately 20 cat fleas (Ctenocephalides felis) were introduced into a sealed chamber, with gauze on top and bottom. A metal cylinder is placed in the chamber, the lower side of which is sealed with 134 parafilm. The cylinder contains the preparation of the active compound with the blood that can be absorbed by the fleas through the Parafilm membrane. After 2 days mortality is determined as a %. 100% means all fleas are dead; 0% means that none of the fleas died. In this test, for example, the following compounds from the preparation examples showed good activity of 100% at an application rate of 100 ppm: I-1, I-5, I-6. In this test, for example, the following compounds from the Preparation Examples showed 90% activity at an application rate of 100 ppm: I-9, I-10, I-11, I-14. In this test, for example, the following compounds from the preparation examples showed an activity of 80% at an application rate of 100 ppm: I-8. Diabrotica balteata: spray test Solvent: 78 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: Alkyl aryl polyglycol ether To produce a suitable preparation of the active compound, 1 part by weight of the active compound is dissolved with the indicated parts by weight of solvent and made up with water containing an emulsifier concentration of 1000 ppm to the desired concentration. To prepare additional test concentrations, it is diluted with water containing emulsifier. Previously swollen wheat grains (Triticum aestivum) are incubated 135 in a multiwell plate with agar and a little water for one day (5 seeds per well). Germinated wheat grains are sprayed with a preparation of the active compound at the desired concentration. Each well is infected with 10-20 beetle larvae of the species Diabrotica balteata. After 7 days, the effect is determined as a %. 100% means that all wheat plants have grown like the untreated, uninfected control; 0% means that no wheat plants have grown. In this test, for example, the following compounds in Preparation Examples have 100% effect at a dose of 160 μg / well: I-12, I15, I-16, I-17, I-19, I- 20, I-21, I-22, I-23, I-24, I-25, I-26. In this test, for example, the following compounds in Preparation Examples have an effect of 80% at a dose of 160 µg / well: I-13, I-18. Myzus persicae: Oral test Solvent: 100 parts by weight of acetone To produce a suitable preparation of the active compound, 1 part by weight of the active compound is dissolved with the indicated parts by weight of solvent and made up with water to the desired concentration. Transfer 50 μΙ of the active compound preparation to microtiter plates and make up with 150 μl IPL41 insect medium (33% + 15% sugars) to a final volume of 200 μl. The plates are then sealed with Parafilm, which can be punctured by a mixed population of green peach aphids (Myzus persicae), found in a second microtiter plate, and thus absorb the solution. After 5 days, the effect is determined as a %. 100% 136 means all aphids have died; 0% means that no aphids have died. In this test, for example, the following compounds from the preparation examples have 100% effect at a dose of 4 ppm: I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8, I-9, I-10, I-11, I-12, I- 13, I-14, I-15, I-16, I17, I-18, I-19, I-20, I-21, I-22, I-23, I-24, I-26. Myzus persicae: spray test Solvent: 78 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: Alkyl aryl polyglycol ether To prepare a suitable preparation of the active compound, 1 part by weight of the active compound is dissolved with the indicated parts by weight of solvent and made up with water containing an emulsifier concentration of 1000 ppm to the desired concentration. To prepare additional test concentrations, it is diluted with water containing emulsifier. Chinese cabbage (Brassica pekinensis) leaf discs infested with all stages of the green peach aphid (Myzus persicae) are sprayed with a preparation of the active compound at the desired concentration. After 5 days, the effect is determined as a %. 100% means all aphids have died; 0% means that no aphids have died. In this test, for example, the following compounds from the preparation examples have 100% effect at a dose of 100 g / ha: I-1, I-4, I-5, I-6, I-8, I-9, I-20. 137 In this test, for example, the following compounds from the preparation examples have an effect of 90% at a dose of 100 g / ha: I-3, I-7, I-10, I-11, I-12, I-13, I-14, I-15, I-16, I-21, I-22. In this test, for example, the following compounds of the preparation examples have an effect of 70% at a dose of 100 g / ha: I-18. Phaedon cochleariae: Spray test Solvent: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: Alkyl aryl polyglycol ether To prepare a suitable preparation of the active compound, 1 part by weight of the active compound is dissolved with the indicated parts by weight of solvent and made up with water containing an emulsifier concentration of 1000 ppm to the desired concentration. To prepare additional test concentrations, it is diluted with water containing emulsifier. Leaf discs of Chinese cabbage (Brassica pekinensis) are sprayed with a preparation of the active compound at the desired concentration, and after drying, larvae of the mustard leaf beetle (Phaedon cochleariae) are introduced. After 7 days, the effect is determined as a %. 100% means that all beetle larvae have died; 0% means that no beetle larvae have died. In this test, for example, the following compounds from the preparation examples have 100% effect at a dose of 100 g / ha: I-5, I-6, I-7, I-9, I-10, I-14. 138 Spodoptera frugiperda: spray test Solvent: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: Alkyl aryl polyglycol ether To prepare a suitable preparation of the active compound, 1 part by weight of the active compound is dissolved with the indicated parts by weight of solvent and made up with water containing an emulsifier concentration of 1000 ppm to the desired concentration. To prepare additional test concentrations, it is diluted with water containing emulsifier. Corn (Zea mays) leaf discs are sprayed with a preparation of the active compound at the desired concentration and, after drying, are infested with caterpillars of the armyworm (Spodoptera frugiperda). After 7 days, the effect is determined as a %. 100% means all caterpillars have died; 0% means that no caterpillars have died. In this test, for example, the following compounds from the preparation examples have 100% effect at a dose of 100 g / ha: I-2, I-3, I-5, I-6, I-8, I-9, I-10, I-11, I-12, I-14, I-15, I-16, I-17, I-18, I-19, I-20, I-21, I- 22, I-23, I24, I-25, I-26. Tetranychus urticae: Spray test, resistant to OP Solvent: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: Alkyl aryl polyglycol ether To prepare a suitable preparation of the active compound, 139 dissolves 1 part by weight of the active compound with the indicated parts by weight of solvent and is completed with water containing an emulsifier concentration of 1000 ppm until the desired concentration is reached. To prepare additional test concentrations, it is diluted with water containing emulsifier. Broad bean (Phaseolus vulgaris) leaf discs infected with all stages of the common spider mite (Tetranychus urticae) are sprayed with a preparation of the active compound at the desired concentration. After 6 days, the effect is determined as a %. 100% means that all mites have died; 0% means that no mites have died. In this test, for example, the following compounds from the preparation examples showed good activity of 90% at an application rate of 20 g / ha: I-10. 140

Claims

1. Compounds, characterized in that they are of Formula (I) (FORMULA I) wherein R1 is (C1-4)alkyl, (C1-4)cyanoalkyl, (C1-4)alkoxy-(C1-4)alkyl, (C1-4)haloalkyl, (C2-4)alkenyl, (C2-4)haloalkenyl, (C2-4)alkynyl, (C2-4)haloalkynyl or (C3-6)cycloalkyl, R2 is hydrogen, (C1-4)alkyl, (C1-4)haloalkyl, (C1-4)cyanoalkyl, (C1-4)hydroxyalkyl, (C1-4)alkoxy-(C1-4)alkyl, (C1-4)haloalkoxy-(C1-4)alkyl, (C3-6)cycloalkyl, (C3-6)cycloalkyl-(C3-6)cycloalkyl, (C1-4)alkyl-(C3-6)cycloalkyl, halo(C3-6)cycloalkyl, cyano(C3-6)cycloalkyl, (C1-4)alkylthio-(C1-4)alkyl, (C1-4)haloalkylthio-(C1-4)alkyl, (C1-4)alkylsulfinyl-(C1-4)alkyl, (C1-4)haloalkylsulfinyl-(C1-4)alkyl, (C1-4)alkylsulfonyl-(C1-4)alkyl or (C1-4)haloalkylsulfonyl-(C1-4)alkyl, R 3 represents an aryl optionally mono- or disubstituted with the same or different substituents or is a saturated ring,partially saturated or heteroaromatic optionally mono- or disubstituted with the same or different substituents, wherein at least one C atom is replaced by a heteroatom from the N, O, or S group, wherein in each case there may optionally be at least one carbonyl group and / or wherein in each case the substituents may comprise: cyano, halogen, nitro, acetyl, amino, (C1-4)alkyl, (C1-4)haloalkyl, (C1-4)cyanoalkyl, (C1-4)hydroxyalkyl, (C1-4)alkoxy-(C1-4)alkyl, (C2-4)alkenyl, (C2-4)haloalkenyl, (C2-4)cyanoalkenyl, (C2-4)alkynyl, (C2-4)haloalkynyl, (C2-4)cyanoalkynyl, (C3-6)cycloalkyl, (C3-6)cycloalkyl-(C3-6)cycloalkyl, (C1-4)alkyl-(C3-6)cycloalkyl, (C1-4)alkoxy, (C1-4)haloalkoxy, (C1-4)cyanoalkoxy, (C1-4)alkoxy-(C1-4)alkoxy, (C1-4)alkoxyimino, -N=C(H)-O(C1-4)alkyl, -C(H)=NO(C1-4)alkyl, (C1-4)haloalkyl-(C1-4)alkoxyimino, (C1-4)alkylthio, (C1-4)haloalkylthio, (C1-4)alkylthio-(C1-4)alkyl, (C1-4)alkylsulfinyl,(C1-4)haloalkylsulfinyl, (C1-4)alkylsulfinyl-(C1-4)alkyl, (C1-4)alkylsulfonyl, (C1-4)haloalkylsulfonyl, (C1-4)alkylsulfonyl-(C1-4)alkyl, (C1-4)alkylsulfonyloxy, (C1-4)alkylcarbonyl, (C1-4)haloalkylcarbonyl, aminocarbonyl, (C1-4)alkylaminocarbonyl, di-(C1-4)alkylaminocarbonyl, (C1-4)alkylsulfonylamino, (C1-4)alkylamino, di-(C1-4)alkylamino, aminosulfonyl, (C1-4)alkylaminosulfonyl, di-(C1-4)alkylaminosulfonyl, (C1-4)alkylcarbonylamino, V represents, in each case, a (C3-6)cycloalkyl or aryl optionally monosubstituted or disubstituted with the same or different substituents or optionally is a saturated, partially saturated or heteroaromatic ring, optionally monosubstituted or disubstituted with the same or different substituents, in which at least one C atom is replaced by a heteroatom from the N, O or S group,wherein in each case there may optionally be at least one carbonyl group and / or wherein in each case the substituents may comprise: cyano, halogen, nitro, acetyl, amino, (C1-4)alkyl, (C1-4)haloalkyl, (C1-4)cyanoalkyl, (C1-4)hydroxyalkyl, (C1-4)alkoxy-(C1-4)alkyl, (C2-4)alkenyl, (C2-4)haloalkenyl, (C2-4)cyanoalkenyl, (C2-4)alkynyl, (C2-4)haloalkynyl, (C2-4)cyanoalkynyl, (C3-6)cycloalkyl, (C3-6)cycloalkyl-(C3-6)cycloalkyl, (C1-4)alkyl-(C3-6)cycloalkyl, (C1-4)alkoxy, (C1-4)haloalkoxy, (C1-4)cyanoalkoxy, (C1-4)alkoxy-(C1-4)alkoxy, (C1-4)alkoxyimino, -N=C(H)-O(C1-4)alkyl, -C(H)=NO(C1-4)alkyl, (C1-4)haloalkyl-(C1-4)alkoxyimino, (C1-4)alkylthio, (C1-4)haloalkylthio, (C1-4)alkylthio-(C1-4)alkyl, (C1-4)alkylsulfinyl, (C1-4)haloalkylsulfinyl, (C1-4)alkylsulfinyl-(C1-4)alkyl, (C1-4)alkylsulfonyl, (C1-4)haloalkylsulfonyl, (C1-4)alkylsulfonyl-(C1-4)alkyl, (C1-4)alkylsulfonyloxy, (C1-4)alkylcarbonyl, (C1-4)haloalkylcarbonyl,aminocarbonyl, (C1-4)alkylaminocarbonyl, di-(C1-4)alkylaminocarbonyl, (C1-4)alkylsulfonylamino, (C1-4)alkylamino, di-(C1-4)alkylamino, aminosulfonyl, (C1-4)alkylaminosulfonyl, di-(C1-4)alkylaminosulfonyl, (C1-4)alkylcarbonylamino, X is a heteroaromatic ring system of the Q2 series, (FORMULA Q2), R4 is hydrogen, (C1-4)alkyl, (C1-4)haloalkyl, (C1-4)cyanoalkyl, (C1-4)alkoxy-(C1-4)alkyl, (C1-4)haloalkoxy-(C1-4)alkyl, (C2-4)alkenyl, (C2-4)haloalkenyl, (C2-4)alkynyl, (C2-4)haloalkynyl or (C3-6)cycloalkyl, R 5 , R 6 are, independently of each other, hydrogen, cyano, halogen, (C1-4)alkyl, (C1-4)haloalkyl, (C2-4)alkenyl, (C2-4)haloalkenyl, (C2-4)alkynyl, (C2-4)haloalkynyl, (C3-6)cycloalkyl, (C3-6)cycloalkyl-(C3-6)cycloalkyl, (C1-4)alkyl-(C3-6)cycloalkyl, (C1-4)haloalkyl-(C3-6)cycloalkyl, cyano-(C3-6)cycloalkyl, halo-(C3-6)cycloalkyl, (C1-4)alkoxy, (C1-4)haloalkoxy, (C1-4)alkoxyimino, (C1-4)haloalkoxyimino,(C1-4)alkylthio, (C1-4)haloalkylthio, (C1-4)alkylsulfinyl, (C1-4)haloalkylsulfinyl, (C1-4)alkylsulfonyl, (C1-4)haloalkylsulfonyl, (C1-4)alkylsulfonyloxy, (C1-4)haloalkylsulfonyloxy, (C1-4)alkylcarbonyl or (C1-4)haloalkylcarbonyl, n is 0, 1 or 2. 8 Claims follow,